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Summary.
The reperfusion injury after myocardial ischemia is relevant in the clinical setting,
after cardiopulmonary bypass for cardiac surgery, after PTCA and stenting and
after cardiopulmonary resuscitation. The components of the reperfusion injury
considered in this study were myocardial stunning and reperfusion arrhythmias.
Calcium antagonists have been shown to be beneficial in attenuating the
myocardial reperfusion injury in the in vitro and in vivo laboratory setting
(Lamping, Gross 1985, Przyklenk and Kloner 1988, Taylor 1990, Ehring 1992,
Gross and Piper 1992). However systemic administration of a dose of calcium
antagonist, large enough to attenuate the myocardial reperfusion injury in the
clinical setting, would inevitably lead to unwanted systemic side effects of the
drug.
The aim of this study was to investigate the hypothesis that an adequate dose of
verapamil administered timeously, directly into the ischemic myocardium, would
attenuate the reperfusion injury, either when administered from the onset of
ischemia, or from 3 minutes before reperfusion.
The anesthetized open chest porcine model of myocardial ischemia (15 min total
LAD occlusion) and reperfusion was employed in this study. A low dose of
verapamil (0.5 mg/8mt or 0.0625mg/mt), a high dose of verapamil (2mg/8m or
2
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O.25mg/ml), or vehicle (saline) (8ml) was infused over 8 minutes, directly into
the LAD coronary artery supplying the ischemic segment. The infusion was
started either at the onset of ischemia, or from 3 minutes before reperfusion.
The time taken for the various parameters to return to pre ischemic values was
compared between the different groups.
The results showed that the high dose of verapamil (2mg) attenuated the
reperfusion injury both when administered from the onset of ischemia, and when
administered from 3 minutes before reperfusion, compared to either the low dose
of verapamil, or the saline infusions. The high dose of verapamil groups had a
faster recovery of both systolic contractile function and diastolic function and a
lower incidence of ventricular fibrillation on reperfusion. There were no systemic
effects of verapamil infusion in any of the groups.
The clinical setting of cardiac surgery expressly lends itself to the clinical
application of this finding. There is direct access to the coronary arteries both
before ischemia and before reperfusion. A small dose of calcium channel
blocking drug, with no systemic effect can be administered into the aortic root at
the onset of ischemia, just prior to cardioplegia (when the heart is still warm),
and after rewarming a few minutes prior to removal of the aortic cross clamp.
3
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Opsomming.
Die reperfusie besering na miokardiale isgemie is klinies relevant na
kardiopulmonêre omleiding vir hart chirurgie, na kardiologiese PTKA en stut
prosedures en na kardiopulmonale ressussitasie. Die komponente van die
reperfusie besering wat in hierdie studie oorweeg is, is miokardiale tydelike
omkeerbare onderdrukking (stunning) en reperfusie arritmieë.
Kalsium antagoniste is gewys om effektief te wees in beperking van die
reperfusie besering in beide in vitro en in vivo laboratorium eksperimente
(Lamping, Gross 1985, Przyklenk en Kloner 1988, Taylor 1990, Ehring 1992,
Gross en Piper 1992). Sistemiese toediening van 'n dosis kalsium kanaal
blokker, voldoende om die miokardiale reperfusie besering in die pasiënt te
beperk, lei egter tot ongewenste sistemiese newe effekte van die middel.
Die doel van die studie was om die hipotese te ondersoek dat 'n voldoende dosis
verapamil, wat betyds direk toegedien is aan die isgemiese miokardium, die
reperfusie besering sal beperk, ongeag of dit toegedien is vanaf die begin van
isgemie, of van 3 minute voor reperfusie.
Die vark model van miokardiale isgemie en reperfusie is aangewend in die studie.
Die varke was tydens die eksperiment onder narkose, met die borskas oop, en
15 minute totale LAD okklusie is toegepas. 'n Lae dosis verapamil (0.5mg/8ml
4
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of 0.0625 mg/mt), of hoë dosis veraparnil (2mg/8mt of 0.25mg/mt), of saline
(8mt) is oor 8 minute toegedien direk in die LAD arterie wat die isgemiese
segment voorsien. Die infuus is begin direk na die aanvang van isgemie, of 3
minute voor die aanvang van reperfusie. Die tyd geneem vir terugvoer van
parameters na pre isgemiese waardes is tussen die groepe vergelyk.
Die resultate toon dat die hoë dosis veraparnil die reperfusie besering beperk in
vergelyking met die lae dosis veraparnil of saline infusies, ongeag of dit van die
begin van isgemie, of van 3 minute voor reperfusie toegedien word. Die groepe
wat die hoë dosis veraparnil ontvang het, het vinniger herstel van sistoliese en
diastoliese funksie getoon en het'n laer insidensie van reperfusie disritmieë,
gewys. Geen sistemiese effekte van veraparnail infuus is waargeneem nie.
Die kliniese toepassing van hierdie bevinding is by uitstek geskik vir toepassing
tydens kardiopulmonale omleiding by kardiale chirurgie. Daar is direkte toegang
tot koronêre arteries voor isgemie en voor reperfusie. 'n Klein dosis kalsium
antagonis, met weglaatbare sistemiese effekte, kan toegedien word in die aorta
wortel met die aanvang van isgemie, net voor kardioplegie toediening (hart
steeds warm), en na verwarming, 'n paar minute voor verwydering van die aorta
kruis klem.
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1. Literature review
1.1 Calcium and the reperfusion injury.
1.2 Physiology.
1.3 Calcium channel blocking drugs and the reperfusion injury.
1.4 Hypothesis and proposed clinical application.
6
Stellenbosch University http://scholar.sun.ac.za
1.1 Calcium and reperfusion injury.
1.1.1 Introduction.
1.1 .2 Pathophysiology of the reperfusion injury.
1.1.2.1
1.1.2.2
Ischemia.
Reperfusion.
1.1.3 Secondary effects of calcium in the reperfusion injury.
1.1.3.1
1.1.3.2
1.1.3.3
1.1.3.4
1.1.3.5
Mitochondrial permeability transition pore (MPTP)
opening.
Gap junction mediated intracellular communication
(GJMIC).
Apoptosis.
Decreased nitric oxide (NO) production.
Production of oxidants.
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1.1 Calcium and the reperfusioninjury.
Experiments at Harvard Medical School in 1975 (Heyndrickx et al. 1975) in
which the consequences of ischemia and reperfusion on myocardial function
were examined, revealed prolonged dysfunction with eventual return of normal
contractile activity once ischemia was relieved. In 1982 Braunwald and Kloner
termed this condition myocardial stunning.
During the 1980's there was a growth of interest in this phenomenon due to the
advent of thrombolytic therapy and other forms of interventional
revascularization.
Early animal studies demonstrated that once the myocardium becomes severely
ischemic, restoration of blood flow is a pre-requisite for myocardial salvage.
However restoration of blood flow after transient ischemia is associated with
arrhythmias, myocardial stunning (reversible prolonged dysfunction), acceleration
of necrosis in cells, and microvascular injury. These events were termed
reperfusion injury.
Despite the evidence of a detrimental reperfusion injury in animal studies, the
clinical experience demonstrated that reperfusion therapy in patients with
evolving acute myocardial infarction is always preferable to permanent coronary
8
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occlusion. Also studies aimed at attenuating the effects of the reperfusion injury
in the clinical setting yielded controversial results (Bolli, 1991, Rahimtoola 1985;
Serruys 1984; Labovitz 1987). Therefore the reperfusion injury was considered
by many to be either non-existent or clinically irrelevant compared to the
ischemic injury.
However in contrast to cardiologists, many cardiovascular surgeons were
convinced of the clinical relevance of the reperfusion injury in the clinical setting
following cardioplegic arrest during surgery (Garcia Dorado 2004).
The reperfusion injury must be differentiated from ischemic injury. Firm evidence
for reperfusion injury would require:
• The appearance of an entirely new phenomenon at the time of
reperfusion.
• Proof that a reperfusion associated event can be diminished in
severity by an intervention given only at the time of reperfusion (apie
1989).
In recent years, due to better understanding of the mechanisms of cell
injury/death during myocardial ischemia/reperfusion, the reperfusion injury, as a
well documented and clinically relevant phenomenon, is widely accepted.
9
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The following are salient facts with regard to cardiomyocyte death associated
with reperfusion (Garda Dorado 2004):
1 . It occurs mainly during the initial minutes of reflow.
2. It involves rupture of the cell membrane.
3. It is due to mechanisms originating in the cardiomyocyte (not blood born
celis).
4. It can be prevented by interventions applied at the time of reperfusion.
The reperfusion injury is relevant in the following clinical settings:
1. After acute coronary occlusion (normothermic).
2. After extra corporeal circulation (hypothermic).
3. After donor graph preservation (deep hypothermia).
4. During resuscitation after cardiac arrest.
Cellular mechanisms of the reperfusion injury:
1.1.2.1 Ischemia.
This is characterized by a rapid reduction in ATP content. When the cytosolic
ATP decreases into the window between 100 f.1Mand zero, contracture of the
myocytes develops. Shortly thereafter when the ATP stores are depleted, this
10
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shortening stays fixed as the cross bridges between actin and myocin remain
intact (Altschuld 1985, Nichols 1990). This ischemic contracture is moderate
and causes no structural damage. It does however make the myocyte more
fragile and therefore susceptible to mechanical damage (SchlOter 1996) (Fig.
1.3).
Consequences of ischemic AlP depletion (Piper 2004) (Fig. 1.1, fig. 1.2).
• Intracellular acidosis develops due to anaerobic glycolysis and
accumulation of lactate (Cobbe 1980) .
• To combat intracellular acidosis the Na+/H+ exchanger extrudes hydrogen
ions in exchange for sodium ions (Lazdunski 1995) and the Na+ IHCO-3
symporter transports sodium and bicarbonate into the cell. This results in
an accumulation of cytosolic sodium. Neubauer (1987) reported that
[Na "l, increased during ischemia in proportion to the reduction of
intracellular pH.
• Activity of the Na +IK + ATP-ase is inhibited rapidly after the onset of
ischemia due to a decrease in extracellular pH and ATP depletion. The
Na +IK + ATP-ase is exquisitely sensitive to extracellular pH (Piwnica-
Worms 1985, Lazdunksi 1985) and failure of the Na+ IK+ ATP-ase results
in the inability of the cell to extrude sodium. Large increases in
intracellular sodium ion concentration during ischemia do not occur
without the inhibition of Na +IK + ATP-ase activity (Hoerter 1986).
• Intracellular sodium ion concentrations are further increased due to the
fact that sodium influx through the fast sodium channel (3 - 6 jJg/g/min)
Il
Stellenbosch University http://scholar.sun.ac.za
(Cohen 1982) during the upstroke of the action potential, is not affected
during the first 10 - 20 minutes of ischemia (Sperelakis 1988). The initial
upstroke of the action potential during ischemia remains unchanged until
the heart reaches quiescence (Tani 1990).
• Marked elevation of intracellular sodium ion concentration during ischemia
has been confirmed with nuclear magnetic resonance (Pike 1988, Balschi
1985, Van Echteld 991), and with ion selective microelectrodes (Wilde
1986).
• The cytosol is now sodium overloaded and the cell membrane depolarized.
This causes the Na+/Ca2+ exchanger to operate in reverse mode,
(extruding sodium ions in exchange for calcium ions) leading to an
absolute increase in the total intracellularcalcium ([Ca2+];l (Tani 1990,
Silverman 1994).
• Reversal of the Na+/Ca2+ exchanger is the major source of calcium
overload during ischemia (Tani 1990).
• The Na+/Ca2+ exchanger reverses during hypoxia/ischemia once ATP
depletion has occurred, and is not rate limiting for intracellular calcium
loading after complete ATP depletion. Pharmacological inhibition of the
exchanger at this point will reduce calcium loading and improve cell
survival later at reoxygenation (Ziegelstein 1992, Hagney 1992).
• Sarcolemmal and sarcoplasmic reticulum calcium ATP-ase fail (ATP
depleted) (Chemnitus 1985), resulting in an inability to extrude excess
calcium.
12
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• Steenbergen (1987) reported that cytosolic free calcium ion concentration
started to increase after 6 minutes of ischemia and reached 3J1M after 9 -
15 minutes.
• Cell outcome following hypoxia/ischemia is tightly correlated with the
absolute level of [Ca2+Jj achieved at the end of the ischemic period prior
to reperfusion. Single rat myocytes will hypercontract immediately if
[Ca2 +Jj exceeds 5J1M just prior to reperfusion. However if the cell is
reoxygenated before [Ca2+Jj reaches 2 - 3 JIM, the cell will relengthen
and survive (Snowdone 1985, Allshire 1987).
1.1.2.2 Reperfusion (reoxygenation) (Fig. 1.1, Fig. 1.2).
On reperfusion, extracellular fluid is quickly replaced by perfusate with a normal
pH, this results in rapid reactivation of Na+/K + ATP-ase. In addition, restoration
of mitochondrial oxidative phosphorylation, recovery from tissue acidosis and
washout of ischemic metabolites on reperfusion together with an increased
intracellular sodium ion concentration, accelerates Na +/K + ATP-ase function
(Tani 1990). The Na+/K+ ATP-ase accounts for most of the decline in
intracellular sodium during reperfusion (Sejersted 1988).
Due to the recovery of oxydative phosphorylation, the ATP necessary for the
functioning of the contractile machinery and for the functioning of Ca2+ ATP-ase
and Na +/K + ATP-ase is immediately available.
13
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Contractile function is activated and the cell membrane is repolarized by Na+IK +
ATP-ase before the excess calcium has been extruded (Piper 2003). Besides
repolarizing the cell membrane the functioning sodium pump (Na+IK + ATP-ase)
also restores the [Na+]j :[Na+] 0 gradient. This gradient is the major driving force
for calcium efflux via the Na+ICa2+ exchanger. The Na+ICa2+ exchangers
switches again to the forward mode, extruding calcium in exchange for sodium.
Extrusion of calcium from the cell is dependant on:
• The plasma membrane calcium pump (Ca2+ ATP-ase) which has a high
affinity for calcium, but a limited capacity and can be overwhelmed .
• The Na+/Ca2+ exchanger has a greater capacity (10 times that of the
sarcolemmal Ca2+ ATP-ase) (Carafoli 1985, Barry 1985), but is dependant
on sodium movement. It transports calcium outwards during diastole and
inwards during systole.
Thus the lowering of total intracellular calcium is not immediate.
During ischemia, due to ATP depletion and acidosis, the sarcoplasmic reticulum
and mitochondria cannot take up the excess calcium ions accumulating in the
cytosol (Mandel 1982, Williams 1983). On reperfusion however, ATP
production is restored and intracellular acidosis is corrected, this will allow the
sarcoplasmic reticulum and mitochondria to accumulate calcium ions (Meno
1984, Nakanishi 1982, Williams 1983). Once the sarcoplasmic reticulum is full
14
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it starts releasing calcium leading to oscillatory cytosolic calcium concentration
elevations (Siegmund 1997, Schafer 2001). Calcium spontaneously released
from a calcium overloaded sarcoplasmic reticulum may induce adjacent
sarcoplasmic reticulum calcium release via the calcium release channel, resulting
in a propagating wave of increasing [Ca2+]j' This triggers calcium overload
induced hypercontracture (Berlin 1989, Wier 1991, Williams 1992).
The explanation for the hypercontracture caused by the excessive cytosolic
calcium oscillations during the first few moments of reperfusion is as follows:
Rapid beat to beat changes in cardiac performance (contractility) are brought
about largely by variations in the amount of calcium bound to troponin C.
Maximum isometric tension is generated when all available troponin C molecules
are bound to calcium (Katz 2001 b). The most important determinant of the
number of troponin C molecules to be bound, is the amount of calcium released
by the sarcoplasmic reticulum during the excitation/contraction coupling (Katz
2001, b).
All striated muscle myocytes have a transverse tubular system (t-tubules) that
opens into the extracellular space. The composition of the fluid in the t-tubules
is identical to that of the extracellular fluid: high calcium and sodium
concentration and low potassium concentration. The t-tubule membrane is an
extension of the sarcolemma and its purpose is to carry the action potentials
deep into the myosite (Katz 2001; c).
15
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Although electrical depolarization of the cell is essential for rapid activation,
muscle contraction depends on calcium which must bind to troponin C. There is
a massive inward concentration and electrical gradient for calcium. The calcium
concentration in the extracellular fluid is > 1mM which is 5000 times higher than
the calcium concentration in the cytosol of the resting heart (0,2IlM). The
calcium concentration required to saturate troponin C is less than 10llM
(Kretsinger 1977).
The initial event for excitation of the myocyte is a brief inward (depolarizing)
sodium current. This leads to a partial depolarization of the cell membrane,
enough to open voltage gated calcium channels. A small amount of calcium
enters the cell, following the electrochemical gradient and binds to the ryanodine
receptor (calcium release channel) on the sarcoplasmic reticulum. This triggers
a much larger calcium release from the sarcoplasmic reticulum (Katz 2001; c).
The normal influx of calcium ions via the voltage gated calcium channels is 0,1 -
0,3 pmol/g/min (1nmol 19/beat) (LulIman 1983).
The most important voltage gated calcium channels are the L-type calcium
channels. Opening of these channels is prolonged, and they are also known as
dihydropyridine receptors as they bind calcium channel blocking drugs (Katz
2001; c).
There are two calcium cycles important to the cardiomyocyte (Katz 2001; d):
16
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1. Extracellular cycle:
Calcium moves across the sarcolemma between the extra cellular fluid and
the cytosol.
2. Intracellular cycle:
Calcium moves between the cytosol and the stores in the sarcoplasmic
reticulum.
The extracellular cycle triggers the intracellular cycle and the intracellular cycle
provides the calcium needed to bind troponin C. The sarcoplasmic reticulum is
the primary source and sink controlling intracellular calcium ion transients that
mediate myofilament interaction (Fabiato 1983, Wier 1990, Barry 1993). The
sarcoplasmic reticulum calcium release determines the cytosolic calcium
concentration. The higher the cytosolic calcium concentration during each cycle,
the stronger the contraction.
Calcium release channels in the cardiomyocyte sarcoplasmic reticulum (ryanodine
receptors) are highly regulated: (Katz 2001; d)
• Increased entry of extracellular calcium through the L-type plasma
membrane calcium channels increases calcium release from the
sarcoplasmic reticulum.
17
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• The L-type plasma membrane calcium channels regulate calcium release
by the sarcoplasmic reticulum, as well a sarcoplasmic reticulum calcium
content (Barry 1993, Beukelmann 1988, Sperelakis 1988).
• Most importantly: The larger the size of the calcium store in the
sarcoplasmic reticulum, the more calcium is released.
• ATP exerts an allosteric effect that promotes channel opening.
• Xanthines (caffeine) initiate calcium release.
• Acidosis inhibits channel opening.
In skeletal muscles the intracellular sarcoplasmic reticulum calcium stores are
large and release so much calcium that all the potential interacting sites between
actin and myosin are activated (all troponin C is bound). Maximum tension is
developed on every contraction. This is an all or nothing response.
Cardiomyocytes have the ability to vary contractility, therefore calcium fluxes
across the sarcoplasmic reticulum are regulated. Under normal conditions the
sarcoplasmic reticulum calcium stores are variable, but much smaller than those
of skeletal muscles. A varying, but smaller amount of calcium is released, and
fewer troponin C molecules are bound. This allows the contractile response to
be graded (Katz 2001; d).
However, in the first few moments of reperfusion all the excess calcium
accumulated in the cytosol during ischemia is taken up by the sarcoplasmic
reticulum, resulting in a calcium overloading of the sarcoplasmic reticulum.
18
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Every time the sarcolemma depolarizes and the voltage gated calcium channels
open, there is an inward movement of a relatively small amount of calcium
(extracellular cycle) which triggers the intracellular cycle. Because of the large
sarcoplasmic reticulum calcium store early in reperfusion, a large amount of
calcium is released and a large proportion of troponin C molecules are bound
leading to hypercontracture. Furthermore, the maximal rate of calcium ion influx
through the L-type voltage gated sarcolemmal calcium channels during early
reperfusion is 0,5jJmol/g/min, 2 - 5 times more than normal (Tani 1988, 1989)
Therefore these channels may account for significant increases in cytosolic
calcium ion concentration during early reperfusion, and induce further
accumulation of calcium ions by the sarcoplasmic reticulum.
In support of the importance of the roll of sarcoplasmic reticulum calcium release
in hypercontracture and myocardial stunning, Mitchell (1993), using isolated rat
hearts subjected to 20 minutes of ischemia followed by 40 minutes of
reperfusion, reported that when sarcoplasmic reticulum calcium release on
reperfusion was inhibited with sodium dantrolene, myocardial stunning was
attenuated. Systolic and diastolic function was improved as compared to
controls. It is important to note that dantrolene most likely inhibits sarcoplasmic
calcium ion release by interfering with the coupling of the sarcoplasmic reticulum
to sarcolemmal depolarization (it prevents the extracellular cycle from triggering
the intracellular cycle). (Honerjager 1983, Hiraoka 1985). Ryanodine (a direct
sarcoplasmic reticulum calcium channel inhibitor) administered either before
19
Stellenbosch University http://scholar.sun.ac.za
ischemia or during early reperfusion also attenuates stunning in the isolated rat
heart (Du Toit 1992).
In conclusion, hypercontracture and stunning on reperfusion are the result of
intracellular calcium accumulation during ischemia, and further calcium
accumulation and rapid calcium cycling on reperfusion (Fig. 1.3).
Reperfusion induced hypercontracture leads to a marked rise in end-diastolic
pressure and ventricular wall stiffness during the first few minutes of
reperfusion. (Piper 2004).
Cell death occurs almost exclusively in the first minutes of reperfusion and hyper
contracture is the primary cause of cardiomyocyte necrosis (contraction band
necrosis) in this early stage. Thereafter, for the next few hours, other causes
lead to a further increase in cell death, either by necrosis or apoptosis (Piper
2003, Humphrey 1986).
The first few minutes of reperfusion represent a window of opportunity for
cardio protection: (Piper 2004).
• Reduction of sarcoplasmic reticulum calcium oscillations by:
Inhibition of calcium influx into cells.
Inhibition of calcium release by the sarcoplasmic reticulum
(Siegmund 1997, Ladilov 1995, Schafer 2000).
20
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Inhibition of the contractile machinery until intracellular
calcium concentration has normalized by:
Acidosis (Ladilov 1995, Schafer 2000).
Inhibition of troponin I (protein kinase G)
(Garcia-Dorado 1992, Siegmund 1991).
The later reperfusion injury - during the first two hours of the reflow, includes
the following pathological processes: (Piper 2003, Padilla 2000, Schluter 1994).
1. The endothelium of blood vessels becomes permeable leading to interstitial
edema.
2. Endothelial cells are activated, express adhesion molecules, release
cytokines and stop producing nitric oxide.
3. This leads to adherence, activation and accumulation of neutrophils and
monocytes in the myocardium.
4. These activated leucocytes release oxygen free radicals and proteolytic
enzymes which further damage myocytes and endothelial cells.
5. Adherent leucocytes, in addition to tissue contracture and interstitial
edema, plug blood vessels causing slow/no ref low phenomena.
21
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Left: During ischemia the cardiomyocyte accumulates sodium via the sodium/hydrogen
exchanger (1) , the sodium/bicarbonate symporter (2) and failure of the sodium/potassium
ATPase (4) Due to increased intracellular sodium and the membrane depolarization, the
sodium/calcium exchanger switches to reverse mode. This results in intracellular calcium
accumulation.
At the onset of reperfusion the energy recovery reactivates the sodium/potassium ATPase
(4). This restores the sodium gradient and reduces the intracellular sodium. The cell
membrane is repolarized. The sodium/calcium exchanger switches to forward mode and
extrudes the accumulated calcium.
Right: Typical changes in cytosolic calcium and cell length. in a single cardiomyocyte during
ischemia and reperfusion. Cells elongated in normoxia , rigor shortened during ischemia and
hypercontracted on reperfusion. During ischemia intracellular calcium rises; at the onset of
reperfusion intracellular calcium declines (as the calcium is taken up by the SR). but
immediately starts to oscillate. During these oscillations extensive contracture develop.
H.Piper Ann Thorac Surg 2003; 75: S644 - S648
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Ca2+
Ischemia
(30-60 min)
Reperfusion
(5-15 min)
Fig.1.2
Cytosolic calsium overload during ischemia due to reverse mode operation
of the sodium/calcium exchanger as a result of increased intracellular
sodium and membrane depolarization. The intracellular sodium is increased
due to sodium/hydrogen exchange, sodium/bicarbonate symport and the
failure of sodium/potassium ATPase. The latter also causes membrane
depolarization. At the onset of reperfusion , sodium/potassium ATPase is
restored, intracellular sodium decreases ; the membrane repolarized and
the SR sequesters excess cytosolic calcium. Spontaneous release and
reuptake of calcium by the sarcoplasmic reticulum leads to cytosolic
oscillations of calcium
H Piper Cardiovasc Res 2004; 61: 365 - 371
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Figure 1.3
Electron micrographs of single cardiomyocytes:.
A: During normoxia.
B: During anoxia following rigor development.
C: Reoxygenation following hypercontracture. Note the numerous
spherical blebs.
HS Silverman Cadiovasc Res 1994: 28: 581 -597
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Because this does not relate to the primary aim of this thesis (see section 1.4) it
will be dealt with in relative brevity, and only for completeness sake.
1.1.3.1 Mitochondrial permeability transition pore (MPTP) opening.
The main function of mitochondria under normal conditions is ATP production
through oxidative phosphorylation. The mitochondrial inner membrane is usually
impermeable to all, but a few selected ions.
Under certain conditions latent mechanisms within the mitochondria can be
activated. The mitochondria will then be converted from organelles that support
the life of the cell to those that actively induce both apoptotic and necrotic cell
death. This conversion is mediated by the opening of a nonspecific pore in the
mitochondrial inner membrane, known as the mitochondrial permeability
transition pore (MPTP). This pore normally remains closed, but can open under
conditions of cellular stress, with dire consequences (Halestrap 1999).
During reperfusion mitochondrial calcium overload (increased mitochondrial
matrix calcium concentration) is the key factor responsible for MPTP opening,
and the extent of MPTP opening is a critical determinant of the reperfusion injury
(Halestrap 2004). At the onset of reperfusion mitochondria are again able to
respire and generate a membrane potential to drive ATP synthesis, but this also
results in a rapid accumulation of calcium within the mitochondria, leading to
22
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calcium overload. The high intramitochondrial phosphate, oxidative stress and
low adrenergic nucleotide concentrations, present at this time, all potentiate the
effect of calcium (Silverman 1994).
Calcium triggers a conformational change that causes the opening of the MPTP.
When the MPTP opens, the permeability barrier of the inner membrane becomes
disrupted with two major consequences (Halestrap 1998):
• Small molecular weight solutes can now move freely across the
membrane, but proteins cannot, and as a result they exert a colloid
osmotic pressure, which causes the mitochondria to swell. The inner
membrane expands easily, but the outer membrane ruptures, spilling
proteins such as cytochrome C, which triggers apoptosis.
• The inner membrane becomes freely permeable to protons. This
leads to the uncoupling of oxidative phosphorylation and the
mitochondria convert from ATP synthesis to ATP hydrolysis.
If the pores remain open these changes will cause irreversible damage to the cell
resulting in necrotic death. Even if the pores close, mitochondrial swelling and
outer membrane rupture may be sufficient to set the apoptotic cascade in motion
(Crompton 1999).
These pathways are summarized as follows:
23
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Ischemia/reperfusion
~
cal1um overload
MPTP opening
~
Mitochondrial swelling and outer membrane rupture
~
Release of cytochrome C
~
Moderate insult, pores reseal /'
MPTP close
Activation of caspases
~ Severe insult, pores stay open
ATP production maintained
MPTP stay open
ATP depleted
Apoptosis Necrosis
1.1.3.2 Gap junction mediated intracellular communication (GJMIC).
GJMIC is essential in electrical impulse propagation in the heart and altered
GJMIC may lead to arrhythmias (Garcia Dorado 2004). Gap junctions are
specialized membrane areas that contain tightly packed channels that allow
direct connection of the cytoplasm of two adjacent cells (Harris 2001; Sosinsky
2000).
During reperfusion GJMIC mediates cell to cell propagation of hypercontracture
and cell death (Garcia Dorado 1989).
24
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Most of the cell death induced by transient ischemia occurs during the first few
minutes of reperfusion due to contraction band necrosis (Humphrey 1986).
Hypercontracted, dead cardiomyocytes are connected to other dead myocytes in
well defined areas of contraction band necrosis. Cell to cell propagation of
hypercontracture is dependent on induction of a rapid increase in intracellular
calcium concentration in the adjacent cell (Garcia Dorado 2000).
The rapid rise in intercellular calcium concentration in the second cell is probably
caused by passage of sodium from the hypercontracting cell through the gap
junction and a subsequent reverse mode operation of the Na + /Ca2 + exchanger in
the second cell (Ruiz-Meana 1999).
Propagation stops when an adjacent less injured cell is able to cope with sodium
and calcium influx efficiently and so prevents severe calcium overload.
1.1.3.3 Apoptosis.
Apoptosis indicates cell death and removal without activation of an inflammatory
process. Caspase activation is required (Hunot 2001).
Prolonged ischemia causes necrosis while reperfusion enhances apoptosis
(Eefting 2004; Gottlieb 1994). Mitochondrial calcium overload on reperfusion
triggers opening of MPTP which results in the release of cytochrome C which in
turn activates caspase (Borutaite 2003).
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Ion channels play an important role in calcium overload and hypercontracture
(Piper 2003). There is no debate on the role of membrane channel blockers in
the prevention of calcium overload and hyper contracture; the question is
whether apoptosis will also be reduced.
Blocking calcium fluxes through L-type calcium channels does seem to inhibit
apoptosis and reduce infarct size; as Gourine (2001) demonstrated with the use
of clevidipine in the porcine model and Jang (2003) with the use of nicardipine in
the canine model.
1.1.3.4 Decreased nitric oxide (NO) production.
Endothelial NO is formed from L-arginine by the constitutive form of the enzyme
NO-synthase. NO is an important regulator of vascular tone, prevents platelet
and leukocyte adherence and is a scavenger of super oxide (Moncada 1999).
During myocardial ischemia and reperfusion endothelial dysfunction occurs
during early reperfusion, and is an important event in the development of
ischemia-reperfusion injury (Tsao 1990).
Early reperfusion results in impaired endothelium dependant vasodilatation which
is the result of reduced NO formation or rapid inactivation of NO by oxygen-
derived free radicals (Lefer 1997). Augmentation of NO levels during reperfusion
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preserved endothelial function, reduced neutrophil accumulation and decreased
myocardial injury (Lefer 1996). Thus NO appears to be a crucial factor
mediating protection against the ischemia-reperfusion injury.
Calcium antagonists can release NO from coronary micro vessels (Zhang 1998),
reduce infarct size and preserve endothelial function by maintaining the local bio
availability of NO (Gourine 2001).
1.1.3.5 Production of reactive oxygen species.
Polymorphonuclear leucocytes are a major source of toxic oxidants in vivo,
causing tissue injury in ischemia and reperfusion (Feng 1996).
Calcium ions are a key mediator in the regulation of oxidant formation by
polymorphonuclear leucocytes and in maintaining optimal function of these cells
(Romeo 1975). The production of superoxide anions by stimulated neutrophils is
augmented when calcium ions are available in the extracellular environment
(Goldstein 1975). Pharmacological stimulation of calcium ion movement across
the neutrophil membrane produces a burst of metabolic activity culminating in
the release of oxidants (Korchak 1978).
Calcium antagonists can suppress the capacity of neutrophils to produce
oxidants, even though drug sensitive calcium channels have not been
demonstrated in neutrophils (Pennington 1986). Thus the ability of these drugs
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to inhibit oxidant production seems to be attributable to some mechanism other
than their calcium channel blocking properties.
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1.2 Physiology
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1.2 Physiology.
Ion movement through these channels is down electrochemical gradients and no
energy expenditure is required. These channels are membrane protein
complexes made up of several subunits: a1, a2, 13, y, o.
Voltage gated ion channels contain ion selective pores that favour the passage
of the single ion species.
The channel has three states:
Closed (resting)
Open
Closed (inactive/refractory)
The same depolarizing signal that opens the resting channel causes it to close in
a refractory state (closing takes slightly longer). Reactivation in the case of
sodium and calcium channels occurs when the membrane is repolarized by
outward potassium currents (Fig. 1.4).
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Fig.1.4
The three states of the voltage gated ion channel. In the refractory
(inactive) state, it cannot be reopened. In the resting (recovered)
state, the channel can be opened by membrane depolarization.
A Katz Physiology of the heart.
Lippencott Williams and Wilkens
Philadelphia. 3rd Ed. 2000; 457
Stellenbosch University http://scholar.sun.ac.za
1.2.1.1 Sodium fluxes and sodium channels.
The sodium currents that generate initial upstroke of the cardiac action potential
serve two major roles (Katz 2001; c).
1. To propagate the action potential.
2. The large inward depolarizing sodium current opens the plasma membrane
L-type voltage gated calcium channels. Calcium influx through these
channels in turn triggers calcium release from the internal stores.
In 1952 Hodgkin and Huxley described two different gating mechanisms in the
sodium channel; mand h. Opening the m gate activates (opens) the channel.
Closing the h gate inactivates (closes) the channel (Fig. 1.4).
Depolarization opens (activates) the m channel leading to an inward current of
sodium. The same depolarization initiates a slower process that closes the h
gate so inactivating the channel. Sodium ions can enter only when both gates
are open thus only in the brief time between the opening of the m gate and
closing of the h gate.
The h gate can only be reopened after repolarization has returned the membrane
potential to its resting level. Then the cycle can be reactivated (Katz 2001 g).
Influx of Na + through the fast Na+ channel is 20 - 40 nmol/g/beat or 3 - 6
.umol/g/min (Cohen 1992).
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1.2.1.2 Calcium currents and calcium channels.
Calcium channels become activated and inactivated in the same way as sodium
channels but in the case of calcium, the transitions occur at more positive
membrane potentials and more slowly; therefore, calcium channels have been
termed slow channels. Opening of the voltage gated calcium channels in the
plasma membrane allows relatively small amounts of calcium to enter the cell,
driven by a large electrochemical gradient. (Extracellular [Ca2+] = 1mM;
cytosolic [Ca2+] during diastole = 0.2 JIM hence the 5000 fold gradient) (Katz
2001 h).
The most important calcium channel is the L-type calcium channel. It's opening
is prolonged and it is also called the dihydropyridine receptor because it binds
with high affinity to this class of calcium channel blocking drugs (Katz 2001 c).
In normal myocytes calcium ion influx through this channel is less than
1nmol/g/beat or 0,1 - 0,3 Jlmol/g/min (LulIman 1983). This amount of Ca2+
must be extruded each cycle by mainly the Na+/Ca2+ exchanger (Wier 1990).
The calcium that enters the cell in this way has five functions (Katz 2001 c):
1. It causes further depolarization of the cell.
2. It activates potassium channels thus initiating repolarization.
3. It provides calcium for binding to troponin C (only a small amount).
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4. It fills the stores in the sarcoplasmic reticulum, maintaining contractility.
5. Most importantly it triggers calcium release from the sarcoplasmic
reticulum, thus activating contraction.
Sarcolemmal voltage gated slow calcium ion channels regulate sarcoplasmic
calcium content and sarcoplasmic reticulum calcium release (Barry 1993,
Beukelman 1988, Sperelakis 1988) and Ca2+ entry accross the cell membrane is
the major regulatory site for the force of contraction (Sperelakis 1988).
The Treppe effect can be explained as follows: More frequent opening of
voltage gated calcium channels leads to more calcium entering the cell. This has
two consequences (Katz 2001f):
1. Larger sarcoplasmic reticulum calcium stores.
2. More frequent triggering of calcium release from the sarcoplasmic
reticulum.
The net result is an increase of tension development.
Post extrasystolic potentiation is caused when a premature depolarization
increases calcium entry via the voltage gated calcium channels and so increases
the calcium stores in the sarcoplasmic reticulum. The premature depolarization
prolongs the opening time of the voltage gated calcium channel. All the extra
calcium is taken up by the sarcoplasmic reticulum thus adding to the store, and
so to the tension of subsequent contractions (Katz 2001 f).
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Cyclic AMP: l3-adrenergic agonists and POE inhibitors both increase cyclic AMP
(cAMP). cAMP-dependant protein kinases cause phosphorylation of plasma
membrane voltage gated calcium channels. Phosphorylation increases the
probability of the calcium channel being open, leading to increased calcium entry
and so a positive inotropic effect (Katz 2001 f).
Calcium channel blocking drugs modify L-type calcium channel opening so as to
reduce calcium entry. This results in:
1. Smaller sarcoplasmic reticulum calcium stores.
2. Diminished calcium triggered calcium release from the sarcoplasmic
reticulum.
Both of the above lead to a negative inotropic effect (Katz 2001 f).
Despite their quite different chemical structures, verapamil, nifedipine, diltiazem
and bepridil all depress Ca2+ influx through the slow (L-type) channels by a direct
action on the channel itself (Vogel 1979, Molyvdas 1983). Binding of a drug to
a receptor within an ion channel is influenced by the state of the channel, which
is determined by the membrane potential. Binding of the calcium antagonists is
approximately 1000 times stronger to inactivated channels than to resting
channels (Sanguinetti 1984). During ischemia the sarcolemma is depolarized and
the calcium channels are all in the inactive state.
34
Stellenbosch University http://scholar.sun.ac.za
Voltage gated calcium channels are membrane protein complexes made up of
several subunits: 0.1, 0.2, p, y, 8. Two forms of calcium channel 0.1 peptide are
found in muscle. The larger molecule is found in L-type channels responsible for
the depolarizing calcium currents that create the plateau of the cardiac action
potential. (The smaller molecule is the voltage sensor that opens calcium release
channels of skeletal muscle sarcoplasmic reticulum).
L-type calcium channels are the most abundant calcium channels in
cardiomyocytes and vascular smooth muscle cells. The long lasting depolarizing
currents carried by these channels are responsible for the plateau of the cardiac
action potential (Katz 2001; g).
L-type calcium channels are located in the transverse tubular system (t-tubules)
very close to the calcium release channels of the sarcoplasmic reticulum
(ryanodine receptors). This is important for calcium triggered calcium release.
T-type calcium channels are not concentrated in the t-tubules (Bogdanov 1995).
The 0.1 subunit of the L-type calcium channel is the substrate for cAMP-
dependant protein kinase-catalyzed phosphorylation. This increases the chance
of the channel being open and increases the number of available channels
(Cachelin 1983), thus causing a positive inotropic effect. Phosphorylation
therefore, increases the slow inward Ca2+ current during the action potential,
thus elevating [Ca2]; directly (by increasing the mean open time and number of L-
type channels) and indirectly (by Ca2+ induced Ca2+ release from the
35
Stellenbosch University http://scholar.sun.ac.za
sarcoplasmic reticulum), and thus increasing the force of contraction (Sperelakis
1988, Bean 1984).
In addition to the closed state (mode 0), l-type calcium channels can be open in
two states: Brief openings (mode 1) and long lasting opening (mode 2). Both
modes are natural states of the channel (Bean 1990). cAMP induced
phosphorylation initiated by p adrenergic agonists favours the appearance of
mode 2 as do strong depolarizations (Yue 1990, Pietrobon and Hess 1990).
Ca2+ influx via the l-type Ca2+ channel is inhibited by cGMP-mediated
phosphorylation of a protein involved in l-type Ca2+ channel function
(Fischmeister 1987). Acetylcholine depresses Ca2+ influx via the l-type
channels by reversing cAMP elevation produced by various agonists (Wahler
1986, Josephson 1982), and by elevation of cGMP levels (Macleod 1986).
The myocardial slow (l-type) Ca2+ channels are selectively blocked by acidosis
(Chesnais 1975, Vogel 1977). As pH decreases [Ca2+]; decreases, and
contractions become depressed and abolished as a function of the degree of
acidosis. Due to the fact that acidosis has little effect on the normal fast action
potential, (only Ca2+ channels are blocked), excitation - contraction uncoupling
occurs (Sperelakis 1988).
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Due to the fact that Ca2+ flux through the L-type Ca2+ channels is modulated by
pH and ATP availibility, the channels are inactivated within 5 - 15 minutes after
the induction of myocardial ischemia (Sperelakis 1988).
The T-type calcium channels are inactivated more rapidly than the L-type calcium
channels. Once the membrane is depolarized the T-type channels quickly close
and become refractory (Katz 2001 g).
T-type calcium channels also have less conductance and so admit less calcium
than L-type channels. The threshold of T-type channels is lower so they are
opened by smaller depolarizations than L-type channels (Nilius 1985, Tsien
1998). This explains their role in generating pacemaker potentials in the SA
node.
However in atria, ventricles and the His-Purkinje system, the transient currents
carried by the T-type calcium channels occur at the same time as the much
larger sodium currents so that they play almost no role in membrane
depolarization (Arreola 1991).
The ability of T-type calcium channels to slowly admit small amounts of calcium
leads to the generation of prolonged calcium signals that regulate cell growth
and proliferation (Katz 2001 g).
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1.2.1.3 Potassium channels.
These are the most primitive of the voltage gated channels, they are also the
most complex. The diversity of potassium channel structure is the reason why
so many types of potassium channels are found in the human heart (Katz
2001 g). Futher discussion of the potassium channels is beyond the scope of
this thesis.
There are two mechanisms by which the cardiomyocyte extrudes calcium across
the cell membrane.
1. ATP dependant calcium pumps (Ca2+-ATP-ase).
2. Na+/Ca2+ -exchanger.
The Na+/Ca2+ -exchanger has a greater capacity than the Ca2+ -ATP-ase pump,
but a lower affinity for calcium. The Ca2+ -ATP-ase is the primary mechanism for
calcium extrusion but it is easily overwhelmed thus requiring an additional high
capacity system namely the Na+/Ca2+ exchanger (Katz 2001 c).
1.2.2.1 The plasma membrane calcium pump (Ca2+ ATP-ase).
Like all the ATP-dependant cation pumps:
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• It uses energy derived from hydrolyses of ATP to actively transport ions.
• It is an intrinsic membrane protein with 10 transmembrane segments.
• It contains ATP binding, phosphorylation and cation-binding sites in the
cytosol.
In its basal state the plasma membrane Ca2+ -ATP-ase is inhibited by a large C-
terminal loop in the cytosol. The inhibitory effect is reversed when it binds to
calcium-calmodulin complex. Hence elevated intracellular calcium concentration
stimulates calcium efflux and so helps avoid cytosolic calcium overload (Katz
2001f).
Even though the sarcolemmal Ca2+ ATP-ase has a relatively high affinity for Ca2+
it plays a small (almost negligible) role in removal of Ca2+ from cardiomyocytes
(Carafoli 1985). Its capacity for removing Ca2+ is less than one tenth that of the
Na+/Ca2+ exchanger (Barry 1993). Activity of the Ca2+ ATP-ase is reduced
during ischemia, resulting in a reduction in Ca2+ efflux and net Ca2+ uptake by
the cell (Chemnitius 1985).
1.2.2.2 The sodium calcium exchanger.
This antiport can carry sodium and calcium in both directions across the plasma
membrane. The amount of each, and the direction of transport is determined by
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the ratio between sodium and calcium concentrations on either side of the
membrane.
The main driving force for calcium efflux via the Na+ICa2+ exchanger is the
sodium gradient: [Na+] ;I[Na+]o. This gradient is established by the Na+IK+ -ATP-
ase. Thus the energy source for the "uphill" transport of calcium out of the cell
via the Na+ICa2 + exchanger is the ATP used by the Na+IK +-ATP-ase to establish
the sodium gradient.
The sodium calcium exchanger is responsible for about 80% of calcium efflux
from the cardiomyocyte. It is a large protein with 11 membrane spanning a.
helices organized in two clusters (Katz 2001 c).
It mediates Ca2+ efflux during diastole, and in the steady state Na+ICa2+
exchange extrudes all the Ca2+ that enters the sarcolemmal voltage gated Ca2+
channels, and so contributes to the decline of the [Ca2+]j transient (Wier 1990).
During diastole the Na+ICa2+ exchanger also competes with the sarcoplasmic
reticulum Ca2+ ATP-ase for Ca2+ uptake out of the cytosol, hence it helps
regulate Ca2+ content of the sarcoplasmic reticulum (Wier 1990, Barry 1993).
Electrogenisity.
The sodium calcium exchanger is electrogenic as the it transports three sodium
ions in one direction and one calcium ion in the opposite direction. However, ion
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fluxes through the exchanger are 1000 times slower than those through the
voltage gated ion channel so the exchanger contributes no more than a few
millivolts to the membrane potential (Sjodin 1980).
In the resting cell the negative intracellular potential draws sodium into the cell:
Sodium follows the electrical and chemical gradient. Calcium is exchanged, so
during diastole the exchanger favours calcium efflux. During systole when the
cell is depolarized (the inside of the cell becomes positive) and intracellular
sodium concentration is higher, three sodium ions will now leave the cell and be
exchanged for a single calcium ion. Thus during systole there is a calcium influx.
Calcium efflux during diastole helps to relax the heart and calcium influx during
systole increases contractility. Sodium is the driver, following the
electrochemical gradient, calcium is just exchanged (Katz 2001 c).
During ischemia the cell membrane is depolarized and [Na+]j is increased (Van
Echteld 1991), therefore sodium will be extruded in exchange for calcium (Tani
1990, Silverman 1994). However, rapid repolarization of the cell membrane on
reperfusion will favour calcium efflux in exchange for sodium.
The driving force for calcium efflux is determined by:
1. The sodium gradient across the plasma membranes. [Na"}: [Na2+]o
(Barcenas-Ruiz 1987).
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2. The calcium gradient across the plasma membrane:
(Beukelmann 1989).
3. The membrane potential (Barcenas-Ruiz 1987, Beukelmann 1989).
The sodium-calcium exchanger and contractility (Katz 2001c).
If [Ca2+]0:[Na+]0 remains constant, the relative rates of sodium and calcium influx
remains constant and there is no change in contractility.
If [Na +]0 is increased, more sodium will enter the cell causing increased calcium
efflux and thus decreased intracellular calcium and decreased contractility.
If [Ca2+]0 is increased the ratio of [Ca2+]0:[Na+]0 will increase. Sodium efflux will
increase in order to restore equilibrium and calcium influx will increase,
increasing contractility.
If [Na+]j increases there is more sodium to compete with calcium ions for binding
to the intracellular side of the receptor, so calcium efflux will decrease resulting
in increased intracellular calcium and increased contractility.
If [Na "l, decreases it will have the opposite effect resulting in more calcium ion
efflux and thus decreasing contractility. Cardiac glycosides make use of these
principles. These drugs increase contractility by inhibiting the Na+IK +-ATP-ase ,
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resulting in increased intracellular sodium concentration, hence decreasing
calcium efflux via the sodium calcium exchanger.
Regulation of the sodium calcium exchanger.
Although the sodium calcium exchanger is not ATP dependant, phosphorylation
of the exchanger by ATP will accelerate the exchange (Blaustein 1977, DiPoio
1974).
When intracellular calcium is high, calcium binds to a high affinity site on the
exchanger in the cytosol, separate from the calcium transport site and stimulates
the turnover of the exchanger (this helps prevent intracellular calcium overload).
Protein kinases A and C and calcium-calmodulin kinase may also activate the
exchanger.
It is possible that calcium entry via the sodium calcium exchanger inhibits
calcium release from the sarcoplasmic reticulum, but this is controversial
(LeBlanc and Hume 1990).
1.2.2.3 The sodium pump (Na + IK +AlP-ase).
This pump uses energy from ATP hydrolysis for the active transport of sodium
and potassium across the plasma membrane. It clears the cytosol of the small
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amount of sodium that enters through the voltage gated sodium channel during
each action potential. The pump exchanges this sodium for the small amount of
potassium which is lost during repolarization (Katz 2001 c).
Both sodium efflux and potassium influx occur against the chemical gradient and
so the process requires energy. The fact that the pump exchanges positively
charged sodium for potassium ions, helps minimize the electrochemical work
(Katz 2001 c).
The sodium pump creates a large sodium gradient across the plasma membrane
([Na+]o> > »INa t l}. This provides potential energy to drive the sodium calcium
exchanger and the sodium hydrogen exchanger, and therefore to drive calcium
and protons respectively, out of the cell, against their electrochemical gradient.
The sodium gradient also provides the driving force for the inward sodium
currents that depolarize the cardiomyocyte (Katz 2001 c).
Electrogenisity.
The sodium pump generates an electric current that repolarizes the cell, as three
sodium ions are transported out of the cell in exchange for two potassium ions
brought in. This increases the negativity of the cell interior.
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During diastole the pump maintains the resting membrane potential. During
systole when the myocyte is depolarized the sodium pump repolarizes the cell.
During ischemia, once ATP is depleted, the sodium pump fails and the cell
becomes and remains depolarized. On reperfusion, ATP is immediately available
and the sodium pump rapidly repolarizes the cell membrane.
Drugs or conditions that inhibit the sodium pump tend to depolarize the cell and
decrease the potassium gradient across the cell membrane. The resting
membrane potential is now more positive and closer to the threshold, causing
dysrhythmias (Katz 2001 c).
Structure.
The sodium pump has three subunits. The largest is the a-subunit which
contains the phosphorylation site for ATP and the sodium and potassium binding
sites. ATP and sodium bind to separate sites in the cytosol and the potassium
binds on the extracellular surface. (Glycosides compete with potassium for its
binding site). The j3-subunit regulates sodium and potassium binding (Katz
2001c).
Regulation.
Protein kinase A and C accelerate the pump.
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Sympathetic activity increases cAMP, which activates phosphorylation and so
stimulates the pump.
High ATP concentrations accelerate the reactions.
Acidosis inhibits the Na+/K+ ATP-ase (Piwnica-Worms 1985, Lazdunski 1985).
1.2.2.4 The sodium hydrogen exchanger (Na+/H+ exchanger).
Acidosis reduces myocardial contractility because protons compete with calcium
for binding sites on the contractile proteins.
Protons are generated by anaerobic glycolysis and oxidative metabolism.
Intracellular pH must be maintained at 7.2, maintaining this low [H "l, requires the
following active transport mechanisms.
• Sodium-bicarbonate symport.
• Chloride bicarbonate exchange.
• Chloride hydroxyl exchange.
• Sodium-hydrogen exchange (most important).
The Na+/H + exchanger uses the energy of the sodium gradient generated by the
sodium pump to transport protons out of the cell. Hydrogen is exchanged for
sodium in a 1:1 exchange and so is electrically neutral (Katz 2001c). Na+/H+
exchange therefore, regulates pH balance in myocytes (Imai 1991).
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Structure (Katz 2001 c).
The major Na +JH+ exchanger isoform in cardiac plasma membrane is a large
glycoprotein with 12 membrane spanning a-helices, an N-terminal that mediates
the ion exchange, and a large intracellular C-terminal region that contains
regulatory sites.
Regulation (Katz 2001c).
• Intracellular acidosis activates this antiport.
• ATP and increased cytosolic calcium potentiate its action.
• When the exchanger is phosphorylated by protein kinases A and C it can
mediate signals that regulate protein synthesis and apoptosis.
Myocardial contractility is controlled by calcium fluxes across the sarcoplasmic
reticulum. This is the intracellular calcium cycle. These calcium fluxes are
stimulated by sympathetic activation and inhibited by acidosis and decreased
cytosolic ATP levels.
Calcium uptake and release from the sarcoplasmic reticulum are both highly
regulated. [Ca2+] in the sarcoplasmic reticulum is high, hence calcium release
during excitation is a passive process which accounts for 90% of the calcium
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transient in mammals (Wier 1990, Barry 1993). Calcium uptake by the
sarcoplasmic reticulum, which relaxes the heart, is however energy dependant
(Katz 2001d).
1.2.3.1 Structure of the sarcoplasmic reticulum (Fig. 1.5).
There are two important regions (Katz 2001 d).
1. The subsarcolemmal cisternae which contain the calcium release channels.
The cisternae form special junctions with the plasma membrane and t-
tubules called dyads. At these dyads the plasma membrane and t-tubules
contain a high concentration of L-type voltage gated calcium channels
which are in close proximity to the calcium release channels on the
cisternae of the sarcoplasmic reticulum. These calcium release channels
are also called ryanodine receptors.
2. An extensive sarco tubular network that contains the Ca2+ -ATP-ase pump
proteins responsible for calcium uptake by the sarcoplasmic reticulum.
1.2.3.2 Calcium release channels (ryanodine receptors).
In cardiac muscle membrane depolarization leads to opening of the L-type
voltage gated calcium channels. Calcium flows into the dyad and generates a
chemical signal that opens the calcium release channels in the cisternae of the
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sarcoplasmic reticulum (Anderson 1989, Katz 2001 f). Calcium released by the
sarcoplasmic reticulum is responsible for the initial rapid increase in [Ca2+]i after
depolarization (Barcenas-Ruiz 1987, Beukelmann 1988).
Intracellular calcium release channels and plasma membrane L-type calcium
channels are not randomly scattered across the surface of the dyad, they are
grouped together in functional clusters (Sham 1995, Stern 1999).
The inositol triphosphate (IP3)-gated calcium release channels playa major role in
smooth muscle contraction. They have a small calcium conductance i.e. they
pass ions very slowly. The function of the small number of lP3 gated channels in
the heart is unclear, they mediate the slow release of only a small amount of
calcium and cannot play an important role in excitation contraction coupling.
However IP3-gated channels are activated by neurohumoral mediators like (X-
agonists and angiotensin II and may play an important role in calcium activated
protein syntheses, cell cycling and apoptosis (Katz 2001d).
Regulation of calcium release channels.
• Increased entry of calcium through the L-type plasma membrane calcium
channels increases calcium release from the sarcoplasmic reticulum. This
is the most important physiological regulator. (Beukelman 1988).
• The mechanism of calcium induced calcium release is widely accepted
(Beukelmann 1988, Calleweart 1988, Isenberg 1988).
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• The bigger the calcium store in the sarcoplasmic reticulum, the more
calcium is released (longer and more frequent opening L-type calcium
channels increases the sarcoplasmic reticulum calcium store) (Barry
1993).
• ATP promotes channel opening and a fall in ATP reduces calcium triggered
calcium release and contractility.
• Xanthines initiate calcium release.
• Acidosis inhibits channel opening.
• Under conditions of calcium overload, [Ca2+]i in cardiac cells can oscillate
spontaneously.
1.2.3.3 The calcium pump of the sarcoplasmic reticulum (SERCA).
This pump couples ATP-hydrolysis to calcium transport across the sarcoplasmic
reticulum membrane (ATP dependant purnp.Ca" ' -ATP-ase), and has the
dominant role in determining the decline of the [Ca2+]j transient (Carafoli 1988,
Inesi 1985).
This pump does not exchange calcium for a counter ion.
The movement of positively charged calcium ions across the sarcoplasmic
reticulum membrane does not generate an electrical current, because movement
of chloride and phosphate anions balance the movement of calcium ions (Katz
2001 d).
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SERCA is a smaller molecule than the plasma membrane calcium pump (Shull
and Greeb 1998) and is regulated differently.
Regulation (Katz 2001d).
During systole the cvtosolic calcium concentration is high and the pump operates
rapidly. During diastole the low cytosolic calcium level is rate limiting.
• The most important regulator of SERCA is the level of cytosolic
calcium.
• ATP has an important regulatory effect on calcium transport via the
sarcoplasmic reticulum. ATP provides the energy for this active
transport. This pump however requires very low (micromolar) ATP
concentrations to function, but low ATP levels will slow it down, and
ATP at high concentrations stimulates the pump.
Phospholamban (Katz 2001 d).
This protein is one of the most important regulators of the cardiac sarcoplasmic
reticulum, and it plays an important role in the increased inotropy and lusitropy
due to sympathetic stimulation (Tada and Katz 1982).
Under basal conditions phospholamban inhibits SERCA.
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l3-adrenergic stimulation generates cAMP. A cAMP dependant protein kinase
phosphorylates phospholamban. The inhibiting effect of phospholamban on
SERCA is reversed. There is an increase in the rate of calcium uptake by the
SERCA, and this accelerates relaxation (Iusitropy) . Phosphorylation of
phospholamban also increases intracellular calcium stores and so increases
contractility (inotropy).
When phospholamban is phosphorylated the SERCA is much more sensitive to
[Ca2+]j' It will now compete more strongly with a plasma membrane calcium
pump (which extrudes calcium from the cell) for calcium binding, and so calcium
will be retained in the cell (and in the sarcoplasmic reticulum), increasing
contractility.
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Fig 1.5
The sarcoplasmic reticulum is an intracellular membrane system
surrounding the contractile proteins. It consists of the
sarcotubular network and the cisternae which abut the t-tubules
and the sarcolemma.
A Katz
Physiology of the heart.
Lippencott Williams and Wilkens
Philadelphia. 3 rd Ed. 2000; 192
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In the mitochondrium the respiratory chain generates a negative
intra mitochondrial potential. This negative potential is a driving force for calcium
uptake into the mitochondrium. However in normal cells the cytosolic calcium
concentration is so low that very little calcium enters the mitochondrium.
Mitochondrial calcium uptake is too slow, and calcium affinity of the
mitochondrial calcium pump too low for the mitochondrium to play an important
role in relaxation of the normal heart (Katz 2001 j).
Uptake of Ca2+ is mediated by a uniporter and is driven by mitochondrial
membrane potential (± 180mV negative to cytosol). This membrane potential is
set up by outward proton pumping which is coupled to electron transport
(Gunter 1990). Ca2+ efflux from the mitochondrium is mainly via the Na+ICa2+
exchanger (Gunter 1990). The maximum capacity of Ca2+ efflux is one tenth
that of Ca2+ influx via the uniporter (Gunter 1990).
When the cytosol is calcium overloaded (ischemia and reperfusion) the
mitochondria will take up calcium. This will dissipate the proton electrochemical
gradient across the mitochondrial inner membrane, leading to uncoupling of
oxidation from phosphorylation and impairing ATP production. A vicious cycle
will be started.
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A large increase in mitochondrial matrix [Ca2+) will activate a regulatory pathway
namely the mitochondrial permeability transition pore. This megapore leads to
permeabilization of the mitochondrial inner membrane to ions, including Ca2+,
and small solutes (Silverman 1994, Crompton 1988).
The increase in intramitochondrial [Ca2+) during ischemia correlates with the
degree of cell injury on reperfusion (Miyata 1992). In myocytes which ultimately
recover function after reperfusion, reversible rises in intramitochondrial [Ca2+)
occur during ischemia (Silverman 1994). Blocking mitochondrial Ca2+ uptake
during ischemia is beneficial (Gupta 1989), and inhibition of the mitochondrial
megachannel by cvclosporin during ischemia, enhanced recovery of contractile
function and ATP levels on reperfusion (Griffiths 1993).
Calcium ions are an important intracellular messenger. They carry signals
generated at the cell surface to a variety of intracellular proteins and organelles.
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Calcium is the essential final step in excitation-contraction coupling in the
myocardial cell.
Kretsinger (1977) postulated how calcium became the intracellular messenger:
Phosphate anion is needed in the cell for ATP and nucleic acid (RNA and DNA)
synthesis. Calcium phosphate is insoluble, so the primitive cell excluded calcium
in order to concentrate phosphate anion. The result is that the calcium
concentration in the extracellular fluid which is ± 1mM (like seawater), is 5000
times higher than the calcium concentration in the cytosol, which is 0.2 JIM.
The cell has thus effectively evolved calcium free cytosol. Now calcium entry
through regulated ion channels in the plasma membrane is a useful vehicle for
signaling processes in the cell. Calcium ions generate an electrical and chemical
signal when they enter the cell. Calcium binding proteins have evolved to
become intracellular calcium sensors.
Fig. 1.6, Fig. 1.7
Calcium is available in the extracellular space and in the intracellular stores
(sarcoplasmic reticulum). The large amount of calcium required for excitation-
contraction coupling is provided by two calcium cycles (Katz 2001 c):
The extracellular cycle where calcium enters the cell through voltage gated L-
type calcium channels and efflux occurs via the plasma membrane calcium pump
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(Ca2+ -ATP-ase) and the sodium calcium exchanger. Most of the calcium that
enters the cytosol via the external calcium cycle opens calcium release channels
in the sarcoplasmic reticulum (calcium triggered calcium release), and only a
small fraction binds to troponin C (Katz 2001 d).
The intracellular cycle in which calcium moves between the stores in the
sarcoplasmic reticulum and the cytosol where it binds to troponin C. The
calcium fluxes out of and into the sarcoplasmic reticulum are much greater than
those out of and into the extracellular fluid. The calcium that activates the
contractile proteins binds to and is released from high affinity binding sites on
troponin C. Mitochondria are also able to buffer high cytosolic calcium levels
(Katz 2001 d).
In mammalian myocardial cells calcium release from the sarcoplasmic reticulum
is smaller than in skeletal muscle, and graded, and does not saturate all the
available troponin C (Fabiato 1989). This allows the contractile response to be
graded (Katz 2001 c).
During the two cycles calcium moves among five compartments (Katz 2001 d):
(Fig. 1.6).
1. Extracellular space.
2. Sarcoplasmic reticulum.
3. Cytosol.
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4. Contractile proteins.
5. Mitochondria.
Calcium fluxes among these compartments initiate and terminate contraction and
regulate contractility (Katz 2001 d).
Contractility is regulated by:
• Calcium channels (L-type voltage gated calcium channels and
sarcoplasmic reticulum calcium release channels).
• Calcium exchangers.
• Calcium pumps.
• Calcium affinity of the contractile proteins.
The numbers of plasma membrane L-type calcium channels and calcium release
channels on the sarcoplasmic reticulum are about the same. However calcium
flux through a sarcoplasmic reticulum calcium release channel is ten times faster
(750 000 ions per s) than through a L-type calcium channel (75 000 ions per sj.
This explains why calcium influx via the extracellular cycle is much smaller than
calcium release via the sarcoplasmic reticulum.
Calcium uptake by each sarcoplasmic reticulum calcium pump is only 30 ions per
second, there are however 170 times more sarcoplasmic reticulum calcium
pumps than sarcoplasmic reticulum calcium release channels. The large number
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of sarcoplasmic reticulum calcium pumps provide some compensation for their
much slower rate, but calcium release is still twice as fast as calcium removal by
the sarcoplasmic reticulum.
It is more difficult to relax than to contract, because diffusion is so much faster
than active transport. Relaxation takes twice as long as contraction so the heart
spend longer in diastole than in systole. Relaxation is markedly impaired in the
energy starved heart (ATP is needed for the sarcoplasmic reticulum calcium
pump to work). A fall in ATP concentration locks the contractile proteins in
rigger bands and causes the cytosol to become flooded with calcium (Katz
2001d).
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The key structures and calcium fluxes that control cardiac exitation-contraction
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Figure 1.7
The thickness of the arrow indicates the magnitude of the calcium fluxes. Downward
arrows represent passive calcium fluxes and upward asrrows represent energy
dependant active calcium transport. Calcium that enters the cell from the extracellular
fluid via the L type calcium channels (arrow A) triggers calcium release from the SR
(arrow C). Only a small amount directly activates contractile proteins (arrow A1).
Calcium is actively pumped back into the extracellular fluid by plasma membrane
calcium ATP ase (arrow 81) and exchanged for sodium via the sodium/calcium
exchanger (arrow 82).The sodium that enters the cell in exchange for calcium(dashed
line) is pumped out by the sodium pump. Most cytosolic calcium is taken up by calcium
ATPase pump on the SR (arrow D). Calcium diffuses within the SR from the
sarcotubular network to the sarcolemmal cisternae (arrow G). Here it is stored ready for
release. Calcium binding to high affinity calcium binding sites on troponin C (arrow E) ,
activates the interaction of contractile proteins; and dissociation (arrow F) inhibits the
interaction of contractile proteins. Calcium movements into and out of the mitochondriae
(arrow H) buffer cytosolic calcium concentration. The extracellular cycle is represented
by arrow A, 81,82; the intracellular cycle is represented by arrows C,E,F,D and G.
A Katz Physiology of the heart. Lippencott Williams and Wilkens, Philadelphia.
2000;232
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1.3 Calcium channel blocking drugs and the reperfusion injury
If we are to evaluate stunning as the part of the reperfusion injury the following
criteria should be met (Bolli 1992):
1. Lack of permanent damage (no infarction).
2. Eventual full mechanical recovery.
3. Fully restored coronary bloodflow.
Many experiments do not meet these criteria for stunning because of permanent
ischemic induced necrosis. Hearts which are reperfused after more than 20
minutes of normothermic ischemia have extensive ultrastructural damage, remain
energy depleted, and show permanent contractile dysfunction (Jennings, 1986).
Total ischemia results in the rapid development of irreversible damage which is
already morphologically evident after 30 minutes (Elz, 1988).
The greater the duration and severity of ischemia, the more likely there is to be
serious damage to the cell membrane at the end of the ischemic period. There is
then a greater chance of calcium entry by non-specific mechanisms during
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subsequent reperfusion (Nayler 1988). For ischemia, without infarction, in the in
vivo model, the ischemia duration should be limited to 15 to 20 minutes at
normothermia. After 30 minutes of severe ischemia in various animal species it
is difficult to differentiate between attenuation of stunning and tissue salvage
due to calcium antagonists (Heusch 1992).
The paucity of collateral vessels in the porcine heart eliminates the variability in
collateral flow inherent in dog models (Heusch 1997). This results in a more
reproducible post-ischemic dysfunction in pigs.
The canine heart has a native coronary collateral circulation, thus the more
appropriate way to ascertain whether calcium channel blockers attenuate
myocardial stunning in vivo, in conditions of zero flow ischemia, is to use the
porcine model. Like the human heart, the porcine heart lacks preformed
collateral anastomoses and has minimal xanthine oxidase activity (Dodds 1982).
Results obtained in open chest models may be confounded by the effects of
anesthesia, surgical trauma, abnormal hemodynamic conditions, excessive levels
of circulating catecholamines, and other factors. Certain conclusions derived
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from open chest preparations may indeed not be applicable to conscious models.
(Bolli 1986, Ning 1990).
It has been shown that in the 15 minute coronary occlusion model of myocardial
stunning, both the severity of post-ischemic dysfunction (Triana 1991) and the
magnitude of free radical generation (Li 1993) are greatly exaggerated in the
open chest as compared to conscious models.
The stunned myocardium, like the myopathic heart, is sensitive to hemodynamic
variables, hence reduction in afterioad, variations in preload, heart rate and
regional myocardial blood flow, could increase systolic shortening independently
of changes in intrinsic contractile properties (Przyklenk 1989).
1.3.4.1 How do calcium channel blocking drugs attenuate the reperfusion
injury?
In the in vivo model, when calcium antagonists are administered systemically
(intravenously), there usually is a decrease in arterial pressure resulting in a
decreased afterload and an improvement of ejection function, as well as baro-
receptor mediated increased cardiac sympathetic nerve activity. However, even
in studies where afterload was kept constant (Bëhm 1991) or calcium
antagonists were administered into coronary arteries, with minimal systemic
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effects (Przyklenk 1989, Rohmann 1991), there was improved recovery of
regional contractile function compared to placebo.
It has been suggested that calcium antagonists may attenuate stunning by
reducing the severity of the preceding ischemia due to increased myocardial
blood flow via collaterals. However, in the vast majority of studies regional
myocardial blood flow was not increased by calcium antagonists during ischemia
and ischemic contractile function was not improved (Lamping 1985, Gross
1987, Dunlap 1989, Bëhm 1991, Przyklenk 1988, Farber 1989, Taylor 1990).
Calcium antagonists may improve myocardial function due to improved blood
flow during reperfusion (Gregg phenomenon: an increase in myocardial function
secondary to an increase in coronary blood flow). This is probably not the
underlying mechanism for improved function associated with calcium
antagonists, as improved functional recovery was also found in the absence of
improved blood flow during reperfusion. (Lamping 1985, Przyklenk 1989, Taylor
1990). The Gregg phenomenon is of minimal significance in the normal
myocardium, but may be operative in the reperfused myocardium (Bolli 1990).
Thus the consistent attenuation of stunning by calcium antagonists cannot be
explained only by more favorable hemodynamic conditions such as reduced
afterioad, or increased myocardial bloodflow during ischemia or reperfusion.
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Studies have suggested that an important mechanism involved in the protective
effect of calcium antagonists in isolated preparations, is indirect. Due to the
ability of the calcium antagonists to spare ATP during ischemia, as a
consequence of their negative inotropic properties, they could induce some
protection against ischemia, resulting in less stunning (Klein 1984, Reimer
1985).
Boraso (1993) showed that the protective effect of lacidipine is independent of a
cardioplegic action occurring before ischemia, as oxygen consumption in their
preparation was not affected by the drug.
Kirkels (1992) demonstrated that anipamil (lipophilic verapamil) protects against
ischemia and reperfusion in the absence of a negative inotropic effect.
It has also been suggested that damage to the myocardial vascular endothelium
is involved in myocardial injury following ischemia and reperfusion (Yao 1994).
The mechanism for this endothelial injury may be platelet- or leucocyte-
endothelial interaction and oxygen free radicals delivered from neutrophils or
generated on re-oxygenation of ischemic tissue. Some calcium antagonists eg.
benidipin can prevent this vascular dysfunction (Becker 2004, Kitakaze 2001).
The effect of calcium antagonists on the attenuation of stunning is probably due
to the attenuation of cytosolic calcium overload during early reperfusion and the
protection of the membrane against free radical induced damage. (Amende
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1991, Janero 1989). Different types of calcium antagonists are all equally
effective in improving functional recovery of the stunned myocardium (Watts
1986).
Gallopamil administered at the onset of reperfusion in the isolated guinea pig
heart resulted in improved recovery of contractile function. Gallopamil has no
oxygen radical scavenging effect and its protective effect is probably purely due
to a reduction in calcium overload (Massoudi 1995).
Binding of a drug to a receptor within an ion channel is influenced by the state of
the channel, which in turn is determined by the membrane potential. Binding of
the calcium antagonists is approximately 1000 times stronger to inactivated
channels than to resting channels (Sanguinetti and Kass 1984) (Bean 1984).
Verapamil and diltiazem bind the calcium channel in the open and inactive state
(Kanaya 1983). The block will therefore be greater if the channel is opened
frequently, or if it stays in the inactive or depolarized state. Nifedipine and
nisoldipine bind the calcium receptor in the calcium channel in the inactive state
(when the membrane is depolarized). As smooth muscle cells of the vasculature
spend a longer time in the depolarized state, this explains the vascular selectivity
of these drugs (Sanguinetti 1984). Green (1985) observed that in isolated
myocytes binding sites of nitrendipine a dihydropyridine calcium antagonist,
reversibly increased by 115 % as a function of increasing membrane
depolarization.
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During ischemia the sarcolemma is depolarized and the calcium channels are in
the inactive state. At the onset of reperfusion there is rapid calcium cycling
(Piper 2004) and more channels are opened more frequently so increasing the
binding of verapamil.
Thus ischemia may modify the calcium channel in such a way that calcium entry
may be facilitated and that the effect of calcium antagonists is potentiated.
1.3.4.2 Effect of calcium channel blocking drugs on apoptosis.
Mitochondria play a critical regulatory role in the signal transduction pathway
leading to apoptosis (Gross 1999). Calcium antagonists attenuate mitochondrial
injury resulting from ischemia and reperfusion (Boraso 1993).
Calcium antagonists may prevent the formation of the mitochondrial permeability
transition pore and so inhibit the release of pro-apoptotic molecules i.e.
cytochrome C from the mitochondrium. Reduced calcium overloading due to
calcium antagonists may further attenuate myocardial apoptosis through
prevention of dephosphorylation of pro-apoptotic proteins by calcineurin. By
preventing the activation of calcineurin the calcium antagonists prevent
cytochrome C release from the mitochondrion (Wang 1999). Calcium overload
has also been demonstrated to activate calcium- and magnesium dependant
endonuclease and so results in DNA fragmentation and cell apoptosis (Gottlieb
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1999). Calcium antagonists may prevent endonuclease activation and reduce
myocardial apoptosis.
Calcium overload increases the generation of free radicals, which induce
apoptotic cell death (Bianchi 1997, Das 1999). Calcium antagonists significantly
reduce free radical generation in ischemic/reperfused tissue, and this may
contribute to their anti- apoptotic effect.
1.3.4.3 Effect of calcium antagonists on NO preservation and endothelial
function.
Endothelial NO is formed from L-arginine by the enzyme NO synthase. This
enzyme can be inhibited competitively by L-arginine analogs such as N-
monomethyl-L-arginine (L-NMMA).
Early reperfusion leads to impaired endothelium dependant vasodilatation
resulting from either reduced NO formation or rapid inactivation of NO by free
radicals (Lefer 1996). Augmentation of NO levels during reperfusion preserves
endothelial function, reduces neutrophil accumulation and decreases myocardial
injury (Lefer 1996). Thus, NO appears to be an important factor mediating
protection against the ischemia reperfusion injury.
Gourine (2001) showed that local administration of clevidipine during the last 10
minutes of severe ischemia and early reperfusion reduces infarct size and
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preserves endothelial function. These effects are largely dependant on
maintained local bio availability of NO.
Zhang (1999) showed that amlodipine releases NO from coronary microvessels.
Kitakaze (2001) demonstrated that benidipine and nifedipine increased coronary
blood flow during low flow ischemia, attenuated the severity of myocardial
ischemia and increased nitrate/nitrite level in the coronary sinus. All these
effects were mediated via a NO-dependant mechanism.
1.3.4.4 Effect of calcium channel blocking drugs on oxidant production in
human neutrophils.
Polymorphonuclear leucocytes are a major source of toxic oxidants in vivo during
ischemia and reperfusion injury and calcium ions are a key mediator in the
production of oxidants by these cells (Romeo 1975, Goldstein 1975).
Feng (1996) examined freshly prepared human neutrophils suspended in a
luminol media and mixed with varying amounts of diltiazem, nifedipine and
verapamil. They found that calcium antagonists inhibited oxidant production by
neutrophils (all three agents were effective).
No drug sensitive calcium channels have yet been demonstrated in neutrophils
(Pennington 1986), but protein kinase C is located in the plasma membrane
(Hirota 1985) and NADPH oxidase is associated with the plasma membrane
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(Babior 1984). It is possible that calcium antagonists may inhibit NADPH
oxidase directly and so block signal transmission responsible for oxidant
generation (Feng 1996).
Very high concentrations of drug are required to suppress oxidant production
(Feng 1996). However because these drugs are highly lipophilic the
concentrations of the drug may be 1000 fold higher in the cell membrane than in
the plasma (Hamman 1984). The drug may also accumulate in high
concentration in neutrophil membranes and inhibit NADPH oxidase and protein
kinase C.
1.3.4.5 Summary of calcium antagonist effects during ischemia and
reperfusion.
Effects of calcium antagonists during ischemia.
Calcium channel blockers prevent ATP depletion during ischemia (Lange 1984).
They also preserve mitochondrial oxidative phosphorylation during ischemia and
on reperfusion (Nayler 1980). Therefore if the calcium antagonist is present
from the onset of ischemia, ATP stores, ATP dependant processes, and ATP
dependent pump function (Na+ IK + ATP-ase, Ca2+ ATP-ase) are better preserved
during ischemia, and their recovery is enhanced on reperfusion.
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Verapamil treatment before ischemia has been shown to prevent the reduction of
Na+IK + ATP-ase activity in membrane vesicles from isolated perfused ischemic
hearts (Daly 1985). Preservation of Na+IK + ATP pump function attenuated
intracellular sodium ion accumulation during ischemia (Balshi 1985, Fiolet 1984,
Pike 1988, Tani 1988). Nayler (1976) also demonstrated that verapamil reduces
sodium ion uptake and potassium loss during ischemia. Calcium antagonists also
have a direct interaction with the voltage gated sodium ion channel (Yatani
1985) and reduce the influx of sodium ion into myocytes (Grima 1987).
Furthermore, pretreatment with calcium antagonists has consistently been
shown to attenuate intracellular acidosis during ischemia (Kirkels 1992,
Bernstein 1996). A lower ll+"], , means less H+ exchange for Na+ by the Na+IH+
exchanger and consequently less intracellular accumulation of Na+.
Maintenance of Na+IK + ATP-ase activity and inhibition of the Na+ channel and
the Na+IH +exchanger all result in less intracellular sodium ion accumulation, and
therefore a reduction of Ca2+ influx via the Na+ICa2+ exchanger.
Verapamil (calcium antagonist) pretreatment would therefore reduce the
tendency of the myocyte in general, and the mitochondrium in particular, to
become overloaded with calcium during ischemia (Bourdillon 1982, Nayler
1980). Prevention of mitocondrial calcium overloading preserves the ATP
generating capacity of the mitochondrium (Nayler 1980, Robb-Nicholson 1978).
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It is possible that maintenance of the enzymatic profile of the sarcolemma at or
near normal levels, due to ATP preservation despite periods of ischemia, could
contribute to verapamil' s ability to protect against the deleterious effects of
ischemia (Daly 1985).
Several investigators have demonstrated that treatment with calcium channel
blockers before coronary artery occlusion will decrease calcium influx (Bean
1984, Ashraf 1984, Nayler 1980, Bourdillon 1982).
Other effects of calcium antagonists during ischemia are attenuation of alpha
adrenergic vaso-constrictor effect (Serruys 1983, Nayler 1988), and antagonism
of endothelin induced coronary vasoconstriction (Nayler 1990).
Possible effects of calcium antagonists on reperfusion mediated cell damage.
• By blocking calcium entry into reperfused cells, they reduce calcium
induced calcium release from the sarcoplasmic reticulum, hence
prevent rapid calcium cycling and calcium overload, and therefore
decrease hypercontracture (Piper 2004).
• Inhibit oxygen free radical mediated peroxidation of membrane lipids
(Janero 1988; Mak 1990 and 1992).
• Reduce activation of stimulated neutrophils and suppress the capacity
of neutrophils to produce oxidants (Feng 1996).
• Release nitric oxide (NO) from the coronary arteries (Gourine 2001).
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• Protect the vascular endothelium (Me Donagh and Roberts 1986).
• Inhibit platelet aggregation (Zhang 1998).
• Protect the sarcolemma (Daly 1985).
• Reduce the severity of ischemia and slow the loss of adenine
precursors (Przyklenk 1988, De Jong 1982).
• Reduce apoptosis by inhibiting caspase activation (Gao 2001).
• Attenuate ischemia reperfusion induced displacement of endogenous
noradrenaline (Nayler 1988).
1.3.4.6 Effects of verapamil and mechanisms by which verapamil might
improve contractile function in the stunned myocardium.
General effects of verapamil (Ferarri 1997)
• It has direct myocardial and electrophysiological effects - it reduces
inotropism and heart rate.
• It is cardioprotective in a variety of experimental models even after
ischemia.
• It does not induce reflex sympathetic activation.
• It may reduce myocardial catecholamine content.
• It is the only calcium antagonist proven to improve prognosis post
myocardial infarction.
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Mechanisms by which verapamil might improve contractile function in the
stunned myocardium (Przyklenk 1989).
• During ischemia, and especially at reperfusion, intracellular calcium
overload leads to hypercontracture and production of cytotoxic free
radicals. Verapamil has a specific action as a calcium channel blocker on
the myocyte and prevents calcium overload.
• Systemic vasodilatation and afterload reduction during occlusion or
reperfusion. However beneficial results have been obtained using isolated
heart preparations not complicated by changes in systemic pressures.
• Coronary vasodilatation and increased myocardial blood flow during
reperfusion.
In summary:
Verapamil administered before ischemia will:
• Maintain calcium homeostasis during occlusion.
• Decrease mean arterial pressure during occlusion.
• Maintain calcium homeostasis at reperfusion.
• Increase regional myocardial bloodflow during reperfusion.
Verapamil administered at the time of reperfusion will:
• Maintain calcium homeostasis at reperfusion.
• Decrease mean arterial pressure during reperfusion.
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• Increase regional myocardial blood flow during reperfusion.
Verapamil administered post reperfusion will:
• Decrease mean arterial pressure during reperfusion.
• Increase regional myocardial blood flow during reperfusion.
1
The increase in cytosolic calcium during ischemia has very little to do with
voltage gated calcium channels which are blocked by calcium antagonists as
these channels are sensitive to both acidosis and decreased ATP, and are
inactivated within 5 - 15 minutes after the onset of ischemia (Sperelakis 1988).
However during the first few moments of reperfusion calcium influx through the
voltage gated calcium channels triggers massive calcium release from the
sarcoplasmic reticulum and this causes contraction band necrosis. T0 be
effective the calcium antagonist must be present in an adequate dose at the
onset of reperfusion, which it will be if it is administered before or during
ischemia, but not if administration is delayed until after the onset of reperfusion.
The increased cytosolic calcium levels due to ischemia and reperfusion usually
return to normal within a few minutes after reperfusion, by which time the
damage has already been done (Steenbergen 1987, Guarnieri 1989).
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From the work of Du Toit and Opie (1992) it is evident that the timing of the
calcium antagonist administration is very important. Early nisoldipine avoided
subsequent stunning in the isolated rat heart. Late nisoldipine given to isolated
rat hearts already stunned, decreased contractile function. The early protective
effect is due to the inhibition of calcium entry via the voltage gated L-type
calcium channels and consequently less calcium triggered calcium release from
the sarcoplasmic reticulum. The degree of stunning is proportional to the
calcium ion concentration in the early reperfusion medium. The higher the dose
of nisoldipine, the lower the calcium ion concentration.
The early reperfusion period has been demonstrated to be the most important
period for treatment with calcium antagonists. Herzog (1997) showed that low
dose intracoronary diltiazem delivered exclusively during early reperfusion
diminished infarct size in swine.
Ryanodine, which inhibits sarcoplasmic reticulum release of calcium, has a
similar effect if present at the onset of reperfusion (Du Toit 1992). A reduction
in stunning in the vivo dog heart is seen if verapamil is present at the onset of
reperfusion (Przyklenk 1989). Later, following established reperfusion, cytosolic
calcium concentration in the stunned myocytes is low, and calcium antagonists
given this time will exacerbate the myopathy.
In most of the earlier studies treatment with calcium antagonists was started
either before ischemia (where it was generally effective), or after reperfusion
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was already established for at least several minutes (where it was generally
ineffective) .
The reason why calcium antagonists are beneficial only when given before
reperfusion may be that the time required for drug binding and action is longer
than the time required for calcium overload on reperfusion (Taylor 1990).
Segawa (2002) used the ultra short acting drug clevidipine (t% in pigs 0.5
minutes) administered directly into the left anterior descending coronary artery
(LAD) to demonstrate the importance of timing of calcium antagonist
administration. Clevidipine is effective in limiting infarct size if it is administered
early during ischemia (the first 5 to 10 minutes) and especially if it is
administered from 1 minute before reperfusion (for 5 minutes) but not if it is
given during late ischemia. The beneficial effect was not due to change in
afterlaad or increased coronary flow. This indicates that calcium influx, both
during the early phase of ischemia and at the time of reperfusion, is involved in
tissue damage induced by ischemia.
The increase in calcium influx into the cell occurs mainly in the very early phase
of ischemia and during the first few minutes of reperfusion. The calcium current
is markedly reduced or absent within 15 minutes of ischemia due to low pH and
ATP levels (Sperelakis 1988). Consequently the beneficial effect of cJevidipine
given between 5 to 10 minutes of ischemia and just before reperfusion may be
due to blockade of calcium entry through the L-channel. Administration of
77
Stellenbosch University http://scholar.sun.ac.za
clevidipine after 35 minutes of ischemia is too late too influence the calcium
influx during ischemia and too early to influence calcium influx during
reperfusion.
Long acting calcium antagonists administered before ischemia may remain in the
jeopardized myocardium not only throughout the ischemic period, but also up to
the onset of reperfusion and so exert a protective effect during both ischemia
and reperfusion.
In one study intracoronary administration of nifedipine 30 minutes after
reperfusion in dogs led to marked improvement in contractile function.
(Przyklenk 1989). However, other studies have failed to document any
protective effect following delayed administration of calcium antagonists. The
interpretation of these results is uncertain:
• Nifedipine is a vascular selective calcium antagonist and would be
expected to exert coronary vasodilator effects before effects on the
myocardium.
• The result is not due to protection against intracellular calcium
overload as calcium levels return to normal within a few minutes of
reperfusion.
• The result is not due to the protection of membranes from free
radicals, as free radicals responsible for stunning are the ones
generated in the first few minutes of reperfusion. Also, 80 to 1000
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times higher dose of nifedipine is required for a 50% attenuation of
free radical induced lipid peroxidation of myocardial membranes in
vitro (Janero 1989).
If calcium antagonists are given before or at the onset of ischemia they may
attenuate ischemia. The severity of ischemia determines the severity of the
reperfusion damage (Bolli 1990, Li 1993), so the calcium antagonists indirectly
diminish the reperfusion injury.
When calcium antagonists are administered before or exactly at the time of
reperfusion they probably specifically limit the entry of calcium ions via the
calcium channels and so diminish pathogenic cytosolic calcium oscillations.
Post reperfusion administration of calcium antagonists in the presence of
established stunning is of controversial significance (Opie 1994). Intravenously
given agents could act by altering hemodynamic parameters. Where loading
conditions are constant the calcium antagonist either has no effect (Ehring 1992)
or a marked negative inotropic effect (Du Toit 1992).
In conclusion, it appears that there is sufficient evidence that calcium
antagonists are indeed useful in attenuating myocardial stunning, but that timing
of the administration is of vital importance. There seems to be a very narrow
window of benefit.
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1.3.6 A summary of studies where calcium antagonists were administered
bsfors or during ischsmia in in vitro modsls.
Author Ischemic Drug & dose Preparation Result Comment
time & type
Nayler WB 1976 15 min total Veraparnil Isolated Langendorff Less ultrastructural
0.5-1mg.!-' perfused rabbit hearts damage less ATP &
CP depletion
Yamamoto F 1983 35 min 35°C Diltiazem Isolated Langendorff Improved post Diltiazem afforded no
total 0.21 mgt! perfused rat hearts. ischemic aortic flow. additional protection
Infusion of St. Reduced post under hypothermic
Thomas cardioplegic ischemic creatine conditions (20°C
solution with/without kinase leakage (40%t) 180min)
diltiazem for 3 min
before ischemia
De Jong 1982 10 - 15 min Nifedipine Isolated rat heart Less stunning Metabolic
subtotal 3x108M - 3x106M Nifedipine given 10 improvement during
min before ischemia ischemia
Yamamoto 1983 30 min 37°C Verapamil 0.5mg/! Isolated working rat Increased recovery of No additional
total heart aortic flow CO and protection during
1. Veraparnil infusion SV t creatinine kinase hypothermia.
for 20 min before leak Post ischemic
ischemia/or placebo. verapamil treatment
2. Infusion of St had no benefit.
Thomas solution with
verapamil for 3 min
before ischemia
Watts 1986 33 min 37°C Verapamil Isolated working rat Enhanced recovery of No protection if given
total Diltiazem hearts. Drugs given contractile function. on reperfusion
Nifedipine before ischemia Less intracellular
calcium overload
Ferrari 1986 60 min total Nifedipine Isolated rabbit heart - Improved mechanical No protection if given
10 min before function (only slight) on reperfusion.
ischemia Long ischemic time.
Van Amsterdam 30 min total Gallopamil Isolated rat heart Faster and better Vasodilatory isomers
etaI 1990 Diltiazem administered before recovery of were used
Bepridil ischemia contractility
Nayler 1994 15 min total Nisoldipine 10-BM Isolated rat heart Stunning eliminated Striking benefit
administered before
ischemia
Buser K 1991 30 min total Verapamil Isolated hypertrophic Improved recovery of Recovery much better
Nifedipine working rat heart. ~ contractile function in rats on chronic
weeks or 3 days verapamil treatment.
before ischemia
Du Toit 1992 20 min total Nisoldipine 10-8m Isolated rat heart. Improved mechanical No stunning
2 min before ischemia function
Ferrari 1992 15 min total Nisoldipine Isolated rabbit heart - Stunning eliminated
0.3mg/kg/day chronic oral pre
treatment
Mitchell 1992 27 min 37°C Nicardipine 4.ug Isolated working rat Significantly better No benefit during
total hearts. Nicardipine in recovery of aortic hypothermia 10°C
cardioplegia before flow, CO, SV
ischemic arrest
Baxter 1993 10 min Diltiazem 18.ug Isolated hypertrophic A very marked Also very effective in
working rat heart. reduction in incidence non hypertrophied
and duration of VT VF hearts
Kirkels, 1993 30min Anipamil 5mg/kg Isolated rat hearts: Greatly improved Protection not
bd for 5 days Rats pretreated with functional and preceded by: tBP,
Anipamil for 5 days metabolic recovery tHR, negative
(p< 0.0005) inotropic effect energy
sparing duringischemia.
But intracellular pH
higher in tr~é'!1ll.g_g[9J!Q
during ischemia
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Author Ischemic Drug & dose Preparation Result Comment
time & type
Boraso 1993 30 min total Lacidipine 10-8M Isolated rabbit hearts Improved functional Not attributed to
infusion of drug for 2 recovery, ATP, CP energy sparing effect
hours ending 1 hour stores, mitochondrial or improved O2
before ischemia function. Reduced: delivery
tissue & mitochondrial
calcium overlaad, NA
release, oxidative
stress
Grover 1993 25 min total Pyranoquinoline Isolated rat hearts. Significant Drug has no KATP
(1 - 10pM) of Drug given for 10 improvement in post effect only calcium
cromakalim (KATP minutes before ischemic contractile antagonist. At 1 pM -
opener) ischemia function [ tectete no negative inotropic
dehydrogenase release effect
Yao 1994 30 min total Benidipine 1 or Isolated Langerdroff- Improved contractile This calcium
10-6M perfusal rat heart. function l release: antagonist clearly
Drug given from 20 LDH and CPK prevents post
min. before to onset preserved vasodilator ischemic vascular
of ischemia response to dysfunction.
acetylcholine At 1nM - no negative
inotrope effect
Massoudy 1995 15 min total Gallopamil 0.1 + Isolated working Improved contractile As effective if given
lnM guinea pig heart. function less oxidative on reperfusion 0.1 nM
Drug given before stress - no negative inotrope
ischemia effect
Bernstein 1996 90 min low flow Felodipine 2 x 10- Isolated isovolumic Improved ischemic No negative inotropic
22-24% of 6M blood perfused rabbit diastolic dysfunction. effect. Less
baseline hearts paced at Improved post contracture
constant HR. Drug ischemic contractile
started after 15 min function.
of ischemia until 15 Improved post
min of reperfusion ischemic diastolic
dysfunction.
Improved post
ischemic coronary
blood flow
Dagenais 1997 30 min total Isolated rat hearts. Improved endothelium- Low dose no negative
Oi"i"~~ 10'M 10min. infusion of dependant relaxation inotropy
Nifedipine - drug before ischemia after ischemia in all 3
Verapamil 1O-6M drugs-dose dependant
(nifedipine most
potent)
Lochner 1998 45 min total Halothane: 1.5% Isolated rat heart. Both halothane and Halothanes protective
Nifedipine: 10-8_ Controls + Halothane nifedipine were effect may be due to
106M alone during protective-(nifedipine inhibition of Ca2 +
Halothane + cardioplegia. better than halothane). influx via voltage
Nifedipine Nifedipine for 10 min The combination gated Ca channels
before cardioplegia offered no added
and for l,t 10 min of protection
reperfusion.
-Halothane +
nifedipine
Nayler 1990 10 min isch then Nifedipine 10-8M Isolated rat heart. Total recovery of Not due to improved
15 min Verapamil 10-8M Drug for 15 min contractile function myocardial perfusion
reperfusion x 3 Diltiazem 1O-7M before first occlusion with all drugs after all
Amlodipine 10-8M and kept in perfusion 3 episodes of ischemia
Felodipine 10-8M medium throughout.
(Before, during, after
ischemia)
co - cardiac output, VT - ventricular tachycardia
SV - stroke volume, VF - ventricular fibrillationt-increase, !-decrease
~ - gave rise to
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Author Ischemic Drug & dose Preparation Result Comment
time & type
Yamamoto 1983 30 min 37° total Verapamil 0.5mglt Isolated working rat No improvement in Does improve
heart. Infusion for the functional recovery recovery if given
first 15 min of before ischemia
reperfusion
Watts 1986 33 min 37° total Verapamil Isolated working rat No improvement in Does improve
Diltiazem hearts. Drug given at functional recovery recovery if given
Nifedipine reperfusion before ischemia
Bolluig 1983 45 min total Verapamil Isolated non working Improved LV recovery Very long ischemic
5 x lO-BM rabbit heart at 37°C better compliance time not true stunning
Higgens and 30 min total Nifedipine Isolated working rat Improved recovery Temp during ischemia
Blackburn 1984 Verapamil heart with N. Worse not controlled
Diltiazem recovery with V + 0
Ferrari 1986 60 min total Nifedipine Isolated rabbit heart No effect Beneficial if given
before ischemia - long
ischemic time
Du Toit 1992 20 min total Nisoldipine 10-BM Isolated working rat Lessened stunning Similar protection by
heart. Dose given for ryanodine or
2 min at onset or magnesium
reperfusion
Du Toit 1992 20 min total Nisoldipine 10-BM Isolated working rat Depressed cardiac
heart. Dose given 20 output
min after re!;1erfusion
Massoudy 1995 15 min total Gallopamil 0.1nM Isolated working Improved contractile As effective as when
guinea pig heart. Dose function less oxidative given before ischemia.
on re!;1erfusionfor 5 stress more effective in
min reducing oxidative
stress if given on
reperfusion
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1.3.8 Summary of studies where calciu were administered
before/during ischemiaand at/after reperfusionin in vitro models.
Yamamoto (1983) studied the effect of verapamil in the isolated perfused
working rat heart:
The addition of verapamil, O.5mg/l to St. Thomas solution before normothermic
ischemic arrest (30 minutes at 37°C), led to an enhancement of the protection
by St. Thomas solution. Under hypothermic conditions (150 minutes at 20°C)
verapamil was unable to confer any additional protection. When verapamil was
used instead of St. Thomas solution before normothermic ischemic arrest, it was
effective in improving post ischemic function and reducing enzyme leakage. It
was however not as effective as St. Thomas solution alone or as the
combination of the two. Verapamil alone before hypothermic ischemic arrest
afforded no protection. Addition of verapamil to the perfusion fluid for 20
minutes prior to ischemia had some beneficial effects. Infusing verapamil during
the first 15 minutes of reperfusion did not improve recovery.
Watts (1986) studied Isolated working rat hearts, made ischemic for 27 to 33
minutes and thereafter reperfused:
There was no enhancement of contractile function when verapamil, diltiazem or
nifedipine were given to hearts during the initial phase of reperfusion. However
when these drugs were given to hearts before ischemia the recovery on
reperfusion was significantly greater than hearts receiving no drug. There were
no major differences between the three drugs. The protection was associated
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with higher energy stores and reduced intracellular calcium overload following
reperfusion.
Massoudy (1995) studied isolated working guinea pig hearts made ischemic for
15 minutes and reperfused for 15 minutes. Gallopamil was given either before
ischemia (0.1 nM and 1 nM) or on reperfusion (0.1 nM) for the first 5 minutes of
reperfusion. Short term post-ischemic application of gallopamil was as effective
at restoring cardiac pump function as pre-ischemic application. Pre-ischemic
application had no negative inotropic effects (0.1 nM) contributing to its
protection. If administered on reperfusion there was an improved reduction in
oxidative stress.
Author Ischemic Drug & dose Preparation Result Comment
time & type
Kinoshita 1989 5 min + LAD Diltiazem: Conscious rats Immediately on Aim was to evaluate
occlusion 0.5 + 2mg/kg reperfusion: reperfusion
Veraparnil: Drugs administered 10 Control group: 100% arrhythmias.Verapamii
0.5 + 5mg/kg min before ischemia VT - 87% VF • death. group 11 HR likely
Nifedipine: (12 in each group Diltiazem due to effect on slow
5 + 50pg/kg Control group (15) (0.5mg/kg): 42% VF calcium channel
(2mg/kg): 35% VF
Verapamil
(0.5mg/kg): 25% VF
(5mg/kg): O%VF
Nifedipine
(5pg/kg): 25% VF
(50pg/kg): 8% VF
Obata 1997 15 min LAD Dilhazem lVI Anesthetized rats Decrease OH •
occlusion 100pg/kg/min Drugs started before generation in
ischemia reperfused segment
Gao 2001 45 min occlusion Benidipine lVI Anesthetized rabbits Decreased myocardial Infarction model. Both
rep 240 min 10p/kg Drug administered 10 apoptosis/necrosis doses effective lower
3pg/kg min before ischemia Reduced infarct size. dose no hemodynamic
Improved functional changes
recovery (lQJJg/kg)
HR - heart rate
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1.3.10 A summary of studies of systemic administration of calcium
antagonists in in vivo caninemodels.
Author Ischemic Drug & dose Preparation Result Comment
time & type
Brooks (1980) 10 min LAD Veraparnil lVI Anesthetized dogs During ischemia and Veraparnil has no
occlusion 0.1 mg/kg bolus Veraparnil infusion reperfusion: reduced effect on VF threshold
0.01 mg/kg/min started 15 min before incidence of VF. Raise in normal hearts. only
ischemia and vulnerable period in ischemic hearts. ?
contained throughout threshold for VF due to antagonism of
ischemia and enhanced adrenergic
reperfusion impulse
Lamping (1985) 15 min LAD Nicorandil lVI Anesthetized dogs. Significant • Significant
occlusion 100 pg/kg -+ Drug/vehicle started improvement in decreases in MAP
25pg/kg/min 10 min before and contractile recovery in during ischemia.
Nifedipine lVI continued throughout both treatment • Recovery not
3pg/kg -+ ischemia groups. related to
lpg/kg/min No change in myocardial
myocardial blood flow bloodflow.
during ischemia or · May be due to Lreperfusion O2 demands
during ischemia
Warltier (1988) 10 min LAD Nitrendipine lVI Conscious dogs Significantly greater Nifedipine - reduced
occlusion 3pg/kg/min Drug/vehicle started recovery of contractile MAP increased HR
30 min before function at 6 h of and coronary blood
ischemia. continued reperfusion flow
30min into reperfusion
Przyklenk (1988) 15 min LAD VerapamillVI Anesthetized dogs Verapamil Verapamil
occlusion 0.2mg/kg 1. Verapamil 30 min administered at or administered before
bolus-+0.6mg/kg/h before ischemia after reperfusion ischemia -+ H
in saline @ throughout 15 min significantly enhanced MAP not so in other
lmllmin ischemia + 180 min the function of the groups. Verapamil no
reperfusion. stunned myocardium. negative inotropic
2. Verapamil started Verapamil effect during ischemia
immediately before administered before
reperfusion. ischemia prevented
3. Verapamil started stunning
30 min after
reperfusion
Lorie (1989) 90 min LAD KT-362 lVI Anesthetized dogs Significant Infarction model. ~
occlusion 300pg/kg/min x Drug /vehicle started improvement in MAP early reperfusion
20 min 10 min before systolic function.
150pg/kg/min x ischemia continued Marked reduction in
80min throughout ischemia infarct size
Taylor (1990) 15 min LAD Dilhazem Conscious unsedated Significant ! MAP during
occlusion. 24h 15pg/kg/min dogs. improvement of diltiazern Rx no
reperfusion Dilhazem started 30 contractile function difference in regional
min before occlusion not due to decrease in myocardial bloodflow
cont 3 h into MAP. Segments with
reperfusion. 3 days most severe ischemic
later repeated with dysfunction benefit
saline most
Ehring (1992) 15 min Nisoldipine 5pg/kg Anesthetized dogs Significant MAP kept constant
circumflex lVI 4 groups: placebo; improvement only (balloon) HR constant.
occlusion drug before occlusion; when drug is given No change in regional
drug at 10 min before ischemia no myocardial blood flow
occlusion. drug at 4 benefit during during ischemia or
min reperfusion ischemia or after reperfusion
reperfusion
Hammerman LAD occlusion lVI nisoldipine Anesthetized dogs Significant reduction Infarction model
(1997) 2h ischemia -+ 6pg/kg/min Drug/saline started 30 in infarct size in BP + HR similar
1 h repertusion-« min after ischemia and nisoldipine group
1 h ischemia -+ continued throughout
2 h reperfusion
Przyklenk (1989) LAD occlusion lVI: nifedipine Anesthetized dogs Significant Sustained reduction in
15 min 0.5mg/kg Drug/saline started 30 improvement in MAP. coronary artery
reperfusion 4.5 h @1mllmin for 30 min after reperfusion systolic contractile bloodflow doubled
min continued for 30 min function
MAP - mean arterial pressure
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1.3.11 Summary of studies of systemic admin
antagonists in in vivo porcine models.
of calcium
Author Ischemic Drug & dose Preparation Result Comment
time & type
Park (1996) 10 x 2 min Nisoldipine lVI Conscious pigs. Significant Systemic
occlusion 0.5pg/kg/min Drug/vehicle from 15 improvement of hemodynamics
separated by 2 min before first contractile function Coronary bloodflow-
min reperfusion ischemia to 30 min after 10th occlusion at constant
LAD after last reperfusion 5 min 15,30 min 1h, Collateral bloodflow -
3h, 4h, 5h reperfusion nil
:. Direct cardio
protection
NB preconditioning
may playa role
Shimizu (1998) 45 min LAD lVI Anesthetized pigs Significant reduction • Infarction model
occlusion 240 -felodipine: Felodipine or SNP in infarct size in the · Beneficial effectmin reperfusion 3nmol/kg/min started 3 hours before felodipine group, but not related to
-SNP: 30 ischemia in dose to not in the SNP group decreased
nmol/kg/min decrease MAP by despite similar afterioad.
-vehicle: 30% (controlIs receive reduction in afterload · Felodipine has novehicle infusion). negative inotropic
Infusion continued effects
through 240 min
reperfusion
Verdouw (1983) 30 min LAD lVI Anesthetized pigs Significant reduction 15% ! systemic
partial occlusion Nifedipine Drug started 10 min in dysrhythmias vascular resistance
(25-30% of N) lpg/kg/min (total: before reperfusion Significant significant increase in
15pg/kg) continued for 15 min improvement in blood flow to ischemic
contractile function segment
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Systemic administration of calcium channel blocking agents is associated with
potent hemodynamic and coronary vasodilator effects. The stunned myocardium
is probably sensitive to both reductions in afterload and increases in regional
myocardial blood flow (Stahl 1986).
Direct intracoronary administration of calcium channel blocking agents allows the
use of small doses that may still achieve the same potential effect on the
myocardium, without altering mean arterial pressure or pulse rate.
Intracoronary infusion of calcium antagonists results in a blood concentration in
the coronary artery 2.5 to 5 times higher than the usual therapeutic plasma level
(Klein 1989).
Author Ischemic Drug & dose Preparation Result Comment
time & type
Lo(1985) 3h occlusion of Verapamil Anesthetized dogs A: Substantial Infarction model (3h
LAD 0.01 mg/kg/min A. Drug/saline started enhancement of ischemia) Was an
3 hr reperfusion intracoronarll 90 min after occlusion myocardial salvage. adequate dose present
continued for 1 h into B: No enhancement of at time of reperfusion
reperfusion. myocardial salvage in B group.
B. Drug/saline started (Long ischemia time -
just before reperfusion cells irreversibly
continued for 3h injured)
Przyklenk (1989) 15 min LAD Nifedipine Anesthetized dogs Significant No change in MAP
occlusion intracoronary Infusion started 30 improvement in No change in regional
1.11 -2.78 x 10-' min after reperfusion regional contractile myocardial bloodflow.
mg/kg/min x 2 h and continued for 2h function 5 min after The 2!l!'i study that
infusion: 80 - 90% clearly shows
of preocclusion values nifedipine also
attenuates contractile
function (without
changing
hemodynamics)
MAP - mean arterial pressure
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1.3.14 A summary of studies of intracoronary administration of calcium
antagonists in porcine models.
Author Ischemic Drug & dose Preparation Result Comment
time & type
Verdouw (1983) Total LAD Nifedipine intracoronary Anesthetized pig Group A no Nifedipine increased LAD
10 min A: 0.05pg/kg/min (11 min) A or B started 1 min protection flow before occlusion.
occlusion B: bolus 2pg/kg then before occlusion Group B: less VF No difference in
20min 0.05pg/kg/min (11 min) Continued through All control animals systemic hemodynamics
reperfusion ischemia stopped on died - cant compare
repeated twice reperfusion control recovery.
But recovery in both
groups better than
controls from other
studies
Klein (1989) Total LAD • Diltiazem: Anesthetized pigs. Infarct size No difference in
occlusion O.25mg/min-+0.125mg/ Intracoronary infusion reduction most in systemic hemodynamics
45 min min started 1 min before diltiazem group less Infarction model
(reperfusion 3 · Nefidipine: reperfusion continued in verapamil groupdays) 0.05mg/min-+O.025mg/ for 45 min (16 min at and no reduction in
min. high dose 30 mm at nifedipine group
• Verapamil: half dose)
0.125mg/min-0.062.· Saline:Haton N (1993) Total LAD Felodipine 7nmol/kg Anesthetized pigs Significant Infarction model
occlusion infusion in great improvement in Stable systemic
45 min cardiac vein. Started contractile function hemodynamics
reperfusion 24h 5 min before from 30 min
reperfusion continued reperfusion onwards
for 30 min Significant reduction
in infarct size
Segawa (2000) Total LAD Clevidipine Anesthetized pigs Significant reduction Infarction model
occlusion 0.3nmol/kg/min infusion in coronary in infarct size Stable systemic
45 min venous sinus started hemodynamics
reperfusion 4h 10 min before Drug short t Y2 :. effect
reperfusion continued due to local mechanism
for 30 min in ischemic tissue
Gourine (2001) Total LAD Clevidipine Anesthetized pigs - Significant reduction Infarction model
occlusion 0.3nmol/kg/min intracoronary infusion in infarct size Stable systemic
45 min started 10 min before hemodynamics
reperfusion 4 h reperfusion continued No differences in LAD
for 15 min blood flow. Protection
possibly due to NO
release and preservation
of coronary endothelial
function
Segawa (2002) Total LAD Clevidipine Anesthetized pigs- Significant reduction Infarction model.
occlusion 0.3nmol/kg/min intracoronary infusion in infarct size in Stable systemic
45 min for 5 min A started 5 min after group A + C but hemodynamic and
reperfusion 4h tYz clevidipine O.5min in occlusion. not group B coronary blood flow.
pigs B started 10 min B too late for ischemia
before reperfusion. protection.
C started 1 min Too early for reperfusion
before reperfusion protection(t Yz too short
continued for 5 min drug not present at
reperfusion
Herzog (1997) Total LAD Diltiazem 2.5mg Anesthetized pigs - Significant reduction Infarction model
occlusion 5.6pg/kg/min for 12 min intracoronary in infarct size Stable systemic
50 min infusion. Drug started hemodynamics
reperfusion 3h on reperfusion
continued for 12 min
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1.3.15 Attentuation of
drugs in the clini
reperfusion injury by calcium channel blocking
etting.
There has been some disparity between experimental results and clinical
applications (Moukarbel 2004).
Possible reasons for this are that in the animal models:
• Coronary arteries are normal.
• Coronary artery occlusion is brief.
• Therapy can be delivered on time directly into the affected area.
• High drug concentrations can be used in animal models (not safe in the
clinical situation).
In the clinical setting:
• Often the drugs are not given when they are most likely to show
benefit i.e. during the first 10 minutes of reperfusion.
• Large doses were used over a prolonged period of time, allowing
negative effects to become apparent.
Calcium channel blockers have a narrow therapeutic window in this setting.
This window is limited by time and dose (Herzog 1997).
Nevertheless, some clinical trials have shown a reduction in reperfusion injury:
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• Fewer reperfusion arrhythmias.
• Improved ejection fraction.
• Reduced mortality.
(Mourkabel 2002)
Nicolau (1996) showed that oral diltiazem given at the time of intravenous
streptokinase therapy improved left ventricular function compared to placebo
(after infarction).
Theroux (1998) demonstrated in 59 patients that intravenous diltiazem given just
before tissue plasminogen activator for thrombolysis significantly decreased
cardiac events from 41 % to 13% (cardiac events: death, myocardial infarction,
recurrent ischemia).
Pizzetti (2001) reported that intravenous diltiazem administered before coronary
reperfusion in patients with acute myocardial infarction led to a reduction in
infarct size and improved recovery of regional function.
Marangelli (2000), in the verapamil acute myocardial infarction (VAMI) trial,
showed that intravenous verapamil administered before thrombolytic therapy in
patients with acute anterior myocardial infarction was beneficial. The treatment
group had smaller left ventricular volumes and a lower prevalence of heart failure
symptoms at 3 months compared to placebo group.
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The following two clinical studies showed:
• Myocardial stunning does exist in the clinical setting.
• Stunning exists in the setting of acute subendocardial myocardial
infarction.
• Calcium overload plays a central role in the pathogenesis of stunning.
• Calcium antagonists are effective in attenuating stunning.
Sheiban (1993) studied 25 patients aged between 40 and 69 years with exercise
induced angina and single vessel disease. All patients had at least 80%
occlusion of LAD without collaterals. All patients underwent routine PTCA and
all patients had normal left ventricular function. Twelve patients received
nitrates (80 to 120 mg/day) and 13 patients received nisoldipine (10 - 20
mg/day) before PTCA and the same drug was continued after PTCA.
Immediately before the first balloon inflation an additional 300 jJg of nitrates or
0.05 mg of nisoldipine was injected into the LAD via the balloon catheter. The
inflation time was 5.5 minutes. The following statistically significant results
were recorded: During ischemia, ST segment shifts were greater in the nitrate
group and 8 patients in the nitrate group and 4 in the nisoldipine group
experienced angina. During ischemia all patients had anterior wall akinesia.
Immediately after reperfusion, 10 patients in the nisoldipine group had normal
motion compared to none in the nitrate group. Fifteen minutes after reperfusion
10 patients in the nitrate group and 1 patient in the nisoldipine group had
anterior wall akinesis. On day one after PTCA all the patients in the nisoldipine
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had normal wall function but 8 patients in the nitrate group still had anterior wall
hypokinesis. The nitrate group achieved total recovery on day 3 after the PTCA.
Immediately after reperfusion ejection fraction (EF) was normal in the nisoldipine
group and still significantly decreased in the nitrate group. Fifteen minutes and 1
day after reperfusion EF was still significantly decreased in the nitrate group.
Total recovery in the nitrate group was again only achieved on day 3.
During ischemia both groups had significant diastolic dysfunction. The diastolic
function in the nisoldipine group normalized immediately on reperfusion, whereas
the nitrate group had significant diastolic dysfunction until day 3 post PTCA.
Sheiban (1996) studied 36 patients with acute anterior myocardial infarction
with single vessel LAD disease who underwent successful early PTCA. The
patients were randomized to either oral nitrates plus enalapril or intracoronary
nisoldipine through a guiding catheter just before PTCA, followed by oral
nisoldipine plus enalapril for 6 months. The nisoldipine group again had faster
recovery of systolic and diastolic left ventricular function. Exercise capacity was
also significantly better at 30 days in the nisoldipine group.
Other investigators reported the following:
Werner (1988) administered 1 mg of verapamil into the post-stenotic vessel area
before the second inflation during PTCA of the LAD. This resulted in a delay in
anginal pain and ST-segment changes compared to the control group.
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Chouairi (1995) showed a similar result in 20 patients undergoing PTCA of the
LAD who were randomized to receive either bepridil or placebo before the
second inflation.
Serruys (1983) injected 0.2mg of nifedipine into the coronary artery before
PTCA in 11 patients, this resulted in decreased myocardial lactate production in
all patients.
Kern (1990) studied the effects of intravenous diltiazem and sublingual nifedipine
on myocardial ischemia in 23 patients for single vessel PTCA. They reported a
small attenuation of myocardial ischemia with both agents.
Feldman (1987) intravenously administered nicardipine during PTCA and noted
an increase in heart rate, a decrease in mean arterial pressure, an increase in
great cardiac vein flow and a decrease in electrical indices of ischemia.
Hanet (1987) administered 0.2mg nicardipine into the coronary artery before
PTCA in 12 patients. They reported a decrease in the clinical and electrical
indices of myocardial ischemia and a reduction in hypoxanthine and lactate
release.
Babbit (1988) and Pomerantz (1991) showed that in patients undergoing PTCA
for unstable angina with coronary spasms refractory to intracoronary
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nitroglycerine, intracoronorary verapamil resulted in complete relief of spasms
with restoration of brisk anterograde flow in all patients.
Sheiban (1992) studied 30 patients with 80% LAD stenosis and exercise
induced angina (normal ventricular function), undergoing PTCA. Patients
received either nisoldipine, nifedipine or nitrates for 7 days before PTCA and an
additional intracoronary dose at the first balloon inflation. They showed that
nisoldipine and nifedipine provided protection against the reperfusion injury
(stunning). Nitrates have no significant effects. Nisoldipine seems to be more
effective in preventing stunning than nifedipine.
Based on these studies, there seems to be consistent evidence of a protective
effect of the calcium antagonists in the clinical setting of ischemia and
reperfusion.
Peri-operative myocardial protection has 3 components (Preusse 1992):
1. Pre ischemic phase.
2. Ischemic phase (cardioplegic arrest).
3. Post ischemic phase (reperfusion) .
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The pre ischemic and ischemic phase
Calcium antagonists are effective in the treatment of chronic stable angina and
hypertension and form part of the treatment in the majority of patients
presenting for cardiac surgery. All calcium antagonists reduce the energy
turnover of the heart (Smith 1976, Watts 1986, Nayler 1976). This leads to an
improved maintenance of energy-rich phosphates which is an important
prerequisite for optimal myocardial protection.
Krukenkamp (1986) reported that diltiazem and other calcium antagonists lose
their protective effect at temperature below 25°C to 27°C. Several authors have
been unable to prove a benefitial diltiazem effect under hypothermic conditions
(Hearse 1983, Piper 1985, Yamamoto 1983). Tschirkov (1992) demonstrated
that diltiazem during open heart surgery was effective only when it was
administered intravenously under normothermic conditions before starting
cardiopulmonary bypass (CPB) and after rewarming. It was not effective when
added to cold cardioplegic solution.
The post ischemic (reperfusion) phase
Calcium antagonists may be beneficial in the first few minutes of reperfusion.
However, if an adequate dose of the drug is administered systemically
immediately before reperfusion, the duration of action of the drug may be much
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longer than the first few minutes of reperfusion when the myocytes are calcium
overloaded and the drug has a beneficial effect. After the first few minutes of
reperfusion the detrimental negative inotropic and chronotropic effects of the
drug persist, and this may be undesirable in the post bypass period.
Tschirkov et al. (1992) reported the following beneficial results if diltiazem was
given orally 60mg 3 times per day for 5 to 7 days preoperatively plus
intravenously 10mg before starting CPB plus 5 to 10mg 10 minutes before
reperfusion (removing the aorta cross clamp) in patient with left ventricular
hypertrophy presenting for aortic valve surgery:
• An earlier onset of cardiac arrest, which can be explained by the
vasodilatory effects of diltiazem on the coronary arteries when it is
given intravenously just before CPB. Rapid delivery of cardioplegia to
all myocardial segments is facilitated.
• Significantly better recovery of left ventricular function and systemic
hemodynamics in the first 48 hours after surgery.
• Significantly better preservation of myocardial tissue with less
contraction band necrosis.
They concluded that diltiazem acts directly on the myocardium, inhibiting the
inappropriate calcium flux during ischemia and reperfusion and so limiting free
radical production. The decreased afterload in the post ischemic period also
contributes to a more rapid recovery.
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Larach (1982) reported a beneficial effect of preoperative diltiazem in coronary
artery surgery, largely due to decreased pulmonary and systemic vascular
resistance.
Usui et al. (1999) showed that preoperative nisoldipine treatment prevented
myocardial damage and reperfusion injury. Their treatment group was given
nisoldipine 10mg/day for weeks before undergoing coronary artery bypass
grafting. Their results were as follows:
• Myocardial blood flow was significantly higher in the nisoldipine group
after cardiopulmonary bypass.
• Serum interleukin-6 levels were significantly lower in the nisoldipine
group one hour after reperfusion.
• Serum lactate dehydrogenase levels were significantly lower
immediately after surgery.
• The nisoldipine group showed a better left ventricular stroke work
index six hours after surgery.
• The inotrope usage was significantly lower in the nisoldipine group.
In summary, stunning is a cardiomyocyte phenomenon due to underlying calcium
overload of the cardiomyocytes (Heusch 1997). Calcium antagonists attenuate
stunning when administered just before or at early reperfusion but not at late
reperfusion (Opie 1991), as the increased calcium levels are normalized within
minutes after the onset of reperfusion (Amende 1992, Carrozza 1992, Marban
1987).
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In the clinical setting calcium antagonists may reduce myocardial blood flow by
the following mechanisms:
• The coronary arteries distal to a severe (critical) stenosis are
maximally vasodilated so any reduction in perfusion pressure will
decrease blood flow to the post stenotic area (Canty 1988).
• Decreased arterial pressure activates the baroreflex thus leading to
tachycardia. Diastolic time is shortened so decreasing blood flow to
the already maximally dilated post stenotic area. To compensate
for the tachycardia (shorter diastolic perfusion time), non-stenotic
normal vessels will dilate, shunting blood away from the ischemic
area (Heusch 1983).
• Transmural steal: In a post stenotic myocardial region auto
regulation is often still present in the subepicardium but the
subendocaridal vessels are already maximally vasodilated. During
tachycardia or pharmacological treatment the subepicardial vessels
can dilate and shunt blood away from the subendocardium resulting
in ischemia (Gallagher 1980).
• Collateral steal: Vasodilatation in a non-ischemic region will cause a
redistribution of blood away from the maximally dilated ischemic
region. (Becker 1978).
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• Post stenotic dilation decreases post stenotic perfusion pressure
and so reduces blood flow within the ischemic region.
In the presence of calcium antagonists, as long as arterial blood pressure is
maintained, there is no redistribution of blood flow at the expense of the
subendocardial layers in the ischemic area. Calcium antagonists do not
aggravate ischemia in this scenario. (Ehring 1997).
Alpha adrenergic coronary vasoconstriction contributes to the initiation and
aggravation of myocardial ischemia during sympathetic activation or exercise
(Hisch 1990) by narrowing epicardial dynamic stenoses.
Nifedipine in anesthetized dogs prevented <x,-adrenergic mediated increase in
epicardial coronary resistance as well as the increase in end diastolic resistance
mediated by <x, - and <x2-adrenergic receptors during sympathetic stimulation
(Hisch 1984). Intracoronary and intravenous nifedipine administration during
exercise (sympathetic stimulation) prevents <x2-adrenergic receptor mediated
increase in coronary resistance distal to severe stenosis as well as contractile
dysfunction and lactate production.
In dogs, during exercise, the dihydropyridine calcium antagonists improve blood
flow and function in the ischemic myocardium. The mechanism is probably the
recruitment of dilator reserve by a reduction in coronary vasomotor tone (Ehring
1997).
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Calium antagonists may interfere with ischemic preconditioning
A transient exposure to exogenous calcium has been shown to mimic ischemic
preconditioning, hence a blockade of calcium channels may interfere with this
reduction of infarct size (Node 1994).
However, in pigs, nisoldipine did not influence the reduction of infarct size by
ischemic preconditioning. Endogenous protective mechanisms of ischemic
preconditioning appear not to be affected by nisoldipine (Ehring 1997).
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1.4 Hypothesis and proposed clinical application.
Based on the preceeding information it is hypothesized that:
Verapamil, when administered in an adequate dose, directly into the LAD
coronary artery supplying the ischemic segment, at normothermia, would
attenuate the reperfusion injury i.e. stunning and arrhythmias.
Verapamil would be effective either when administered from the onset of
ischemia (for 8 minutes) or directly before and during early reperfusion (but with
enough time for drug binding and effect before reperfusion).
If given from the onset of ischemia verapamil has the following effects:
• Preservation of ATP stores during ischemia.
• Preservation of membrane ATP-ase during ischemia.
• Attenuation of intracellular Na+ accumulation during ischemia.
• Attenuation of intracellular and mitochondrial Ca2+overload during
ischemia.
• Antagonism of the L-type voltage gated calcium channels and attenuation
of calcium induced calcium release from the sarcoplasmic reticulum during
reperfusion.
If given just before and during early reperfusion verapamil would:
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• Block L-type voltage gated calcium channels on the sarcolemma.
• Attenuate calcium induced calcium release from the calcium overloaded
sarcoplasmic reticulum on reperfusion.
• Reduce calcium cycling by the sarcoplasmic reticulum during early
reperfusion.
• Prevent/attenuate calcium induced hypercontracture and arrhythmias.
The clinical application of this hypothesis is in protecting the reperfused heart
during cardiac surgery, where the application of this method (intracoronary
administration of verapamill is a distinct possibility.
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2. Methods
2.1 Generalmethods.
2.2 Measurements.
2.3 Calculations.
2.4 Statistical analysis.
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2.1 General methods.
This study was conducted with the permission of the Ethics Committee of the
University of Stellenbosch Medical School (letter dated 4/3/2002) and animals
were cared for in accordance with institutional and international guidelines.
Pigs of both sexes (26 - 32kg) were premedicated with intramuscular ketamine
(5 rnq.kq'). Intravenous access was established via an ear vein and the animals
received 25 ml.kg-l.h-l normal saline for the duration of the procedure.
Anesthesia was induced with pentobarbital (8 mq.kq': Eutha-naze, Centaur, SA)
and thiopental Zrnq.kq" and fentanyl (16,ug.kg-l, Tanyl: Intramed, SA). With loss
of eyelid reflex, a tracheotomy was performed, the trachea was intubated and
the animals ventilated (Julian, Drager, Germany) with 50% oxygen and nitrogen.
The tidal volume was set at 'l Zrnê.kq" and the rate adjusted to maintain the end-
expired PC02 at 35 mmHg. Anesthesia was maintained with a constant infusion
of pentobarbital (3mg.kg-l.h-l) and fentanyl (14,ug.kg-l .h'). Muscle relaxation
was achieved with pancuronium bromide (Organon, Sanofi-Synthelabo) initially
administered as a bolus of 0.2mg.kg-l, followed by a constant infusion of
0.3mg.kg-l.h-l).
The temperature of the animals was maintained using an under table heating
device.
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A neck dissection was performed and a stiff 16 gauge catheter inserted into the
carotid artery and advanced to within 3cm of the aortic valve. This was
connected to a transducer (Medex, Med Inc., UK) and used to display aortic
systolic, diastolic and mean arterial pressures (SAP, DAP, MAP) continuously
(Cardiocap, Datex, Finland). The latter was obtained from the area under the
aortic pressure recording. lead I of the ECG was monitored continuously.
The right femoral area was dissected and an occlusion catheter (Fogarty, Baxter,
USA) was inserted into the femoral artery and advanced into the descending
thoracic aorta. This balloon was used to raise left ventricular (lV) afterload for
the determination of end-systolic lV elastance (Ees) as described below.
A sternotomy was performed and the pericardium opened. A short stiff 14
gauge cannula, connected to a pressure transducer (Medex, Medex ltd, UK) was
inserted into the lV cavity via a stab incision in the lV apex. The catheter was
sutured to the myocardium and was used to determine lV peak, lV end diastolic
(lVEDP) and end-systolic pressures (PES), as well as the rate of pressure
increase during isovolumic contraction (+ dp/dt) and the rate of pressure
decrease during isovolumic relaxation (-dp/dt). PES was taken at the time of the
aortic valve closure (as judged from the dicrotic notch on the aortic pressure
recording) .
Two pairs of microsonometers were inserted into the lV subendocardium, one
pair in the region supplied by the lAD artery and the second in the region
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supplied by the circumflex coronary artery (lX), which was used as a control
during the interventions. Signals were transduced (digital ultrasonic
measurement system TRX series 8, Sonometries Corporation, Canada) and the
maximum segment length (lmax) at the end of diastole, as well as the minimum
segment length at the end of systole (lmin), were recorded. The difference
between lmax and lmin reflected regional segmental shortening (dL).
Shortening that occurred after aortic valve closure was termed post-systolic
shortening (PSS), and was expressed as a % of the total regional shortening
(PSS%). This was an indication of early (isovolumic) diastolic dysfunction.
lV and regional length signals were combined to give beat-by-beat pressure
length loops. By raising the afterload with the aortic balloon, various pressure -
length loops were recorded. The computer recognized the end-systolic pressure-
length points of the various loops and performed a linear regression on these
points. The slope of this was termed the end-systolic pressure-length
relationship or end-systolic elastance (Ees), and was used as an index of regional
myocardial contractility (Sagawa, 1997 and Kaseda 1985). The intercept of this
regression on the length axis (x-axis) is the extrapolated regional segment length
when the lV pressure is zero. This is the unstressed lV volume (lo).
The product of the Pes and the dl, i.e. the area under the pressure-length loop
(excluding the post-systolic shortening), is an index of regional strokework
(RSW).
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A one cm length of the proximal left anterior descending (LAD) coronary artery
was mobilized from the underlying muscle. A soft silastic loop was placed
around the artery. This was used to cause total occlusion of the LAD for 15
minutes as part of the experimental protocol. A laser doppler flow meter (small
animal blood flow meter, Tl06, Transonic Systems Inc. New York, USA) was
placed around the LAD just proximal to the silastic loop. This was to measure
coronary artery blood flow. The LAD coronary artery was cannulated just distal
to the silastic loop by means of a 26 gauge catheter (Abbocat-T. Abbott,
Ireland), in order to administer drug or saline directly into the coronary artery.
The coronary vein in the same region was cannulated by means of a 26 gauge
catheter (Abbocat-T, Abbott, Ireland) in order to obtain venous blood gas
samples from the affected area. Just before cannulation of the LAD, 1mq.kq'
heparin (Heparin, Intramed, SA) was given intravenously to prevent clot
formation in the LAD artery during the period of occlusion.
All the transduced signals were digitized at a sampling rate of 100Hz by
computer, running a custom-made program (ALAB, written by Ralph Pinna, Paul
Bailey and Johan Coetzee, SED and the Department of Anesthesiology and
Critical Care, University of Stellenbosch).
Data was recorded for 30 seconds at zero airway pressure and later redisplayed
to evaluate the quality of the measurements.
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During each recording blood samples were taken both from the proximal aorta
and from the coronary vein. Analysis of blood samples was performed by easy
blood gas blood analyzer (Medica, Bedford, Massachusetts). Blood lactate
measurements were performed by a micro lactate analyzer (Akray Inc, Japan).
An initial dose finding protocol demonstrated that a dose of up to and including
2mg of verapamil administered intravenously over 8 minutes did not decrease
mean arterial pressure by more than 10%.
Protocol
After completion of surgery, a 10 minute stabilization period was allowed, before
control measurements were made (control). The study was then performed in
three sections.
Section 1: No ischemia
Group 1: Verapamil 2mg
Section 2: Intervention 3 minutes before reperfusion.
Group 2: Verapamil 0.5mg.
Group 3: Verapamil 2 mg.
Group 4: Saline.
Section 3: Intervention at onset of ischemia.
Group 5: Verapamil 2mg.
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Group 6: Saline
Section 1:
Group 1: (n = 6)
Verapamil was administered into the LAD coronary artery at 8Jlg.kg-1.min-1 for 8
minutes (total dose ± 2mg, total volume: 8 rnê). Recordings were performed
directly after the infusion ended, and after 10, 30, 60 and 90 minutes.
Sections 2 and 3:
Sections 2 and 3 are the ischemia models. In these groups the LAD coronary
artery was occluded for 15 minutes. Recordings were made at 10 minutes after
occlusion (ischemia), and after 10, 30, 60 and 90 minutes of reperfusion
(reperfusion + 10 minutes; reperfusion + 30 minutes; reperfusion + 60
minutes and reperfusion + 90 minutes).
Group 2 (n = 8)
Three minutes before reperfusion (at 12 minutes of occlusion) an intracoronary
verapamil infusion was started at 2Jlg.kg-1.min-1 for 8 minutes i.e. 5 minutes into
reperfusion (total dose ± 0.5mg, total volume: 8mf).
Group 3 (n = 7)
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Three minutes before reperfusion (at 12 minutes of occlusion) an intracoronary
verapamil infusion was started at 8J1g.kg"1.min"1for 8 minutes i.e. 5 minutes into
reperfusion (total dose ± 2mg, total volume: 8 ml).
Group 4 (n = 9)
Three minutes before reperfusion (at 12 minutes of occlusion) an intracoronary
saline infusion was started at 1rnê.rnin' for 8 minutes i.e. 5 minutes into
reperfusion (total volume 8ml).
Group 5 (n = 6)
An intracoronary verapamil infusion was started at the onset of LAD coronary
artery occlusion at 8J1g.kg"1.min"1and continued for 8 minutes (total dose ±
2mg, total volume: 8ml).
Group 6 (n = 6)
An intracoronary saline infusion was started at the onset of LAD coronary artery
occlusion at 1rnt.mln' and continued for 8 minutes (total volume 8ml).
If more than three ventricular ectopic beats per minutes occurred, or if they were
multifocal in origin, 1rnq.kq' intravenous lidocaine was administered. This was
repeated if necessary. The total dose of lidocain required was recorded.
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Ventricular tachycardia and ventricular fibrillation were treated with 1rnq.kq"
lidocaine intravenously, followed by direct defibrillation of the heart with 5, 5,
10, 10 and 15 Joules. The total amount of lidocaine and joules required to
control the ventricular arrhythmias were recorded for each animal.
At the end of the experiment the heart was arrested with KCI intravenously
while the animal was maintained under deep anesthesia. The heart was
removed and the LAD artery cannulated with the tip of the cannula situated at
the point where the artery had been occluded. Five ml of ink diluted with saline
was injected into the coronary artery. The ventricles were opened and the area
demarcated by the ink on the endocardium was excised from the heart. The
mass of this area as well as the total LV mass were measured and recorded.
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fig. 2.1
A schematic drawing of the model used in this study. Two pairs of
piezo-electric crystals were inserted into the subendocardium in areas
supplied by the left descending (LAD) and circumflex (LX) coronary
artery. LV pressure was obtained via a stiff cannula. The pressure
and length signals were combined by computer and resulted in real
time pressure-length loops. Aortic pressure was transduced from a
catheter in the aorta. The position of the occlusion on the LAD is
indicated.
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Fig.2.2
The pressure length loop, demonstrating post-systolic shortening
(PSS). This is shortening which occurs after the closure of the aortic
valve and hence into early diastole. PSS does not contribute towards
ejection. PSS is then expressed as a % of the total shortening i.e. the
sum of dl and PSS.
A Coetzee
PhD (Stell) Effects of inhalation anesthesia on myocardial ischemia and
reperfusion injury. University of Stellenbosch 1994
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Fig 2.3
An example of pressure-length loops generated by altering the
afterioad. The end-systolic pressure and length points for the
various afterloaded contractions were identified by computer and
subjected to linear regression. The slope of this line is termed the
end-systolic pressure-length relationship (ESPLR). It is also known
as the Emax or Ees. It is regarded as a load independent index of
regional myocardial contractility.
A Coetzee
PhD(Stell). Effect of inhalation anesthesia on myocardial ischemia
and the reperfusion injury. University of Stellenbosch. 1994
Stellenbosch University http://scholar.sun.ac.za
lV pressure
(mm Hg)
lV pressure
(mm Hg)
Fig.2.4
lo ESPlR lV regional
length (mm)
Pes
dl )
.2 §
E '';:;
0) ~o ,_> .....o c
C/) 0.- ()
SW = dl x Pes.2 cE .20) .....- coo x
> co0-
C/) 0).- ,_ end-diastolic
pressu re/length
[lmax]~-------r--------~~-------------
[lmin]
lV regional
length (mm)
Top: A schematic representation of regional pressure-length loops and the end-
systolic pressure length relationship (ESPLR).
Bottom: The various components of the pressure-length loop depicting a single
cardiac cycle. The product of regional shortening (dl) and end-systolic pressure (Pes)
is the regional stroke work (SW).
A Coetzee
PhD(SteJl). Effect of inhalation anesthesia on myocardial ischemia and reperfusion
injury. University of Stellenbosch 1994
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2.2 Measurements.
Total animal mass (kg)
Ischemic segment mass (g)
LV mass (g)
temperature (OC)
coronary bloodflow (rnt.mln')
heart rate
SAP (mmHg)
DAP (mmHg)
MAP (mmHg)
+dp/dtmax (mm Hq.s')
-dp/dtmax (mm Hq.s')
LAD Lmax: maximum LAD segment length (mm)
LAD Lmin, : LAD segment length when aortic valve closes (mm)
LAD Lmin2: minimum LAD segment length (mm)
LAD Lo: LAD segment length when LV pressure is zero (mm)
LAD Ees: LAD segment end-systolic elastance (rnrn+lq.mm")
Pes: LV end-systolic pressure (mmHg)
Ped: LVEDP
LX Lmax: maximum LX segment length (mm)
LX Lmin,: LX segment length when aortic valve closes (mm)
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LX Lmin2: minimum LX segment length (mm)
LX Lo: LX segment length when LV pressure is zero (mm)
LX Ees: LAD segment end-systolic elastance (rnml+q.mm')
Bloodgas measurements:
Arterial pH
PaC02 (kPa)
Pa O2 (kPa)
HC03 (art) (rnrnol.t')
Sa02 (%)
Arterial lactate (rnmol.ê")
Haemoglobin (g.dt')
venous pH
PvC02 (kPa)
Pv02 (kPa)
HC03 (ven) Imrnol.I'")
Sv02 (%)
Venous lactate (rnmol.t')
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2.3 Calculations:
lAD tot dl
lAD syst dl :
lAD syst dl %:
lAD PSS
lAD PSS%
lAD SW
lAD stat C
total shortening of the lAD segment (mm)
lAD lmax - lAD t.rnln,
total systolic shortening of the lAD segment (mm)
lAD lmax - lAD lmin,
lAD segment systolic shortening as a percentage of
maximum lAD segment length (%)
lAD syst dL/lAD lmax x 100
lAD segment post-systolic shortening (mm)
lAD lmin, - lAD l.rnin,
lAD segment post-systolic shortening as a
percentage of total lAD segment shortening(%)
lAD PSS/lAD tot dl x 100
lAD segment stroke work (mm.mmHg)
lAD syst dl x Pes
lAD static compliance (mm.mml-tq')
lAD lmax/lVEDP
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lX tot dl
lX syst dl:
lX Syst dl%:
lX PSS
lX PSS%
lS SW
lX stat C
Total shortening of lX segment (mm)
lX lmax - lX Lrnin,
systolic shortening of lX segment (mm)
lX lmax - lx lmin,
lX segment systolic shortening as a percentage of
maximum lX segment length (%)
lX syst dL/lX lmax x 100
lX segment post-systolic shortening (mm)
lX lmin, - lX l.rnin,
lX segment post-systolic shortening as a percentage of
total lX segment shortening (%)
lX PSS/lX tot dl x 100
lX segment stroke work (mm.mmHg)
lX syst dl x Pes
lX segment static compliance (mm.mrnl-lq')
lX lmax/l VEDP
Arterial oxygen content (mt/100mf)
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(1.39 x (Sa02/100) x Hb) + (0.0031 x Pa02 x 7.5006)
Coronary venous oxygen content (ml/1 OOmt)
(1.39x (SV02/100) xHb) + (0.0031 xPv02 x7.5006)
Arterial-venous oxygen content difference (ml/1 OOml)
Ca02 - Cv02
Arterial-venous oxygen content difference as a percentage
of arterial oxygen content (%).
)/Ca02 x 100
Oxygen consumption in the ischemic segment (rnê.rnln")
cbf (Ca02 - Cv02)/100
ratio of oxygen delivery to oxygen consumption
(cbf/100g)/ \1021 OOg)
a-v dlact difference in arterial and venous lactate (rnrnot.t')
art lact - ven lact
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2.4 Statistical analysis
The statistical package Sigmastat en Sigmaplot (SPSS Inc., Chicago, Illinois,
USA. 1997) was used in the analysis of data.
Descriptive statistics included the mean and standard deviation of the mean.
For analysis of data within groups (various experimental sections), one way
repeated measures analysis of variance was used. Data was tested for normality
and equal variance. If the test passed the normality test, specific differences
between various steps were sought with a multiple comparison procedure
(Turkey Test). If normality failed, repeated measures analysis of variance based
on ranks was done.
The power of the test was also evaluated and considered in the results obtained.
The desired power was set at 0.8.
A probability of exceeding .05 was accepted as indicative of statistically
significant differences between steps.
Each step was compared to own control (initial) value. The time at which a
specific parameter recovered to the initial (control) value was noted.
Comparison between the various protocols was then further considered with
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reference to the time it took to recover to control value and this difference was
then used in further deductions and discussions.
For comparison of the incidence of arrhythmias and defibrillation requirements,
Chi2 was applied.
In the following section, in the comments on results, any stated increase or
decrease in any value at any point in time, means a statistically significant
change.
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3. Results
3.1 Group 1: Verapamil 2 mg (8pg.kg"'.min"') in the nonischemic heart.
3.2 Group 2: Verapamil O.5mg (2pg.kg"'.min"') started 3 minutes
before reperfusion and continued for 8 minutes.
3.3 Group 3: Verapamil 2mg (8pg.kg"'.min"') started 3 minutes before
reperfusion and continued for 8 minutes.
3.4 Group 4: Saline infusion started 3 minutes before reperfusion and
continued for 8 minutes.
3.5 Group 5: Verapamil 2 mg (8pg.kg"'.min"') started at the onset of
ischemia and continued for 8 minutes.
3.6 Group 6: Saline infusion started at the onset of ischemia and
continued for 8 minutes.
3.7 Reperfusion arrhythmias.
3.8 Evidence of ischemia.
3.8.1 Myocardial function.
3.8.2 Myocardial metabolism.
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General comments.
The 42 pigs enrolled in the study all had similar mass, temperature, mean arterial
pressure and coronary bloodflow at the onset of the experiments. There was
also no difference in ischemic segment mass or total LV mass between the
groups.
Of the 42 pigs, 6 received 2 mg of intracoronary verapamil in the absence of
ischemia (section 1, group 1). The remaining 36 animals were randomized to
the 5 experimental groups in sections 2 and 3. Three pigs died during the
experiments due to refractory ventricular fibrillation on reperfusion, two in the
saline groups and one in the low dose (O.5mg) verapamil group.
For clarity the sections and groups are again listed:
Section 1 - no ischemia.
Group 1 - verapamil 2mg.
Section 2 - interventions 3 minutes before reperfusion.
Group 2 - O.5mg verapamil over 8 minutes.
Group 3 - 2 mg verapamil over 8 minutes.
Group 4 - saline infusion for 8 minutes.
Section 3 - interventions at the onset of ischemia.
Group 5 - 2 mg verapamil over 8 minutes.
Group 6 - saline infusion for 8 minutes.
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3.1 Group 1: Verapamil 2mg (8pg.kg".min") in the non ischemie heart
Step Tot Isch ~it iT
mass mass • iTemp eSF BR ......• MAP •......•••Pes Ped .+dp/dt -dp/dt
Control 33.167 45.005 107.038 37.733 26.333 101.167 83.000 90.098 12.057 1311.760 1351.490
4.021 10.506 21.723 0.977 10.820 14.331 18.330 22.921 1.438 165.641 292.899
Post 33.167 45.005 107.038 37.717 75.500 100.000 66.333 70.137 14.333 1012.012 1157.550
infusion 4.021 10.506 21.723 1.098 20.686 14.311 10.690 13.865 6.631 155.171 188.633
Infusion 33.167 45.005 107.038 37.700 54.167 95.833 69.500 74.648 13.518 1021.193 1207.047
+10 min 4.021 10.506 21.723 1.135 18.159 17.440 11.777 16.668 4.198 184.295 192.541
,1i1133.167 45.005 107.038 37.617 31.000 88.000 79.833 89.697 13.086 1223.412 1408.8034.021 10.506 21.723 1.230 6.512 16.876 13.393 17.629 5.721 208.097 171.166
~~~hS~~iI33.167 45.005 107.038 37.467 32.500 87.333 86.833 99.235 13.648 1254.082 1432.878
4.021 10.506 21.723 1.397 5.577 16.379 11.548 16.590 6.723 110.217 193.852
hifusion 33.167 45.005 107.038 37.433 31.500 87.000 91.000 102.658 16.108 1238.985 1433.370
+90min 4.021 10.506 21.723 1.477 5.010 14.656 16.637 20.505 4.690 174.998 313.240
Tot mass - total animal mass (kg)
Isch mass - ischemic segment mass (g)
Vent mass - left ventricle mass (g)
Temp - temperature (OC)
CSF - coronary bloodflow (mt/min)
HR - heart rate (min")
MAP - mean arterial pressure (mmHg)
+ dP/dt - maximal positive value of the instantaneous first derivative of
left ventricular pressure Irnrn+lq.sec")
-dP/dt - maximal negative value of the instantaneous first derivative
of left ventricular pressure (rnrn+lq.sec")
Pes - left ventricular pressure at the end of systole (mmHg)
Ped - left ventricular pressure at the end of diastole (mmHg)
Coronary blood flow increased 3 fold upon administration of intracoronary
verapamil and remained higher than baseline throughout the subsequent 90
minutes. However 10 minutes after the infusion it had decreased to twice
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baseline values and 30 min after the infusion eBF was 15% higher than
baseline. It remained at this level for the rest of the experiment.
Heart rate remained constant and similar to control values until 10 minutes after
the verapamil infusion. At 30 minutes after the verapamil infusion, heart rate
was decreased and it remained decreased at the same level for the remainder of
the experiment.
MAP decreased when verapamil was infused, remained decreased 10 minutes
after the infusion, but had returned to control values by 30 minutes after the
infusion where it remained constant for the rest of the experiment.
dP/dt decreased on verapamil infusion and remained decreased 10 minutes after
the infusion. By 30 minutes after infusion dP/dt had normalized to control
values, and remained constant for the rest of the experiment.
-dP/dt: At 60 and 90 minutes post infusion the -dP/dt was higher than the
value directly after the verapamil infusion, but no difference from the control
value.
LV end systolic pressure decreased after verapamil infusion, but returned to
control values by 30 minutes after the infusion.
LV end diastolic pressure did not change during the experiment.
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'Step I..AO
~,j1
...•..LAD.
.•.~~ . ...~ ..Lmax Lmin2 1'11'1nu,y Fyl""'ln. LxLmin~ I..)( Lo I..XEes
"'!oOIIUVI 19.158 14.820 14.513 10.627 37.105 14.575 11.180 11.180 9.198 52.715
3.678 3.181 3.299 2.942 22.397 2.954 2.078 2.078 3.864 22.752
Post 20.803 18.120 16.848 15.023 32.088 15.143 11.933 11.893 10.047 47.808
infusion 3.278 2.618 3.217 2.278 9.129 3.296 2.468 2.461 2.000 18.764
Infusion 20.048 16.695 15.805 12.708 26.768 14.563 11.558 11.475 9.700 48.108
+ 10min 3.420 2.568 2.902 2.468 11.175 2.974 2.017 2.007 2.199 24.227
.~;~s~,~17.878 14.727 14.607 11.020 29.612 14.683 11.492 11.385 9.328 53.3274.708 2.576 2.791 2.470 12.955 3.134 2.127 2.129 1.881 26.633
Inf~Si~~ 18.977 14.407 14.407 9.772 31.455 14.527 11.322 11.238 8.972 53.245
3.273 2.783 2.783 3.428 18.931 3.094 2.071 2.079 1.639 27.251
Infusion 18.925 14.512 14.465 10.488 32.187 14.513 11.483 11.417 9.505 96.090
+90min 3.258 2.607 2.685 2.798 19.635 3.080 2.184 2.190 2.010 118.813
LAD Lmax - maximum LAD segment length (mm)
LAD l.min, - minimum LAD segment length at the end of systole (mm)
LAD Lrnln, - minimum LAD segment length (mm)
LAD Lo - LAD segment length when left ventricular pressure is zero (mm)
LAD Ees - end systolic elastance of the LAD segment Imrnl-iq.mrn")
LX Lmax - maximum circumflex segment length (mm)
LX Lrnin, - minimum circumflex segment length at the end of systole (mm)
LX l.rnin, - minimum circumflex length (mm)
LX Lo - circumflex segment length when left ventricular pressure is zero (mm)
LX Ees - end systolic elastance of the circumflex segment Imrnl-iq.mrn")
LAD segment
Maximum LAD segment length (LAD Lmax) increased directly after verapamil
infusion, but returned to control values by 30 minutes after the infusion.
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LAD Lo (the unstressed LAD segment length) increase directly after the
verapamil infusion, but had returned to control values by 10 minutes after the
infusion.
LAD segment end systolic elastance (index of contractility) remained unaffected
by verapamil infusion.
Circumflex segment (LX)
Maximum LX segment length was unaffected by verapamil infusion, as was LX
Lo and LX ees.
3.955 2.683 12.618 1.272 32.428 194.313 1.812
0.663 1.136 4.438 1.002 23.565 110.183 1.012
4.243 3.353 16.700 0.890 19.430 260.240 1.785
0.940 1.106 3.420 0.604 16.904 126.590 0.825
3.272 3.152 13.609 0.120 2.934 265.727 1.617
3.644 3.623 25.461 0.294 7.187 354.240 0.899
4.570 4.570 24.295 0.000 0.000 453.759 1.757
0.812 0.812 3.554 0.000 0.000 119.440 1.022
4.460 4.413 23.383 0.047 1.296 451.747 1.288
0.780 0.848 2.607 0.114 3.175 125.789 0.517
LAD tot dL - total shortening of LAD segment (mm)
LAD syst dL - total systolic shortening of LAD segment (mm)
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lAD syst dl % - lAD segment systolic shortening as a percentage
of maximum lAD segment length (%)
lAD PSS - lAD segment postsystolic shortening (mm)
lAD PSS% - lAD segment postsystolic shortening as a percentage
of total lAD segment shortening (%)
lAD SW - lAD segment stroke work (mm.mmHg)
lAD stat C - lAD segment static compliance (rnrn.rnml+q')
Total lAD segment shortening (lAD tot dl), total systolic shortening (lAD syst
dl), and lAD segment systolic shortening as a percentage of maximum lAD
segment length (lAD syst dl %) increased 60 minutes after verapamil infusion
compared to directly after the infusion, but were not greater than the control
values.
lAD segment post-systolic shortening (lAD PSS) decreased at 30 minutes after
the infusion, compared to directly after the infusion, to values no different from
controls.
lAD segment postsystolic shortening as a percentage of total lAD segment
shortening (lAD PSS%), increased directly after the verapamil infusion, but
returned to control values 30 minutes after the infusion.
lAD segment stroke work (lAD SW) increased at 60 minutes after the verapamil
infusion and remained increased (compared to directly after the infusion) at
values no different from control values.
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lAD segment static compliance (lAD stat C) remained unchanged throughout
the experiment.
Step
1.097 0.000 0.000 110.656
3.250 3.210 20.926 0.040 1.961 226.815 1.201
1.288 1.336 7.122 0.098 4.803 101.972 0.416
Infusiol1 3.088 3.005 20.051 0.083 3.374 223.571 1.131
+10 1.280 1.343 7.191 0.204 8.264 97.830 0.311
min
hlfuslol1 3.298 3.192 21.285 0.107 3.980 289.912 1.267
+30 1.125 1.222 4.898 0.261 9.749 129.226 0.501
mln
3.288 3.205 21.554 0.083 3.098 321.213 1.288
1.182 1.248 5.157 0.204 7.588 140.708 0.657
3.097 3.030 20.452 0.067 2.699 313.160 0.935
1.097 1.154 5.020 0.163 6.611 144.499 0.184
lX tot dl - lX segment total shortening (mm)
lX syst dl - lX segment total systolic shortening (mm)
lX syst dl % - lX segment systolic shortening as a percentage of
maximum lX segment length (%)
lX PSS - lX segment post systolic shortening (mm)
lX PSS% - lX segment post systolic shortening as a percentage of total
lX segment shortening (%)
lX SW - lX segment stroke work (mm.mmHg)
lX stat C - lX segment static compliance (mrn.mml+q')
There were no changes in: lX segment total shortening (lx tot dl), lX segment
systolic shortening (lX syst dl) or lX segment systolic shortening as a
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percentage of maximum lX segment length (lX syst dl %) during the
experiment.
There were no changes in lX segment post systolic shortening (lXPSS), or lX
segment postsystolic shortening as a percentage of total lX segment shortening
lX PSS% during the experiment. There was also no change in lX segment
static compliance (lX stat C) throughout the experiment.
0.731 1.744 2.227 1.491 7.021
7.413 5.312 49.500 28.917 99.950 10.667 7.385 5.488 9.567 27.850 94.050 0.567 0.683
0.021 0.679 13.255 1.685 0.084 1.780 0.016 0.622 1.776 1.359 2.944 0.513 0.668
7.388 5.552 37.967 27.900 99.833 10.667 7.365 6.368 6.283 29.667 82.083 0.583 0.617
0.016 0.755 14.610 1.207 0.103 1.780 0.018 1.022 0.325 1.524 3.338 0.531 0.624
7.433 5.407 45.833 28.283 99.833 10.750 7.363 6.690 4.083 30.200 56.033 0.567 0.533
0.083 1.018 20.707 1.474 0.225 1.782 0.039 1.454 0.671 2.252 12.857 0.520 0.493
7.398 5.610 48.800 28.650 99.883 10.750 7.367 6.315 4.283 29.633 61.150 0.950 0.583
0.018 0.769 18.902 1.495 0.117 1.782 0.025 1.128 0.387 2.024 10.075 0.826 0.875
7.412 5.303 46.700 28.233 99.883 10.750 7.368 6.627 3.650 30.167 50.017 0.733 0.667
0.010 0.988 20.479 1.760 0.147 1.782 0.032 1.425 0.152 2.199 5.406 0.509 0.745
pH a - arterial pH
PaC02 - arterial PC02 (kPa)
Pa 02 - arterial P02 (kPa)
HC03a - arterial HC03 (mrnol.t')
Sa02 - arterial saturation (%)
Hb - hemoglobin (g.dt')
pH v - coronary venous pH
PvC02 - coronary venous PC02 (kPa)
Pv02 - coronary venous P02 (kPa)
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HC03 V - coronary venous HC03 (mmol.ê")
Sv02 - coronary venous saturation (%)
lac a - arterial lactate (rnrnol.t")
lac v - coronary venous lactate (mrnol.t')
Bloodgas data
Hb and venous lactate remained constant throughout the experiment.
1.747 1.159 0.384 0.371
15.971 14.201 1.770 11.297 1.346 3.160 0.032 180.923 1.901 -0.117
2.640 2.550 0.300 2.549 0.503 1.494 0.016 81.623 1.098 0.240
15.684 12.346 3.338 21.565 1.763 4.070 0.045 124.818 1.354 -0.033
2.395 2.292 0.553 3.776 0.452 1.360 0.021 47.627 0.586 0.301
15.982 8.629 7.354 47.052 2.208 5.080 0.062 69.900 0.821 0.033
2.673 3.257 1.704 11.613 0.366 1.278 0.030 11.221 0.228 0.513
16.060 9.169 6.891 42.743 2.174 5.141 0.062 74.830 0.897 0.367
2.509 1.907 1.692 8.076 0.362 1.701 0.030 18.190 0.351 0.484
16.011 7.535 8.476 52.794 2.680 6.347 0.076 72.872 0.866 0.067
2.659 1.423 1.623 4.869 0.730 2.546 0.038 19.339 0.322 0.774
Ca02 - arterial oxygen content (mt 1OOml"l)
Cv02 - coronary venous oxygen content (mt 1OOml"l)
a-v d02 - arterial-coronary venous oxygen content difference (mt 1OOml"l)
a-v d02 % - arterial-coronary venous oxygen content difference as a percentage
of arterial oxygen content (%)
V02 - oxygen consumption in LAD segment (mt.min")
V02/100g - oxygen consumption per 100g LAD segment tissue (mt.min")
V02/100g/beat - oxygen consumption per 100g LAD segment tissue per
beat (ml)
CBF/100g - coronary blood flow per 100g LAD segment tissue (rnt.min')
CBF/100g/beat - coronary blood flow per 100g LAD segment tissue per
beat (ml)
a-v d lact - difference in arterial and venous lactate (rnmol.t")
Arterial oxygen content remained constant throughout the experiment.
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V02 and V02/100g LAD segment tissue in the LAD segment, decreased directly
after the verapamil infusion. Ten minutes after the infusion the V02 was again
no different from control values, and at 90 minutes after the infusion V02 was
significantly higher than directly after the infusion, but no different from the
control value.
V02/100g/beat decreased directly after the infusion. Ten minutes after the
infusion there was again no difference from control values, and at 90 minutes
after the infusion the V02/100g/beat was significantly higher than directly after
the infusion, but no different from control values.
CBF/100g in the LAD segment increased directly after the verapamil infusion and
had returned to control values by 30 minutes after the infusion. By 10 minutes
after the infusion CBF/100g was already significantly lower than directly after
the infusion, but still higher than control values.
CBF/100g/beat in the LAD segment increased directly after the verapamil
infusion, and had returned to control values by 30 minutes after the infusion.
The difference in arterial and venous lactate (a-v dlact) remained unchanged
throughout the experiment.
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3.2 Group 2: Verapamil O.5mg (2J..lg.kg·1.min'1) started 3 minutes before
reperfusion and continued for 8 minutes
Step Tótal Iseh Vent
mass mass mass Temp CSF HR MAP Pes Ped +dP/dt ·dP/dt
Control 28.857 38.877 96.185 37.314 33.857 105.000 70.667 74.905 10.302 1205.500 1202.190
2.035 8.005 18.271 0.953 8.395 26.245 12.144 15.984 4.487 388.125 160.434
Iseh 28.857 38.877 96.185 37.143 2.743 105.143 65.857 69.060 13.863 1077.020 1076.121
2.035 8.005 18.271 0.971 3.010 24.464 15.214 20.105 5.143 323.828 254.895
Rep+10 28.857 38.877 96.185 36.971 64.571 101.429 65.286 70.853 13.251 959.579 1018.060
min 2.035 8.005 18.271 0.948 22.337 29.748 15.141 21.107 4.417 200.136 359.056
Rep +;3.0 28.857 38.877 96.185 36.671 34.714 98.143 76.000 84.221 13.980 1036.436 1234.764
min 2.035 8.005 18.271 0.780 12.593 21.629 12.490 15.791 4.396 231.314 240.208
Rep+60 28.857 38.877 96.185 36.300 35.000 100.857 73.571 80.041 10.981 1134.451 1145.069
min 2.035 8.005 18.271 0.627 12.247 24.162 12.354 17.264 4.755 354.026 226.379
Rep+90 28.857 38.877 96.185 36.300 32.714 101.000 75.000 84.561 11.430 1127.013 1104.667
min 2.035 8.005 18.271 0.661 10.259 25.443 8.794 11.618 4.962 412.008 118.521
Tot mass - total animal mass (kg)
Isch mass - ischemic segment mass (g)
Vent mass - left ventricle mass (g)
Temp - temperature (OC)
CBF - coronary bloodflow (mt/min)
HR - heart rate (min")
MAP - mean arterial pressure (mmHg)
+dP/dt - maximal positive value of the instantaneous first derivative of
left ventricular pressure (mrn+tq.sec")
-dP/dt - maximal negative value of the instantaneous first derivative
of left ventricular pressure (rnrnl-lq.sec')
Pes - left ventricular pressure at the end of systole (mmHg)
Ped - left ventricular pressure at the end of diastole (mmHg)
CBF decreased at the onset of ischemia, but had returned to control values by
10 minutes after reperfusion.
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Heart rate and MAP remained constant throughout the experiment.
dP/dt and - dP/dt were both decreased at 10 minutes after reperfusion
compared to control values. However both had returned to control values by 30
minutes after reperfusion.
LV endsystolic pressure was increased at 30 and 90 minutes post reperfusion,
compared to ischemic values, and the values at 10 minutes post reperfusion.
LV endsystolic pressure did not change during the experiment.
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22.949 21.656 19.723 18.907 37.084 15.917 12.677 12.677 12.844 48.679
1.433 1.800 1.489 1.785 19.677 4.305 3.464 3.464 6.043 22.442
22.386 19.646 18.623 16.049 24.490 15.490 12.799 12.799 11.069 42.104
1.634 1.896 1.730 3.118 8.165 4.675 3.554 3.554 3.998 15.839
21.927 18.651 17.911 13.723 20.174 15.486 12.636 12.607 12.024 80.540
1.675 1.961 1.827 2.421 11.391 4.484 3.441 3.479 2.726 81.416
20.779 17.453 17.149 12.644 25.841 15.080 12.461 12.464 9.84 40.441
1.375 1.958 1.979 2.714 26.883 4.408 3.276 3.281 3.36 20.734
20.520 17.323 17.014 11.204 24.164 14.864 12.620 12.620 10.320 57.041
1.589 2.014 1.971 3.198 33.653 4.355 3.515 3.515 3.299 40.665
LAD Lmax - maximum LAD segment length (mm)
LAD l.rnin, - minimum LAD segment length at the end of systole (mm)
LAD Lrnin, - minimum LAD segment length (mm)
LAD Lo - LAD segment length when left ventricular pressure is zero (mm)
LAD Ees - end systolic elastance of the LAD segment (rnml-lq.rnrn']
LX Lmax - maximum circumflex segment length (mm)
LX l.rnin, - minimum circumflex segment length at the end of systole (mm)
LX Lrnin, - minimum circumflex length (mm)
LX Lo - circumflex segment length when left ventricular pressure is zero (mm)
LX Ees - end systolic elastance of the circumflex segment (mrnl-tq.mrn')
LAD segment
Maximum LAD segment length (LAD L max) increased during ischemia and
remained increased at 10 and 30 minutes reperfusion. LAD L max returned to
control values by 60 min reperfusion.
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LAD Lo (the unstressed LAD segment length) increased during ischemia
remained unchanged from this value at 10 minutes reperfusion, but had
normalized to control values by 30 minutes reperfusion.
LO segment endsystolic elastance (Ees) remained unchanged.
Circumflex segment (LX):
LX L max, lX lo and LX Ees remained unchanged during the experiment.
5.801
3.226 1.293 5.656 1.933 61.974 98.016 1.881
0.697 1.015 4.413 0.808 26.319 93.784 0.757
3.763 2.740 12.265 1.023 26.153 196.751 1.859
0.887 1.106 4.740 1.083 24.855 94.366 0.686
4.016 3.276 15.047 0.740 19.440 276.075 1.717
0.824 0.889 4.363 0.288 10.165 96.299 0.616
3.630 3.326 16.175 0.304 8.039 267.666 2.167
0.954 0.926 4.907 0.437 10.403 100.657 0.788
3.506 3.197 15.701 0.309 9.389 269.487 2.170
1.093 1.057 5.505 0.336 8.591 96.085 1.123
LAD tot dl - total shortening of LAD segment (mm)
LAD syst dl - total systolic shortening of lAD segment (mm)
LAD syst dl % - LAD segment systolic shortening as a percentage of maximum
LAD segment length (%)
LAD PSS - lAD segment postsystolic shortening (mm)
LAD PSS% - LAD segment postsystolic shortening as a percentage
of total lAD segment shortening (%)
133
Stellenbosch University http://scholar.sun.ac.za
LAD SW - LAD segment stroke work (mm.mmHg)
LAD stat C - LAD segment static compliance (rnm.rnml+q")
LAD segment calculations
Total LAD segment shortening decreased during ischemia and remained
decreased compared to the control value for the entire 90 minutes after
reperfusion.
Systolic shortening of the LAD segment (LAD syst dl) decreased during ischemia
and remained decreased compared to the control value for the entire 90 minutes
post reperfusion. The systolic shortening during reperfusion was however
consistently greater than that during ischemia.
LAD segment systolic shortening as a percentage of maximum LAD segment
length decrease during ischemia and remained decreased compared to the
control value for the entire 90 minutes post reperfusion. However from 30
minutes post reperfusion the value was consistently greater than that during
ischemia.
LAD segment postsystolic shortening (LAD PSS) increased during ischemia,
remained increased at 10 minutes post reperfusion, and returned to control
values by 30 minutes post reperfusion.
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LAD segment postsystolic shortening as a percentage of total LAD segment
shortening increased during ischemia, and returned to control values by 10
minutes post reperfusion.
LAD segment stroke work decreased during ischemia, remained decreased at 10
minutes post reperfusion, and returned to control values by 30 minutes post
reperfusion.
LAD segment static compliance remained unchanged throughout.
135
Stellenbosch University http://scholar.sun.ac.za
Step LX tot LXs}'st LXsyst LX LX
dL. dL. dL.% LXPSS PSS% LXSW statC
Control 3.350 3.350 21.802 0.000 0.000 258.585 1.630
1.962 1.962 8.303 0.000 0.000 171.370 0.708
Jsêh 3.240 3.240 20.253 0.000 0.000 235.241 1.408
1.671 1.671 8.233 0.000 0.000 141.010 0.915
.~ep.+ 2.691 2.691 16.666 0.000 0.000 205.530 1.301
1.640 1.640 7.265 0.000 0.000 149.627 0.555
Rep+ 2.879 2.850 17.904 0.029 1.832 240.307 1.244
30min 1.450 1.482 6.134 0.076 4.846 127.711 0.598
Rep+ 2.616 2.619 16.651 -0.003 -0.055 214.421 1.674
60min 1.534 1.540 6.376 0.008 0.145 134.224 0.931
ti 2.244 2.244 14.649 0.000 0.000 194.309 1.5971.292 1.292 6.195 0.000 0.000 117.772 0.941
lX tot dl - lX segment total shortening (mm)
lX syst dl - lX segment total systolic shortening (mm)
lX syst dl % - lX segment systolic shortening as a percentage of
maximum lX segment length (%)
lX PSS - lX segment post systolic shortening (mm)
lX PSS% - lX segment post systolic shortening as a percentage of total
lX segment shortening (%)
lX SW - lX segment stroke work (mm.mmHg)
lX stat C - lX segment static compliance (rnm.mrnj+q')
By 60 minutes post reperfusion the lX segment total shortening and the lX
segment systolic shortening had decreased compared to control values, as had
the lX segment systolic shortening as a percentage of maximum lX segment
length.
There were no changes in lX segment post systolic shortening (lX PSS), or lX
segment postsystolic shortening as a percentage of total lX segment shortening
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LX PSS% during the experiment. There was also no change in LX stat C during
the experiment.
p Ti <
·pHV)· •••pvC02 ~THC03VStep pHs PaC02 Pa()2 "'ê03a· Sa02 lib SV02 ./ lacv
Control 7.414 6.070 38.886 29.257 99.771 10.357 7.341 8.004 3.214 32.586 37.557 0.500 0.283
0.050 0.617 16.555 2.231 0.315 0.748 0.048 0.626 0.573 2.527 10.796 0.374 0.390
Isch 7.401 5.781 38.443 28.029 99.800 10.357 7.201 10.417 3.714 29.571 37.129 0.400 4.314
0.041 0.962 16.503 1.986 0.173 0.748 0.104 3.532 1.671 3.182 23.763 0.374 2.769
Rép+ 7.384 6.044 32.400 27.943 99.686 10.500 7.359 6.533 6.529 28.814 81.443 1.100 1.211
to min 0.036 0.680 10.704 2.076 0.313 0.764 0.035 0.651 1.106 2.265 8.425 1.449 1.895
Rep... 7.397 5.727 31.814 27.329 99.729 10.429 7.361 6.640 4.171 29.057 54.843 0.943 0.983
30min 0.034 0.751 12.681 2.105 0.214 0.732 0.031 0.669 1.097 1.984 14.662 0.905 0.978
Rep'" 7.399 5.779 29.457 28.029 99.729 10.429 7.354 6.959 3.929 25.954 50.171 0.814 0.926
60min 0.024 0.616 6.463 2.468 0.189 0.732 0.029 0.642 1.179 8.547 15.566 0.641 0.908
Rep+ 7.403 5.559 31.714 27.671 99.714 10.429 7.370 6.949 3.657 30.529 47.143 0.714 0.710
90rnin 0.028 0.500 13.098 2.112 0.212 0.732 0.039 0.610 0.741 2.845 13.510 0.647 0.729
pH a - arterial pH
PaC02 - arterial PC02 (kPa)
Pa O2 - arterial P02 (kPa)
HC03a - arterial HC03 (rnmol.ê")
Sa02 - arterial saturation (%)
Hb - hemoglobin (g.dl")
pH v - coronary venous pH
PvC02 - coronary venous PC02 (kPa)
Pv02 - coronary venous P02 (kPa)
HC03 v - coronary venous HC03 (rnmol.t")
Sv02 - coronary venous saturation (%)
lac a - arterial lactate (mrnol.t")
lac v - venous lactate (rnrnol.t")
Bloodgas data
Hb remained constant throughout.
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Coronary venous lactate level increased during ischemia, but returned to control
levels by 10 minutes post reperfusion.
Slep V02/1()Ogl CBF/100g/ a--v
cao beat CBF/100 beat d lact
Control 15.268 5.481 64.012 3.254 0.079 90.820 0.880 0.217
0.945 1.599 10.453 0.755 0.013 27.410 0.234 0.372
15.261 5.576 9.685 64.237 0.270 0.644 0.007 6.611 0.066 -3.914
1.014 3.750 3.187 22.980 0.297 0.712 0.007 7.430 0.075 2.808
15.303 12.017 3.285 21.277 2.006 5.228 0.058 169.911 1.790 -0.111
1.097 1.366 1.497 8.845 0.695 1.697 0.026 62.418 0.694 0.531
15.198 8.115 7.082 47.111 2.376 6.049 0.064 89.503 0.906 -0.040
1.200 2.491 1.899 13.789 0.892 1.820 0.021 29.634 0.166 0.483
15.143 7.447 7.696 51.355 2.530 6.585 0.068 90.720 0.891 -0.111
1.148 2.643 2.099 15.158 0.778 1.948 0.022 29.940 0.146 0.320
15.193 6.903 8.290 54.329 2.619 6.690 0.069 85.471 0.847 0.004
1.184 2.022 2.322 13.491 0.753 1.459 0.019 26.492 0.186 0.489
Ca02 - arterial oxygen content (ml.1 OOmf')
Cv02 - coronary venous oxygen content (ml.1 OOmf')
a-v d02 - arterial-venous oxygen content difference (ml.1 OOm!")
a-v d02 % - arterial-venous oxygen content difference as a percentage of
arterial oxygen content (%)
V02 - oxygen consumption in LAD segment (rnt.rnln')
V02/100g - oxygen consumption per 100g LAD segment tissue (mt.mln")
V02/100g/beat - oxygen consumption per 1DOg LAD segment tissue per
beat (ml)
CBF/100g - coronary blood flow per 100g LAD segment tissue Imê.rnin')
CBF/100g/beat - coronary blood flow per 100g LAD segment tissue per
beat (ml)
a-v d lact - difference in arterial and coronary lactate (mmol.t"!
Arterial oxygen content remained constant throughout the experiment.
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Oxygen consumption (V02) and V02/100g LAD segment tissue decreased during
ischemia and remained depressed until 60 minutes post reperfusion when values
once again approached control values. V02 and V02/100g LAD segment tissue
were however consistently greater at all times during reperfusion, than during
ischemia.
V02/100g/beat decreased during ischemia, remained decreased at 10 minutes
after reperfusion, but had returned to control values by 30 minutes after
reperfusion. Values during reperfusion were, at all times, greater than during
ischemia.
CBF/100g and CBF/100g/beat in the LAD segment decreased from control
values during ischemia and increased from control values at 10 minutes post
reperfusion and returned to control values at 30 minutes post reperfusion where
it remained for the rest of the experiment.
The difference in arterial and venous lactate levels increased during ischemia,
and returned to control values at 10 minutes post reperfusion where it remained
for the rest of the experiment.
139
Stellenbosch University http://scholar.sun.ac.za
3.3 Verapamil 2mg (8Jlg.kg·'.min·') started 3 minutes before reperfusion and
continued for 8 minutes
Step
..c:IP/dt
Control 32 44.486 38.129 22.143 90.143 83.429 91.611 13.849 1247.883 1461.109
2.769 15.495 0.892 13.372 14.531 15.925 18.522 4.017 175.552 295.397
Isch 32 44.486 93.701 38.104 0.643 97.143 75.571 81.363 17.089 1027.020 1184.844
2.769 15.495 15.922 0.985 1.092 5.757 11.703 14.352 5.192 259.218 243.899
32 44.486 93.701 37.986 43.857 97.143 73.857 80.829 17.651 1053.980 1238.577
2.769 15.495 15.922 0.942 9.371 11.466 6.842 8.645 6.135 90.474 267.099
32 44.486 93.701 37.486 20.143 88.714 81.429 82.879 15.356 1171.329 1391.809
2.769 15.495 15.922 1.579 3.288 10.339 8.904 21.516 6.309 189.674 265.139
32 44.486 93.701 37.414 21.714 90.000 86.000 96.854 12.597 1093.794 1454.746
2.769 15.495 15.922 1.596 4.112 13.844 9.092 9.100 4.086 478.146 267.164
32 44.486 93.701 37.314 20.286 90.143 85.000 95.627 13.643 1176.987 1419.150
2.769 15.495 15.922 1.782 5.282 18.371 5.000 7.616 5.995 212.745 259.958
Tot mass - total animal mass (kg)
Isch mass - ischemic segment mass (g)
Vent mass - left ventricle mass (g)
Temp - temperature (Oe)
eBF - coronary bloodflow (mt/min)
HR - heart rate (min")
MAP - mean arterial pressure (mmHg)
+ dP/dt - maximal positive value of the instantaneous first derivative of
left ventricular pressure (mm+iq.sec")
-dP/dt - maximal negative value of the instantaneous first derivative
of left ventricular pressure (mml+q.sec")
Pes - left ventricular pressure at the end of systole (mmHg)
Ped - left ventricular pressure at the end of diastole (mmHg)
eBF decreased during ischemia compared to control values and all values during
reperfusion. At 10 minutes post reperfusion eBF was higher than control values
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and all values during the remainder of reperfusion. By 30 minutes post
reperfusion eBF was no different from control values and remained so until the
end of the experiment.
Heart rate remained unchanged during the experiment, as did MAP, LV
endsystolic pressure and LV end diastolic pressure.
dP/dt also remained unchanged.
-dP/dt decreased during ischemia, but returned to control values by 10 minutes
post reperfusion, where it remained.
Step I..AOt LAD I.. LAO I.. LAD lxI.. ···.~~2max mini mini I..ADl..o Ees LXl..max mini LXLo LX Ees
Control 18.821 13.369 13.369 8.463 22.627 16.667 12.884 12.884 9.680 47.517
4.511 2.629 2.629 3.367 7.307 3.270 2.861 2.861 3.103 36.820
15th 21.193 19.391 17.216 16.921 66.047 16.879 13.647 13.493 11.440 60.571
5.553 4.873 4.557 4.639 57.378 3.670 3.020 2.969 3.489 59.918
Rep/+
10 min 20.764 17.220 16.301 14.794 29.704 16.950 13.467 13.330 11.377 48.519
5.124 4.055 3.702 4.470 12.839 3.207 2.714 2.770 2.262 34.402
Rep+ 20.113 15.749 15.437 10.427 22.367 17.030 13.349 13.349 10.804 43.669
30min 4.938 3.549 3.431 2.209 13.468 3.258 2.847 2.847 2.470 27.615
R,ep+ 19.643 15.130 15.043 10.774 26.987 16.747 13.193 13.193 10.944 88.181
60 mill 4.688 3.385 3.379 2.452 14.784 3.146 2.927 2.927 2.302 130.951
Rep+ 19.134 14.859 14.789 11.189 26.850 16.457 13.203 13.203 10.666 56.633
90 min 4.894 3.432 3.441 3.057 17.396 3.488 3.107 3.107 2.694 45.660
LAD Lmax - maximum LAD segment length (mm)
LAD Lmin, - minimum LAD segment length at the end of systole (mm)
LAD Lrnin, - minimum LAD segment length (mm)
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LAD Lo - LAD segment length when left ventricular pressure is zero (mm)
LAD Ees - end systolic elastance of the LAD segment (mm+lq.rnrn')
LX Lmax - maximum circumflex segment length (mm)
LX trnin, - minimum circumflex segment length at the end of systole (mm)
LX t.rnln, - minimum circumflex length (mm)
LX Lo - circumflex segment length when left ventricular pressure is zero (mm)
LX Ees - end systolic elastance of the circumflex segment Imml-lq.rnrn')
LAD segment
Maximum LAD segment length (LAD Lmax) increased during ischemia, remained
increased at 10 minutes post reperfusion compared to control values, and
returned to control values by 30 minutes post reperfusion.
LAD Lo (unstressed LAD segment length) increased during ischemia, remained
increased at 10 minutes post reperfusion, but had returned to control values by
30 minutes post reperfusion.
LAD Ees remained unchanged throughout.
LX segment
LX Lmax, LX Lo and LX Ees remained unchanged during the experiments.
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3.977 1.801 8.262 2.176 54.512 148.181 1.313
1.435 1.470 5.495 1.379 26.461 121.237 0.486
4.463 3.544 16.776 0.919 21.023 290.009 1.234
1.708 1.776 5.512 0.710 15.434 164.047 0.290
4.676 4.364 21.197 0.311 7.715 364.500 1.400
1.810 2.081 6.874 0.777 18.907 203.661 0.373
4.600 4.513 22.631 0.087 2.110 427.152 1.648
1.626 1.671 4.992 0.231 5.583 132.127 0.526
4.346 4.276 21.892 0.070 1.809 408.221 1.500
1.639 1.673 3.888 0.185 4.786 169.558 0.402
lAD tot dl - total shortening of lAD segment (mm)
lAD syst dl - total systolic shortening of lAD segment (mm)
lAD syst dl % - lAD segment systolic shortening as a percentage of
maximum lAD segment length (%)
lAD PSS - lAD segment postsystolic shortening (mm)
lAD PSS% - lAD segment postsystolic shortening as a percentage
of total lAD segment shortening (%)
lAD SW - lAD segment stroke work (mm.mmHg)
lAD stat C - lAD segment static compliance tmrn.rnmHq')
Total lAD segment shortening (lAD tot dl) decreased during ischemia and
returned to control values by 10 minutes post reperfusion.
lAD segment systolic shortening (lAD syst dl) and lAD segment systolic
shortening as a percentage of maximum lAD segment length (lAD syst dl %),
decreased during ischemia and returned to control values by 30 minutes post
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reperfusion. The value at 10 minutes post reperfusion was greater than that
during ischemia, but smaller than both control, and 30 minutes post reperfusion
values.
LAD segment PSS, and PSS as a percentage of total LAD segment shortening,
increased during ischemia, but returned to control values by 10 minutes post
reperfusion.
LAD segment stroke work decreased during ischemia, and returned to control
values by 30 minutes post reperfusion.
LAD segment static compliance remained unchanged during the experiments.
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3.386 3.231 19.030 0.154 5.714 268.471 1.082
1.019 1.205 5.271 0.408 15.119 121.124 0.424
3.620 3.483 20.582 0.137 3.204 276.581 1.028
0.961 0.918 3.917 0.363 8.478 58.070 0.267
3.681 3.681 21.791 0.000 0.000 308.536 1.209
1.077 1.077 4.985 0.000 0.000 118.736 0.358
3.554 3.554 21.540 0.000 0.000 344.383 1.403
1.023 1.023 5.542 0.000 0.000 99.973 0.388
3.254 3.254 19.928 0.000 0.000 309.749 1.305
1.027 1.027 5.078 0.000 0.000 93.893 0.359
lX tot dl - lX segment total shortening (mm)
lX syst dl - lX segment total systolic shortening (mm)
lX syst dl % - lX segment systolic shortening as a percentage of
maximum lX segment length (%)
lX PSS - lX segment post systolic shortening (mm)
lX PSS% - lX segment post systolic shortening as a percentage of total
lX segment shortening (%)
lX SW - lX segment stroke work (mm.mmHg)
lX stat C - lX segment static compliance (rnrn.mn-Hq')
lX tot dl, lX syst dl, lX syst dl %, lX PSS, lX PSS% and lX stat C remained
constant throughout the experiment.
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31.986 39.814 0.586
2.572 15.880 0.691
5.551 37.129 28.271 99.757 10.500 7.304 8.377 3.200 31.014 35.486 0.786 1.857
0.759 18.776 2.854 0.237 1.258 0.078 1.627 0.860 2.556 14.783 0.946 1.024
Rep+ 7.429 5.617 33.071 27.814 98.957 10.500 7.383 6.479 6.443 28.471 81.400 0.729 1.100
10min 0.054 0.966 22.206 3.011 1.191 1.258 0.086 1.414 0.608 2.370 6.627 0.877 0.847
Rep+ 7.423 5.649 34.686 27.614 99.000 10.500 7.397 6.366 4.443 29.214 61.357 0.771 0.614
30min 0.060 0.917 22.651 2.896 1.420 1.258 0.036 0.773 0.852 2.455 13.268 0.739 0.722
Rep+ 7.420 5.703 34.086 27.543 98.657 10.500 7.369 6.931 3.914 29.800 51.200 0.871 0.729
60 min 0.062 0.994 22.833 2.617 2.857 1.258 0.045 0.758 0.838 1.169 14.705 0.655 0.725
7.429 5.596 34.714 27.557 98.643 10.643 7.367 7.016 3.586 29.986 46.214 0.686 0.786
0.053 0.920 22.035 2.578 3.027 1.376 0.046 0.955 0.669 1.874 13.636 0.615 0.604
pH a - arterial pH
PaC02 - arterial PC02 (kPa)
Pa O2 - arterial P02 (kPa)
HC03a - arterial HC03 (mmol.t")
Sa02 - arterial saturation (%)
Hb - hemoglobin (g.dt')
pH v - coronary venous pH
PvC02 - coronary venous PC02 (kPa)
Pv02 - coronary venous P02 (kPa)
HC03 v - coronary venous HC03 (mrnot.t')
Sv02 - coronary venous saturation (%)
lac a - arterial lactate (mmol.t")
lac v - coronary venous lactate (rnrnol.ê")
Hb and coronary venous lactate remained unchanged during the experiments.
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Step a-v .:62% '(r02 yO~100gl CSF/100gl a-vCa02········CV02 d02 V02/100g beat CSF/100g beat d lact
..."'........ 15.237 5.994 9.243 61.474 2.006 4.210 0.048 45.961 0.533 0.000
1.845 2.480 1.790 14.915 1.310 1.681 0.020 15.655 0.231 0.462
lsch 15.423 5.440 9.983 66.051 0.063 0.112 0.001 1.171 0.012 -1.071
1.932 2.648 1.138 13.584 0.111 0.156 0.002 1.602 0.016 1.409
Rep+ 15.212 12.075 3.136 20.891 1.355 3.250 0.033 105.072 1.072 -0.371
10min 1.981 2.089 0.730 5.456 0.320 1.017 0.009 29.484 0.221 0.741
3i~'~.15.249 9.220 6.028 40.614 1.241 3.002 0.034 49.583 0.560 0.1571.956 2.823 1.325 12.338 0.431 1.291 0.014 17.199 0.188 0.351
1[1 15.185 7.713 7.472 50.323 1.620 3.738 0.042 52.310 0.588 0.1432.031 2.701 1.357 12.858 0.437 0.503 0.005 15.653 0.189 0.326
_l3ep_+ 15.393 7.035 8.358 55.115 1.731 3.935 0.044 47.309 0.538 -0.100
2.132 2.404 1.584 12.521 0.682 1.073 0.012 9.910 0.135 0.346
Ca02 - arterial oxygen content (mf. 1OOmtl)
Cv02 - coronary venous oxygen content (mf. 1OOmtl)
a-v d02 - arterial-venous oxygen content difference (mf. 1OOmtl)
a-v d02 % - arterial-venous oxygen content difference as a percentage of
arterial oxygen content (%)
\102 - oxygen consumption in LAD segment (rnt.rntn'!
\102/100g - oxygen consumption per 100g LAD segment tissue (rnt.rnln')
\102/100g/beat - oxygen consumption per 100g LAD segment tissue per
beat (mt)
CBF/100g - coronary blood flow per 100g LAD segment tissue (mê.rnin")
CBF/100g/beat - coronary blood flow per 100g LAD segment tissue per
beat (mt)
a-v d lact - difference in arterial and coronary venous lactate (rnrnol.t')
Arterial oxygen content remained unchanged throughout the experiment.
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V02, V02/100g and V02/100g/beat in the LAD segment decreased during
ischemia, but had returned to control values by 10 minutes post reperfusion, and
remained so for the rest of the experiment.
CBF/100g decreased during ischemia, and increased at 10 minutes post
reperfusion to values higher than both control values, and values at 30 minutes
post reperfusion. By 30 minutes post reperfusion CBF/100g was again the same
as controls.
CBF/100g/beat was increased at 10 minutes post reperfusion compared to
ischemic values, and compared to values during the rest of reperfusion.
The difference in arterial and coronary venous lactate remained unchanged
throughout the experiment.
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3.4 Saline infusion started 3 minutes before reperfusion and continued for 8
minutes.
Step Tót Isch Vent
.. +dP/dt ••..mass mass mass Temp /CBFi ·MR iMAP Pes.··.· Ped -dP/dt
"" ....... "!'.~ 30.857 45.356 98.157 38.100 26.000 93.000 80.286 87.484 7.904 1019.714 1402.260
5.551 9.549 25.450 0.737 5.508 10.231 16.997 19.977 2.812 421.049 324.548
15th 30.857 45.356 98.157 37.871 1.643 98.143 71.143 74.924 11.849 1113.129 1167.880
5.551 9.549 25.450 0.716 2.774 13.459 23.611 27.038 3.832 363.023 410.284
R,p+ 30.857 45.356 98.157 37.914 45.857 98.714 77.857 83.147 13.060 1071.649 1319.491
10min 5.551 9.549 25.450 0.527 21.874 18.795 14.311 17.231 3.230 204.832 273.762
~~'P~30.857 45.356 98.157 37.857 26.000 94.571 80.714 88.010 13.163 1139.914 1368.0175.551 9.549 25.450 0.461 10.017 9.414 14.044 15.185 3.441 169.362 213.282
.~,p+ 30.857 45.356 98.157 37.871 24.714 91.429 79.571 87.769 12.791 1022.340 1277.316
5.551 9.549 25.450 0.468 8.789 11.559 16.682 18.319 3.416 239.886 259.062
fbe~t 30.857 45.356 98.157 37.643 21.571 98.143 74.857 80.893 12.277 1001.600 1194.3695.551 9.549 25.450 0.635 8.810 8.971 19.970 23.305 1.592 267.726 343.227
Tot mass - total animal mass (kg)
Isch mass - ischemic segment mass (g)
Vent mass - left ventricle mass (g)
Temp - temperature (OC)
CBF - coronary bloodflow (mt/min)
HR - heart rate (min")
MAP - mean arterial pressure (mmHg)
+ dP/dt - maximal positive value of the instantaneous first derivative of
left ventricular pressure (mrn+iq.sec")
-dP/dt - maximal negative value of the instantaneous first derivative
of left ventricular pressure (rnrn+iq.sec")
Pes - left ventricular pressure at the end of systole (mmHg)
Ped - left ventricular pressure at the end of diastole (mmHg)
CBF decreased during ischemia, and was increased at 10 minutes post
reperfusion compared to 90 minutes post reperfusion. By 30 minutes post
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reperfusion eBF had returned to control values, and would remain so until the
end of the experiment.
Heart rate, MAP, LV end systolic pressure and dP/dt remained unchanged during
the experiments.
-dP/dt decreased during ischemia then recovered to control values, only to
decrease again compared to control values at 90 minutes post reperfusion.
LV end diastolic pressure increased during ischemia, and remained increased
compared to control values, for the duration of the experiment
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19.811 18.781 16.681 16.219 52.120 16.721 12.410 12.411 9.820 36.656
3.536 3.623 3.031 4.144 27.714 4.095 2.748 2.749 3.033 12.035
19.461 17.239 15.276 11.509 19.399 16.646 12.774 12.776 10.163 35.801
3.746 4.024 3.430 3.531 5.431 4.231 2.615 2.616 2.447 12.679
18.983 16.744 15.051 9.493 17.114 16.383 12.466 12.466 8.851 31.491
3.864 4.247 3.417 5.465 10.524 4.453 3.128 3.128 3.969 16.895
18.496 16.114 14.921 7.815 15.859 16.189 12.296 12.296 8.669 27.431
3.998 4.068 3.420 6.331 11.629 4.352 2.971 2.971 3.286 6.711
18.297 15.663 14.829 7.765 15.574 15.900 12.779 12.779 9.087 25.077
3.656 4.110 3.580 7.194 10.313 3.788 3.745 3.745 3.730 6.097
LAD Lmax - maximum LAD segment length (mm)
LAD t.mln, - minimum LAD segment length at the end of systole (mm)
LAD l.rnin, - minimum LAD segment length (mm)
LAD La - LAD segment length when left ventricular pressure is zero (mm)
LAD Ees - end systolic elastance of the LAD segment (mrnl-lq.mm']
LX Lmax - maximum circumflex segment length (mm)
LX l.min, - minimum circumflex segment length at the end of systole (mm)
LX Lrnin, - minimum circumflex length (mm)
LX La - circumflex segment length when left ventricular pressure is zero (mm)
LX Ees - end systolic elastance of the circumflex segment (rnrnl-lq.rnrn']
LAD segment
Maximum LAD segment length (LAD Lmax) increased during ischemia, and only
decreased again at 60 minutes post reperfusion.
LAD Lo (unstressed LAD segment length) increased during ischemia and returned
to control values by 10 minutes post reperfusion.
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lAD Ees decreased from 60 minutes post reperfusion onwards, compared to
control values.
lX segment
lX lmax, lX lo, lX Ees remained unchanged during the experiments.
LADtQt LAD ~"Psyst L.AD L.AD
dL. s stdL. eu 0/0 PSS PSS%
5.086 4.854 27.220 0.231 4.923 412.370 2.459
1.115 1.230 6.311 0.397 8.491 86.636 0.800
3.130 1.030 5.381 2.100 67.218 76.970 1.876
1.089 0.544 3.433 0.890 13.421 48.869 0.866
4.186 2.223 11.981 1.963 47.907 184.148 1.516
0.883 1.103 7.529 0.886 18.637 102.775 0.255
3.931 2.239 12.606 1.693 42.464 193.511 1.512
0.790 0.849 7.214 0.937 20.289 67.160 0.456
3.574 2.381 13.517 1.193 32.313 206.736 1.604
0.746 0.618 5.279 0.732 18.205 55.192 0.789
3.469 2.634 15.173 0.834 27.162 210.288 1.507
0.854 1.281 7.690 0.669 26.174 92.933 0.347
lAD tot dl - total shortening of lAD segment (mm)
lAD syst dl - total systolic shortening of lAD segment (mm)
lAD syst dl % - lAD segment systolic shortening as a percentage of
maximum lAD segment length (%)
lAD PSS - lAD segment postsystolic shortening (mm)
lAD PSS% - lAD segment postsystolic shortening as a percentage
of total lAD segment shortening (%)
lAD SW - lAD segment stroke work (mm.mmHg)
lAD stat C - lAD segment static compliance (rnm.mrnl-lq")
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Total LAD segment shortening decreased during ischemia, and despite an initial
recovery to control values at 10 minutes post reperfusion, it decreased again by
30 minutes post reperfusion and remained decreased at the end of the
experiment at 90 minutes post reperfusion.
LAD segment systolic shortening (LAD syst dL) and LAD segment systolic
shortening as a percentage of maximum LAD segment length (LAD syst dL%)
decreased during ischemia, and even though the post ischemic values were
higher than the ischemic values, control values has not been reached by the end
of the experiment at 90 minutes post reperfusion.
LAD segment PSS increased during ischemia and remained increased until 90
minutes post reperfusion when control values were once again approached.
LAD segment PSS as a percentage of total LAD segment shortening increased
during ischemia, and although from 30 minutes post reperfusion the values were
lower than ischemic values, control values had not been reached by the end of
the experiment at 90 minutes post reperfusion.
LAD segment stroke work decreased during ischemia, and although post
reperfusion values all increased compared to ischemic values, control values had
not been reached by the end of the experiment at 90 minutes post reperfusion.
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lAD segment static compliance was decreased at 10 minutes post reperfusion,
and remained decreased at the end of the experiment at 90 minutes post
reperfusion.
LXtót LX~ytit LXsyst LXPSS LX LXSW LX stat
dl. dl. dl.% PSS% C
3.986 3.981 23.939 0.004 0.054 326.055 2.139
1.816 1.805 4.786 0.011 0.144 82.530 0.509
4.310 4.311 25.508 -0.001 -0.032 315.511 1.509
1.427 1.427 2.416 0.004 0.086 112.828 0.441
3.870 3.871 22.517 -0.001 -0.035 302.750 1.277
1.820 1.821 5.621 0.004 0.092 95.152 0.134
3.917 3.917 23.607 0.000 0.000 332.533 1.277
1.558 1.558 4.911 0.000 0.000 102.410 0.310
3.893 3.893 23.654 0.000 0.000 329.836 1.353
1.567 1.567 4.171 0.000 0.000 105.656 0.493
3.121 3.121 20.192 0.000 0.000 249.070 1.300
0.976 0.976 5.862 0.000 0.000 84.613 0.292
lX tot dl - lX segment total shortening (mm)
lX syst dl - lX segment total systolic shortening (mm)
lX syst dl % - lX segment systolic shortening as a percentage of
maximum lX segment length (%)
lX PSS - lX segment post systolic shortening (mm)
lX PSS% - lX segment post systolic shortening as a percentage
of total lX segment shortening (%)
lX SW - lX segment stroke work (mm.mmHg)
lX stat C - lX segment static compliance Imrn.mrnl-lq"]
lX tot dl, lX syst dl, lX syst dl %, lXPSS, lX PSS%, and lX stat C remained
constant throughout the experiment.
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Step .P~G92~}1i~9~ pHy P;,]A2il ...·~"02 HC03v ~,,9f J~c: J~c
Contr()1 7.384 6.281 36.000 28.586 98.471 9.857 7.300 8.421 3.171 34.014 35.014 0.357 0.243
0.021 0.985 18.055 2.742 3.400 0.802 0.033 0.901 0.509 4.642 8.083 0.454 0.378
lseh 7.386 6.034 37.171 28.729 99.786 9.857 7.209 10.594 2.943 31.229 25.629 0.457 3.329
0.033 0.591 23.311 1.845 0.195 0.802 0.031 1.548 0.458 2.653 6.650 0.643 1.935
Rep+ 7.379 6.201 36.743 28.243 99.229 9.857 7.363 6.959 5.371 29.800 66.714 0.800 0.743
10min 0.047 0.854 22.486 1.791 1.365 0.802 0.052 1.048 1.855 2.085 20.690 0.723 0.685
Rep+ 7.390 5.920 38.843 27.943 99.729 9.643 7.334 7.173 4.029 29.857 52.014 0.829 0.800
30min 0.038 0.576 19.833 1.868 0.325 0.556 0.036 0.705 0.907 1.585 15.504 0.553 0.493
Rep+ 7.399 5.734 39.129 27.857 99.671 9.643 7.337 7.241 3.671 30.386 46.371 0.900 0.843
60lilin 0.038 0.648 19.653 1.389 0.571 0.556 0.035 0.768 0.716 2.237 12.295 0.632 0.553
R~p+ 7.393 5.723 38.671 27.343 99.643 9.714 7.347 7.269 3.571 30.086 44.186 0.857 2.200
.90.min 0.043 0.655 18.032 1.758 0.645 0.488 0.060 0.916 0.898 2.900 14.972 0.602 3.335
pH a - arterial pH
PaC02 - arterial PC02 (kPa)
Pa O2 - arterial P02 (kPa)
HC03a - arterial HC03 (mrnol.t")
Sa02 - arterial saturation (%)
Hb - hemoglobin (g.d!"1)
pH v - coronary venous pH
PvC02 - coronary venous PC02 (kPa)
Pv02 - coronary venous P02 (kPa)
HC03 v - coronary venous HC03 (rnmol.t")
Sv02 - coronary venous saturation (%)
lac a - arterial lactate (rnmol.ê')
lac v - coronary venous lactate (mrnol.ê')
Hb remained unchanged during the experiments. Coronary venous lactate
increased during ischemia, but returned to control values by 10 minutes post
reperfusion.
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$lep ............. d~~% VOa/100gl CBF/tOOgl a-v....... cá()~ CVOa = a~vcJO~ V02···· V02l1()Og beat CBF/tOOg beat dlact
....":".,~'":"'. 14.336 4.895 9.441 65.972 2.418 5.604 0.060 60.654 0.646 0.114
1.514 1.377 1.376 7.576 0.446 1.760 0.017 19.920 0.188 0.659
Isch 14.537 3.599 10.939 75.454 0.190 0.418 0.004 3.600 0.036 -2.871
1.484 1.000 1.067 5.693 0.337 0.756 0.008 6.171 0.065 1.391
Rep+ 14.457 9.362 5.095 36.189 2.010 4.872 0.047 106.490 1.063 0.057
10m!n 1.607 3.236 2.273 18.548 0.714 3.057 0.019 56.119 0.524 0.439
Rep+ 14.271 7.115 7.157 50.569 1.780 4.121 0.043 60.407 0.629 0.029
30.\mio 1.108 2.285 1.789 14.331 0.637 1.583 0.014 25.309 0.250 0.454
~ell'" 14.272 6.325 7.947 55.887 1.877 4.351 0.047 56.860 0.620 0.057
1.162 1.793 1.500 11.132 0.489 1.378 0.015 21.000 0.232 0.476
~~p"'> 14.355 6.117 8.237 57.993 1.785 4.198 0.043 50.265 0.519 -1.343
1.007 2.317 1.585 13.540 0.697 1.747 0.018 21.432 0.235 2.899
Ca02 - arterial oxygen content (m1.1 OOml'l)
Cv02 - coronary venous oxygen content (m1.1 OOml'l)
a-v d02 - arterial-venous oxygen content difference (m1.1 OOmtl)
a-v d02 % - arterial-venous oxygen content difference as a percentage of
arterial oxygen content (%)
\102 - oxygen consumption in LAD segment (më.rnln')
\102/100g - oxygen consumption per 100g LAD segment tissue (mt.min")
\102/100g/beat - oxygen consumption per 100g LAD segment tissue per
beat (ml)
CBF/100g - coronary blood flow per 100g LAD segment tissue (mê.rnln')
CBF/100g/beat - coronary blood flow per 100g LAD segment tissue per
beat (ml)
a-v d lact - difference in arterial and coronary venous lactate (rnrnol.t')
Arterial oxygen content remained unchanged throughout the experiment.
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V02, V02/100g and V02/100g/beat in the LAD segment decreased during
ischemia, but had returned to control values by 10 minutes post reperfusion, and
remained so for the rest of the experiment.
eSF/100g in the LAD segment decreased during ischemia, and increased at 10
minutes post reperfusion to values higher than both control values, and values
during the remainder of the reperfusion. Sy 30 minutes post reperfusion
eSF/100g was the same as control values, and remained so.
eSF/100g/beat in the LAD segment decreased during ischemia and returned to
control values by 10 minutes post reperfusion, and remained so.
The difference in arterial and coronary venous lactate increased during ischemia,
and returned to control values by 10 minutes post reperfusion.
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3.5.1
3.5 Verapamil 2mg (8Jlg.kg·'.min·') started at the onset of ischemia and
continued for 8 minutes
0.804 15.174
36.098 91.103 38.350 0.750 98.833 60.500 9.572 63.883 1059.982 1077.260
2.639 5.759 10.516 0.841 1.592 15.420 9.138 1.512 10.792 190.441 165.482
28.833 36.098 91.103 38.317 49.000 99.500 63.500 9.563 68.105 1085.090 1181.925
2.639 5.759 10.516 0.997 11.730 11.041 8.019 2.301 7.960 188.310 146.940
28.833 36.098 91.103 38.200 29.833 99.667 72.333 8.590 80.410 1253.888 1334.568
2.639 5.759 10.516 0.906 8.085 10.838 8.847 2.393 9.692 311.463 168.914
28.833 36.098 91.103 38.150 33.667 107.667 78.167 7.700 85.718 1084.253 1366.203
2.639 5.759 10.516 0.963 10.727 16.741 11.125 2.944 11.703 549.734 241.468
28.833 36.098 91.103 38.033 32.333 100.167 77.167 8.830 86.825 1228.285 1325.587
2.639 5.759 10.516 0.850 11.570 12.608 22.266 2.998 24.106 381.280 396.550
Tot mass - total animal mass (kg)
Isch mass - ischemic segment mass (g)
Vent mass - left ventricle mass (g)
Temp - temperature (OC)
CBF - coronary bloodflow (ml/min)
HR - heart rate (min")
MAP - mean arterial pressure (mmHg)
+dP/dt - maximal positive value of the instantaneous first derivative of
left ventricular pressure (mmHg.sec·')
-dP/dt - maximal negative value of the instantaneous first derivative
of left ventricular pressure (mml+q.sec']
Pes - left ventricular pressure at the end of systole (mmHg)
Ped - left ventricular pressure at the end of diastole (mmHg)
CBF decreased during ischemia and increased at 10 minutes post reperfusion
compared to both control, and other post reperfusion values. By 30 minutes
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post reperfusion eSF had returned to control values, and remained so until the
end of the experiment.
Heart rate remained unchanged during the experiment.
MAP and LV end systolic pressure was higher at 60 and 90 minutes post
reperfusion than during ischemia, but no different at any time from control
values. LVEDP remained unchanged throughout.
dP/dt remained unchanged during the experiment.
-dP/dt was higher at 30 and 60 minutes post reperfusion, than during ischemia,
but no different at any time from control values.
18.723 18.346 16.042 15.032 51.765 16.338 12.528 12.528 10.565 40.433
3.410 3.757 3.007 3.813 28.763 2.569 2.206 2.206 2.401 12.572
17.967 14.577 14.102 11.733 30.568 16.398 12.538 12.538 10.747 45.558
3.476 3.768 3.483 3.183 10.352 2.502 2.015 2.015 2.126 15.729
17.170 13.627 13.108 10.588 36.085 15.980 12.040 12.040 10.017 44.637
3.395 4.202 3.411 2.634 15.499 2.460 2.023 2.023 1.682 12.607
16.580 13.177 12.992 9.892 31.487 15.667 12.085 12.085 9.590 40.487
2.928 3.275 3.062 2.673 11.569 2.575 2.271 2.271 1.744 11.261
16.325 12.840 12.737 9.583 34.858 15.388 12.042 12.042 8.577 45.197
2.689 2.675 2.626 3.172 17.945 2.712 2.416 2.416 3.434 22.661
LAD Lmax - maximum LAD segment length (mm)
LAD Lrnin, - minimum LAD segment length at the end of systole (mm)
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LAD trnln, - minimum LAD segment length (mm)
LAD La - LAD segment length when left ventricular pressure is zero (mm)
LAD Ees - end systolic elastance of the LAD segment (rnrnl-iq.mrn')
LX Lmax - maximum circumflex segment length (mm)
LX trnln, - minimum circumflex segment length at the end of systole (mm)
LX trntn, - minimum circumflex length (mm)
LX La - circumflex segment length when left ventricular pressure is zero (mm)
LX Ees - end systolic elastance of the circumflex segment (mrnl+q.rnm')
LAD segment
Maximum LAD segment length (LAD Lmax) increased during ischemia, but had
returned to control values by 10 minutes post reperfusion.
LAD Lo (unstressed LAD segment length) increased during ischemia, but had
returned to control values by 10 minutes post reperfusion.
LAD Ees remained unchanged throughout.
LX segment
LX Lmax increased during ischemia, remained increased at 10 minutes post
reperfusion, but had returned to control values by 30 minutes post reperfusion
(the values at 30 and 60 minutes post reperfusion were no different from those
at 10 minutes post reperfusion, during ischemia, or control values).
LX Lo and LX Ees remained unchanged during the experiment.
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LAD LAD LAD LAD
PSS PSS% SW stélt C
0.000 0.000 290.080 2.647
0.000 0.000 109.062 0.738
3.135 1.145 6.588 2.304 68.698 72.605 1.969
0.695 0.566 3.907 0.841 20.304 34.228 0.276
Rep+ 3.865 3.390 19.481 0.475 12.230 235.253 1.956
10m!., 0.776 0.873 5.891 0.543 12.406 85.872 0.566
R~p+ 4.062 3.543 21.679 0.518 13.222 290.236 2.143
30m!n 0.967 1.234 8.045 0.831 23.362 122.778 0.780
3.588 3.403 21.124 0.185 5.355 299.295 2.463
0.986 0.939 6.033 0.287 8.983 121.489 1.121
3.588 3.485 21.689 0.103 2.026 316.016 2.007
0.909 0.718 4.444 0.253 4.963 150.913 0.695
lAD tot dl - total shortening of lAD segment (mm)
lAD syst dl - total systolic shortening of lAD segment (mm)
lAD syst dl % - lAD segment systolic shortening as a percentage of
maximum lAD segment length (%)
lAD PSS - lAD segment postsystolic shortening (mm)
lAD PSS% - lAD segment postsystolic shortening as a percentage
of total lAD segment shortening (%)
lAD SW - lAD segment stroke work (mm.mmHg)
lAD stat C - lAD segment static compliance (mrn.mrnl+q")
Total lAD segment shortening (lAD to dl) decreased during ischemia, and
returned to control values by 10 minutes post reperfusion.
lAD segment systolic shortening (lAD syst dl) and lAD segment systolic
shortening as a percentage of maximum lAD segment length (lAD syst dl %),
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decreased during ischemia and returned to control values by 10 minutes post
reperfusion.
lAD segment PSS and PSS as a percentage of total lAD segment length
increased during ischemia, but had returned to control values by 10 minutes
after reperfusion.
lAD segment stroke work decreased during ischemia, and returned to control
values by 10 minutes post reperfusion.
lAD segment static compliance remained unchanged during the experiments.
3.810 3.810 23.432 0.000 0.000 251.335 1.723
0.969 0.969 4.550 0.000 0.000 116.399 0.250
3.860 3.860 23.555 0.000 0.000 263.430 1.750
0.974 0.974 4.181 0.000 0.000 76.280 0.233
3.940 3.940 24.682 0.000 0.000 323.056 1.979
1.155 1.155 5.426 0.000 0.000 132.667 0.568
3.582 3.582 23.026 0.000 0.000 313.157 2.286
1.021 1.021 5.346 0.000 0.000 132.979 0.898
3.347 3.347 21.962 0.000 0.000 300.823 1.861
0.922 0.922 5.054 0.000 0.000 167.263 0.491
lX tot dl - lX segment total shortening (mm)
lX syst dl - lX segment total systolic shortening (mm)
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lX syst dl % - lX segment systolic shortening as a percentage of
maximum lX segment length (%)
lX PSS - lX segment post systolic shortening (mm)
lX PSS% - lX segment post systolic shortening as a percentage of total lX
segment shortening (%)
lX SW - lX segment stroke work (mm.mmHg)
lX stat C - lX segment static compliance Irnm.rnml-iq")
lX tot dl; lX syst dl; lX syst dl %; lX PSS; lX PSS% and lX stat C
remained constant throughout the experiment.
0_354 0_796 0_720
5_890 34.767 32_850 99_500 10_750 7_297 8_148 3.233 32_800 37_333 1_000 2.117
0.293 12.472 6.305 1.128 1.173 0.063 0.743 0.686 4.912 8.878 0.797 1.522
6.003 32.467 31.717 99.217 10.750 7.348 6.647 5.950 33.033 79.500 0_783 1.450
0.539 15.183 3.035 1.306 1.173 0.037 0.617 0.948 5.937 6.452 0.786 1.009
6.008 36.550 32.933 99.650 10.750 7.345 6.857 4.733 33.117 64.117 0.833 1.400
0.592 12.881 6.105 0.715 1.173 0.024 0.533 1.513 5.038 13.216 0.843 0.738
5.810 36.183 30.867 99.767 10.750 7.330 7.122 4.217 33.900 59_150 0.900 1.050
0.608 11.855 2_335 0.432 1.173 0.032 0.865 0.337 5.429 9.249 0.654 0.838
5_880 36_550 32.233 99_767 10.750 7.340 6.940 4_067 33.683 57.000 0.767 1.050
0.545 11.631 3.962 0.432 1.173 0.039 0.885 0.728 7.189 12.561 0.539 0.829
pH a - arterial pH
PaC02 - arterial PC02 (kPa)
Pa O2 - arterial P02 (kPa)
HC03a - arterial HC03 (rnrnol.t')
Sa02 - arterial saturation (%)
Hb - hemoglobin (g.dt1)
pH v - coronary venous pH
PvC02 - coronary venous PC02 (kPa)
Pv02 - coronary venous P02 (kPa)
HC03 v - coronary venous HC03 (mmol.t')
Sv02 - coronary venous saturation (%)
lac a - arterial lactate (mrnol.t')
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lac v - coronary venous lactate (mrnol.t')
Hb remained constant throughout. Coronary venous lactate increased on
ischemia, but had returned to control values by 10 minutes post reperfusion.
11.678
15.665 5.625 10.040 64.113 0.092 0.246 0.002 2.001 0.018 -1.117
1.351 1.375 1.503 7.857 0.203 0.534 0.005 4.196 0.038 1.332
15.580 12.032 3.548 22.802 1.660 4.771 0.049 135.796 1.382 -0.667
1.553 1.728 1.160 7.649 0.380 1.514 0.020 23.692 0.310 0.554
15.733 9.633 6.100 38.522 1.801 5.070 0.051 82.191 0.825 -0.567
1.386 1.881 2.136 12.712 0.780 2.032 0.019 16.397 0.130 0.631
8.940 6.805 43.378 2.272 6.208 0.057 92.585 0.865 -0.150
1.421 1.768 1.364 8.379 0.760 1.574 0.007 23.455 0.184 0.647
8.658 7.095 45.361 2.195 6.112 0.061 88.580 0.875 -0.283
1.431 2.283 1.721 12.114 0.687 1.686 0.014 26.299 0.176 0.665
Ca02 - arterial oxygen content (mt.1 00mf1)
Cv02 - coronary venous oxygen content (mt.1 00m!"1)
a-v d02 - arterial-venous oxygen content difference (mt.1 00m!"1)
a-v d02 % - arterial-venous oxygen content difference as a percentage of
arterial oxygen content (%)
V02 - oxygen consumption in LAD segment (rnê.mln')
V02/100g - oxygen consumption per 100g LAD segment tissue (mt.rnln')
V02/100g/beat - oxygen consumption per 100g LAD segment tissue per
beat (mt)
CBF/100g - coronary blood flow per 100g LAD segment tissue (mt.rntn']
CBF/100g/beat - coronary blood flow per 100g LAD segment tissue per
beat (mt)
a-v d lact - difference in arterial and coronary venous lactate (rnrnol.t')
Arterial oxygen content remained unchanged throughout the experiment.
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V02, V02/100g and V02/100g/beat in the LAD segment decreased during
ischemia, but had returned to control values by 10 minutes post reperfusion, and
remained so for the rest of the experiment.
CBF/100g and CBF/100g/beat in the LAD segment decreased during ischemia,
and increased at 10 minutes post reperfusion to values higher than both control
values, and values during the remainder of reperfusion. By 30 minutes post
reperfusion, CBF/100g and CBF/100g/beat was the same as control values and
remained so.
The difference in arterial and coronary venous lactate remained unchanged
throughout the experiment.
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3.6 Saline infusion started at the onset of ischemia and continued for 8
minutes.
Step Tot Isch Vent T~!1lp CEJF tiR MA~ .~t!~ Ped +dP/dt ·dPldt
mass mass mass. ...
• ••• ••••••
Control 30.500 26.860 90.048 38.133 24.333 108.833 71.000 74.908 9.195 1140.187 1269.550
2.665 5.060 9.006 0.572 3.882 10.962 5.831 7.159 3.625 99.410 133.756
Isch 30.500 26.860 90.048 38.060 1.480 106.200 66.800 72.688 15.614 1116.872 1107.486
2.665 5.060 9.006 0.677 3.086 6.301 18.674 20.991 4.064 356.585 334.560
30.500 26.860 90.048 38.133 41.333 109.000 77.500 82.935 11.782 1171.385 1374.440
2.665 5.060 9.006 0.572 18.239 16.297 6.535 11.177 4.223 160.119 206.298
i'f~30.500 26.860 90.048 38.133 26.167 108.000 78.000 84.202 14.385 1023.843 1268.8922.665 5.060 9.006 0.572 14.757 15.192 8.579 11.031 5.641 243.986 149.895
_~ep. 30.500 26.860 90.048 38.133 23.167 109.333 76.667 83.305 11.812 1072.743 1315.868
2.665 5.060 9.006 0.572 9.786 13.952 15.423 16.347 4.400 213.981 229.387
Rep'" 30.500 26.860 90.048 38.133 24.833 117.833 84.333 91.553 11.460 1225.330 1444.763
90min 2.665 5.060 9.006 0.572 11.686 17.971 15.332 15.246 2.581 258.632 194.683
Tot mass - total animal mass (kg)
Isch mass - ischemic segment mass (g)
Vent mass - left ventricle mass (g)
Temp - temperature (OC)
CBF - coronary bloodflow (ml/min)
HR - heart rate (min")
MAP - mean arterial pressure (mmHg)
+ dP/dt - maximal positive value of the instantaneous first derivative of
left ventricular pressure (rnrn+lq.sec')
-dP/dt - maximal negative value of the instantaneous first derivative
of left ventricular pressure Imrnl+q.sec']
Pes - left ventricular pressure at the end of systole (mmHg)
Ped - left ventricular pressure at the end of diastole (mmHg)
CBF decreased during ischemia, and was increased at 10 minutes post
reperfusion, compared to both control, and other post reperfusion values. By 30
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minutes post reperfusion eSF had returned to control values, and would remain
so until the end of the experiment
Heart rate, MAP, LV endsystolic pressure, LV end diastolic pressure, dP/dt and -
dP/dt, remained unchanged during the experiment.
3.515
21.376 19.148 16.832 14.898 25.300 16.890 13.660 13.256 11.430 58.096
4.374 3.791 3.953 3.211 10.498 2.262 2.483 2.093 2.181 57.380
21.440 17.685 16.760 12.050 20.673 16.673 13.330 13.330 11.623 71.338
4.227 3.979 3.559 2.670 9.975 2.068 2.107 2.107 2.315 66.638
21.247 17.803 16.782 12.958 26.627 16.673 13.473 13.473 11.140 42.673
4.115 3.949 3.575 2.662 16.744 1.996 2.050 2.050 2.472 15.284
20.575 17.005 16.383 12.443 22.873 16.392 13.220 13.220 11.570 46.850
3.869 3.929 3.350 2.832 7.337 2.168 1.943 1.943 3.030 18.709
20.493 16.928 16.437 10.517 18.353 16.403 13.363 13.363 10.450 45.638
3.858 4.006 3.486 2.427 6.593 2.326 2.025 2.025 2.433 30.122
LAD Lmax - maximum LAD segment length (mm)
LAD Lmin, - minimum LAD segment length at the end of systole (mm)
LAD l.rnin, - minimum LAD segment length (mm)
LAD Lo - LAD segment length when left ventricular pressure is zero (mm)
LAD Ees - end systolic elastance of the LAD segment Irnrnl-iq.mrn'")
LX Lmax - maximum circumflex segment length (mm)
LX Lmin, - minimum circumflex segment length at the end of systole (mm)
LX t.min, - minimum circumflex length (mm)
LX Lo - circumflex segment length when left ventricular pressure is zero (mm)
LX Ees - end systolic elastance of the circumflex segment (rnm+tq.rnm')
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LAD segment
Maximum LAD segment length (LAD Lmax) increased during ischemia, and only
decreased again at 60 minutes post reperfusion.
LAD Lo (unstressed LAD segment length) increased during ischemia, and
returned to control values by 10 minutes post reperfusion.
LAD Ees remained unchanged throughout.
LX segment
LX Lmax, LXLo, and LX Ees remained unchanged during the experiments.
0.814 0.814 4.384 0.000 56.156 1.849
4.544 2.228 10.155 2.316 31.301 179.286 1.417
0.646 1.075 4.604 1.087 14.619 110.088 0.350
4.680 3.755 17.579 0.925 12.525 323.257 2.447
1.347 1.806 7.327 0.732 9.899 177.179 2.218
4.465 3.443 16.245 1.022 13.833 293.861 1.722
1.334 1.674 6.922 0.623 8.434 149.792 0.789
4.192 3.570 17.682 0.622 8.404 293.952 1.995
1.253 1.461 6.635 0.749 10.111 129.489 0.858
4.057 3.565 17.678 0.492 6.647 318.378 1.853
1.395 1.790 8.130 0.738 9.960 156.580 0.516
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lAD tot dl - total shortening of lAD segment (mm)
lAD syst dl - total systolic shortening of lAD segment (mm)
lAD syst dl % - lAD segment systolic shortening as a percentage of
maximum lAD segment length (%)
lAD PSS - lAD segment postsystolic shortening (mm)
lAD PSS% - lAD segment postsystolic shortening as a percentage
of total lAD segment shortening (%)
lAD SW - lAD segment stroke work (mm.mmHg)
lAD stat C - lAD segment static compliance (mm.mml+q')
Total lAD segment shortening remained decreased at 90 minutes post
reperfusion compared to control values.
lAD segment systolic shortening (lAD syst dl) decreased during ischemia, and
remained decreased at 90 minutes post reperfusion with no improvement from
ischemic values.
lAD segment systolic shortening as a percentage of maximum lAD segment
length (lAD syst dl %) decreased during ischemia and even though the post
ischemic values were higher than the ischemic values, control values had not
been reached by the end of the experiment at 90 minutes post reperfusion.
lAD segment PSS, and PSS as a percentage of total lAD segment shortening
increased during ischemia, and although the post reperfusion values were all
lower than the ischemic values, control values were only reached at 60 minutes
post reperfusion.
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lAD segment stroke work decreased during ischemia, but had returned to
control values by 10 minutes post reperfusion.
lAD segment static compliance remained unchanged during the experiments.
Step LX tot LXsyst LXsyst LXPSS LX LXSW LX
dl dl dl% PSS% statC
3.407 3.407 21.076 0.000 0.000 253.270 2.133
Control 0.785 0.785 4.150 0.000 0.000 52.989 1.216
3.634 3.230 19.335 0.404 10.636 244.703 1.144
1.364 1.200 7.023 0.653 14.615 113.247 0.338
3.343 3.343 20.165 0.000 0.000 275.562 1.803
0.947 0.947 5.387 0.000 0.000 85.723 1.367
3.200 3.200 19.311 0.000 0.000 270.283 1.293
0.874 0.874 5.016 0.000 0.000 82.196 0.433
3.172 3.172 19.371 0.000 0.000 264.943 1.507
0.720 0.720 3.774 0.000 0.000 82.095 0.449
3.040 3.040 18.485 0.000 0.000 277.142 1.500
0.854 0.854 4.345 0.000 0.000 85.420 0.430
lX tot dl - lX segment total shortening (mm)
lX syst dl - lX segment total systolic shortening (mm)
lX syst dl % - lX segment systolic shortening as a percentage of
maximum lX segment length (%)
lX PSS - lX segment post systolic shortening (mm)
lX PSS% - lX segment post systolic shortening as a percentage
of total lX segment shortening (%)
lX SW - lX segment stroke work (mm.mmHg)
lX stat C - lX segment static compliance Imrn.rnml-lq']
lX tot dl; lX syst dl, lX syst dl %, lX PSS, lX PSS% and lX stat C remained
constant throughout the experiment.
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Step pHv
10.250 7.342 7.377 3.517 33.417 46.650 0.867 0.883
5.244 1.084 0.040 1.285 0.462 3.679 9.866 0.393 0.652
5.248 33.840 27.540 99.660 10.300 7.214 8.060 4.660 27.380 51.300 0.740 3.140
0.826 6.497 2.345 0.391 1.204 0.050 0.911 2.196 4.470 19.264 0.602 1.566
Rep" 7.400 5.702 32.258 29.100 99.533 10.250 7.285 6.540 5.797 29.733 73.933 1.083 1.700
10min 0.072 1.231 9.166 5.172 0.476 1.084 0.067 1.380 1.646 3.886 17.908 0.527 0.369
Rep+ 7.385 5.663 33.680 28.900 99.633 10.250 7.330 6.723 4.688 30.867 62.517 1.050 1.417
30min 0.043 0.675 7.166 5.017 0.472 1.084 0.076 1.496 1.323 3.702 19.557 0.497 0.776
~ep+ 7.390 5.610 31.197 29.350 99.650 10.250 7.272 7.035 4.310 31.350 58.117 1.033 1.202
60 mill 0.046 0.799 7.866 4.948 0.351 1.084 0.135 1.108 0.846 2.995 14.833 0.520 0.701
7.392 5.517 33.437 28.683 99.667 10.250 7.320 7.003 4.128 30.883 54.833 1.083 1.483
0.048 0.918 7.609 5.061 0.372 1.084 0.070 1.075 1.015 2.849 17.629 0.214 0.621
pH a - arterial pH
PaC02 - arterial PC02 (kPa)
Pa O2 - arterial P02 (kPa)
HC03a - arterial HC03 (mmol.t")
Sa02 - arterial saturation (%)
Hb - hemoglobin (g.dt')
pH v - coronary venous pH
PvC02 - coronary venous PC02 (kPa)
Pv02 - coronary venous P02 (kPa)
HC03 v - coronary venous HC03 (mrnol.t')
Sv02 - coronary venous saturation (%)
lac a - arterial lactate (mrnol.I")
lac v - venous lactate (rnrnol.t")
Hb remained unchanged during the experiment. Coronary venous lactate
increased during ischemia, but returned to control values by 10 minutes post
reperfusion.
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7.713 50.341 0.152 0.488 0.005 4.763 0.046 -2.400
3.154 19.250 0.324 1.031 0.Q10 9.812 0.095 1.663
14.929 10.794 4.135 28.683 1.461 5.679 0.052 158.147 1.418 -0.617
1.611 3.179 1.993 16.717 0.234 1.775 0.015 68.962 0.457 0.445
14.974 9.064 5.910 39.929 1.322 5.154 0.047 96.901 0.884 -0.367
1.555 2.996 2.523 18.312 0.426 2.206 0.016 49.956 0.370 0.709
14.920 8.438 6.482 43.905 1.412 5.453 0.049 86.211 0.781 -0.168
1.578 2.517 1.889 14.024 0.439 2.178 0.015 32.203 0.241 0.549
14.975 7.970 7.005 47.294 1.588 6.155 0.053 92.512 0.770 -0.400
1.560 2.814 2.284 16.587 0.540 2.608 0.023 39.380 0.253 0.569
Ca02 - arterial oxygen content (mt 1OOmf')
Cv02 - coronary venous oxygen content (mt 1OOmf')
a-v d02 - arterial-venous oxygen content difference (mt 100m!")
a-v d02 % - arterial-venous oxygen content difference as a percentage of
arterial oxygen content (%)
\r02 - oxygen consumption in LAD segment (mt.mln']
\r02/100g - oxygen consumption per 100g LAD segment tissue (rnê.rnln")
\r02/100g/beat - oxygen consumption per 100g LAD segment tissue per
beat (mt)
CBF/100g - coronary blood flow per 100g LAD segment tissue (rnt.mln')
CBF/100g/beat - coronary blood flow per 100g LAD segment tissue per
beat (mt)
a-v d lact - difference in arterial and coronary venous lactate Irnmol.I"}
Arterial oxygen content remained unchanged throughout the experiment.
V02, V02/100g and V02/100g/beat in the LAD segment decreased during
ischemia, and although it increased from ischemic values from 10 minutes post
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reperfusion onwards, it only reaches control values by 90 minutes post
reperfusion.
CBF/100g and CBF/100g/beat in the LAD segment decreased during ischemia,
and increased at 10 minutes post reperfusion to values higher than both control,
and other post reperfusion values. By 30 minutes post reperfusion CBF/100 and
CBF/100g/beat was the same as control values and remained so.
The difference in arterial and coronary venous lactate increased during ischemia
and returned to control values by 10 minutes post reperfusion.
3.7 Reperfusion arrhythmias
8
6 8 265 810 mg15
4 3 100 345 mg
50 37.5 12.5
54 mg
8
40 53.33 17.6715
43.13 mg
n - number of animals in the group.
VF - number of animals developing ventricular fibrillation on reperfusion.
VES - number of animals developing ventricular extrasystoles on reperfusion.
Joules - total joules used for defibrillation according to protocol.
Lignocain - total mg amount of lignocain used according to protocol in
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that group.
Joules/animal - total jouls for that group divided by the number of animals
in the group.
Lignocain/animal - total mg amount of lignocain used divided by the
number of animals in the group.
VF% - percentage of animals in the group developing VF (%).
VES% - percentage of animals in the group developing VES (%).
Animals receiving 2mg of verapamil, either at the onset of ischemia or 3 minutes
prior to reperfusion had a significantly lower incidence of ventricular fibrillation
than animals in the saline groups.
There was no difference in the incidence of ventricular fibrillation or ventricular
extrasystoles between the saline groups and the group receiving O.5mg of
verapamil.
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3.8 Evidence of ischemia
Data in this section was obtained from all animals subjected to ischemia (n =
36).
19.05
0.06
10.6
1.6
4.89
0.78
25.64
3.64
21.6
0.27
16.57
0.89
1.62
1.17
7.68
4.72
-6.6 11.08 11.08 12.5
<0.0000 <0.0000 <0.0000 <0.0000
0.08
o
2.06
o
38422
103.21
29.57
1.09
2.11
0.19
52.65
40.07
124.74
77.03
45.74
4.26
-8.7 -9.01 9.08 -1.96
<0.0000 <0.0000 <0.0000 <0.06
LAD L max - maximum LAD segment length (mm)
LAD Lo - LAD segment length when left ventricular pressure is zero (mm).
LAD syst dL - total systolic shortening of LAD segment (mm).
LAD syst dL% - LAD segment systolic shortening as a percentage of
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maximum LAD segment length.
LAD PSS - LAD segment postsystolic shortening (mm)
LAD PSS% - LAD segment postsystolic shortening as a percentage of
total LAD segment shortening (%).
LAD SW - LAD segment stroke work (mm.mmHg).
LAD Ees - end systolic elastance of the LAD segment [rnrnl+q.rnrn")
7.34
0.08
<0.0000
3.46
0.0
33.48
1.2
7.78
2.67
7.25
0.02
9.72
1.77
2.81
0.8
30.51
0.14
6.88 -4.20 -15.642 4.42
<0.0000 <0.0000 <0.0001
36.51
8.06
0.66
0.92
2.97
0.21
-1465
35.88
No No
difference difference
-6.10 4.13
<0.0000 <0.0001
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15.66 13.62
2.47
0.85
6.61
2.74
1.58
5.59
73.76
26.54
27.13
7.78
4.08
14.27
0.17
0.46
0.42
1.18
13.94 13.04
<0.0000 <0.0000 <0.0000 <0.0000
pHv - coronary venous pH.
PvC02 - coronary venous PC02 (kPa).
Pv02 - coronary venous P02 (kPa).
HC03v - coronary venous HC03 (mrnol.t').
SV02 - coronary venous saturation (%).
lac a - arterial lactate (rnmol.I").
lac v - coronary venous lactate (rnmol.t").
a-v d lact% - difference in arterial and coronary venous lactate as a percentage
of arterial lactate (%).
CSF - coronary blood flow (ml.rnin'}.
CSF/100 g - coronary blood flow per 100g LAD segment tissue rnl.rnin').
\'02 - oxygen consumption in the LAD segment (rnl.min').
\'02/100g - oxygen consumption per 100g LAD segment tissue (ml.mln").
There was a significant increase in maximum LAD segment length and unstressed
LAD segment length during ischemia.
LAD segment systolic shortening and LAD segment systolic shortening as a
percentage of maximum LAD segment length decreased significantly during
ischemia.
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There was a significant increase in LAD segment postsystolic shortening and
postsystolic shortening as a percentage of total LAD segment shortening.
LAD segment stroke work decreased during ischemia.
Coronary venous pH, P02 and HC03 all decreased significantly during ischemia.
There was a significant increase in coronary venous PC02, lactate, and the
difference in arterial and venous lactate as a percentage of arterial lactate.
CBF, CBF/100g, \'02 and \'02/1 OOg all decreased significantly during ischemia.
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Fig.3.1
Changes in regional systolic shortening during experiments.
Values are the mean / SDM.
Note verapamil only group did not undergo coronary occlusion.
In all the LAD occlusion groups dl was significantly less during ischemia
compared to control.
The apparent decrease in dl in the verpamil only group did not reach statistical
significance.
Verapamil during reperfusion: dl returend to control by 30 minutes reperfusion.
Verapamil during ischemia: dl retruned to control by 10 minutes reperfusion.
In both the saline groups: dl did not return to control values for the duration of
the reperfusion.
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Changes in regional normalized systolic shortening during experiments.
Values are the mean I SDM.
Note verapamil only group did not undergo coronary occlusion.
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Fig.3.2
In all the LAD occlusion groups dl % was significantly less during ischemia compared to
control.
The apparent decrease in dl % in the verparnil only group did not reach statistical
significance.
Verapamil during reperfusion: dl % returend to control by 30 minutes reperfusion.
Verapamil during ischemia: dl % retruned to control by 10 minutes reperfusion.
In both the saline groups: dl % did not return to control values for the duration of the
reperfusion.
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Fig.3.3
Changes in percent post systolic shortening during experiments.
Values are the mean / SDM.
Note verapamil only group did not undergo coronary occlusion.
PSS increased form control in all the groups where occlusion was applied to the LAD.
Verapamil only: PSS increased after infusion and returned to control by 30 minutes
after reperfusion.
In verapamil during ischemia and reperfusion: PSS returned to controls by 10
minutes reperfusion.
In saline during reperfusion: PSS did not return to control for the rest of the
experiment.
Saline during ischemia: PSS was back to control by 60 minutes reperfusion.
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Fig.3.4
Changes in extrapolated regional segment length at the time LV
pressure is zero during experiments.
Values are the mean I SDM.
Note verapamil only group did not undergo coronary occlusion.
Verapamil only: lo was increased after infusion and returned to control by 10 minutes
reperfusion.
Verapamil during reperfusion: lo was raised during occlusion and returned to control
by 30 minutes reperfusion.
Verapamil during ischemia: lo increased during ischemia and returned to control by 10
minutes reperfusion.
Saline groups: lo increased during ischemia and returned to control by 10 minutes
reperfusion.
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Fig.3.5
Changes in regional segment length at end-diastole during
experiments.
Values are the mean / SDM.
Note verapamil only group did not undergo coronary occlusion.
In all the groups LADmax increased during ischemia.
Verapamil only: LADmax retruned to control by 30 minutes.
Verapamil during reperfusion : LADmax returned to control by 30 minutes
reperfusion.
Verapamil during ischemia: LADmax retruned to control by 10 minutes.
Saline groups: LADmax returned to control by 60 minutes reperfusion.
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Fig.3.6
Changes in coronary blood flow during experiments. Values are the mean /
SDM.
Note verapamil only group did not undergo coronary occlusion.
eSF decreased in all the groups on occlusion of the LAD artery except for the verapamil only group
where no occlusion was applied.
Verapamil only: eSF increased during infusion and remained higher than control for the rest of the
study.
All the other groups: eSF was raised at the 10 minute reperfusion measurement. At 30 minutes
reperfusion it as no different from control.
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Changes in regional oxygen consumption during experiments.
Values are the mean / SDM.
Note verapamil only group did not undergo coronary occlusion.
In all the occlusion experiments, the oxygen consumption was significantly
reduced on occlusion of the coronary artery.
Verapamil only: Oxygen consumption decreased after infusion and returned to control
values by 10 minutes after infusion.
Verapamil only: Oxygen consumption was no different from control at 10 minutes.
Verapamil during ischemia and reperfusion groups: The oxygen consumption
was no different from controls at 10 minutes reperfusion.
Saline during reperfusion group: Oxygen consumption was no different form
control by 90 minutes reperfusion.
Saline during ischemia group: Oxygen consumption was no different from
control by 10 minutes reperfusion.
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Fig.3.8
Changes in venous lactate during experiments. Values are the
mean I SDM.
Note verapamil only group did not undergo coronary occlusion.
In the verapamil only the lactate did not increase during ischemia.
All the other groups showed an increase during ischemia.
In al the other groups the lactate concentration was back to control by 10 minutes
reperfusion.
Stellenbosch University http://scholar.sun.ac.za
4. Discussion
4.1 Introduction.
4.2 Discussion of the experimental model.
4.2.1 The use of the porcine as opposed to the canine model.
4.2.2 The difference between anesthetized open chest preparations and
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4.1 Introduction.
The reperfusion injury and specifically stunning, poses a problem in the clinical
setting after coronary artery revascularization. Although calcium channel
blocking drugs have been shown to attenuate the reperfusion injury (apie 1992,
Przyklenk 1992, Nayler 1991), the systemic administration of these drugs in the
above clinical setting is often problematic. This is due to the adverse
hemodynamic effects resulting from a dose large enough to be effective in
attenuating the reperfusion injury.
The aim of this thesis is to establish whether verapamil, administered timeously,
directly into the coronary artery supplying the ischemic area, at a dose large
enough to be effective locally, but without systemic effects, will attenuate
calcium induced hypercontracture and the resultant cardiac dysfunction during
reperfusion.
4.2 Discussion of the experimental model.
Factors of importance in this experimental model include:
• The animal species used, and the degree of collateral coronary artery
bloodflow.
• Whether the animal was conscious or the anesthetized open chest model.
• The duration of ischemia.
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• The timing, dosage and location of drug administration.
No animal model will meet all the relevant criteria or be an ideal choice,
however, the one selected should most closely resemble the experimental
objective and natural history of the human counterpart (Dodds 1982). The pig
has become a widely used and important large animal model for research on
human disease. An advantage of this model is that the cardiovascular system is
similar in anatomy and hemodynamics to that of humans (Bustad 1968).
As opposed to the canine model, the porcine heart resembles the human heart in
respect of the lack of native coronary collateral vessels and xanthine oxidase
activity (Eckstein 1954, White and Bloor 1981, Bloor 1986, White 1986,
Muxfeldt and Schaper 1987, Podzuweit 1987, Roth 1987 and Grum 1989). The
paucity of collateral vessels in the porcine heart eliminates the variability in
collateral flow that is inherent in canine models. Collateral flow is the major
determinant of the severity of myocardial stunning (Bolli 1988), and the
elimination of this variable results in a more reproducible post ischemic
dysfunction among different animals.
The canine left ventricle is relatively large and has a left dominant coronary
artery supply with four times more collaterals present. These collaterals are also
larger than any in the pig heart. The capillary density of the left ventricle of the
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dog is significantly greater than that of swine breeds (White 1986). Coronary
flow at maximal heart rate is significantly higher in the dog than in the pig. This
reflects either the higher heart weight to body weight ratio of the dog, or the
greater vascular capacity of the dog heart. During coronary artery occlusion,
collateral blood flow to the dog heart is five times greater than that of the pig
(White 1986). The result of this is that after acute left circumflex coronary
artery occlusion in pigs, the infarct size expressed as a percentage of the left
circumflex perfusion bed is 73 ± 4%. After acute LAD occlusion the infarct size
as a percentage of the LAD perfusion bed is 94 ± 3%. In dogs subjected to
similar acute coronary artery occlusions the infarct size was only 53 ± 7% of the
left circumflex perfusion bed and 61 ± 6% of the LAD perfusion bed (White
1986).
The porcine model was selected for this study for the following reasons:
• The coronary collateral flow in the pig heart is sparse, similar to that
of man and less than one fourth that of the dog (White 1986). Acute
occlusion of the coronary artery will eventually result in infarction of
most of the vascular bed at risk.
• The coronary artery anatomy is similar to the human heart, as is the
maximum coronary blood flow.
• The heart size and its relative weight to body weight is similar to man.
• Pigs are readily available at relatively low cost.
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4.2.2 The differences between anesthetized open chest preparations and
conscious preparations
Several investigators (Vatner 1971, Cobb 1974, Vatner and Braunwald 1975,
Templeton 1975, Manders and Vatner 1976, Jugdutt 1985, Bolli 1986, Laxon
1989, Ning 1990) have pointed out that observations in open chest models may
be confounded by the effects of anesthesia, surgical trauma, abnormal
hemodynamic conditions, and excessive levels of circulating catecholamines. It
has also been shown that in the 15 minute coronary occlusion model of
myocardial stunning, both the severity of the post ischemic dysfunction (Triana
1991) and the magnitude of the associated free radical generation (Li 1993) are
greatly exaggerated in open chest preparations as opposed to conscious animals.
Li et al (1993) showed that a brief episode of regional myocardial ischemia in the
conscious unsedated dog is associated with the generation of free radical
species on reperfusion. However this free radical production is five times less
than that in the open chest anesthetized model. The magnitude of radical
generation is directly related to the magnitude of subsequent depression of
contractility. It follows then that after reperfusion the recovery of contractile
function in the conscious animals was considerably greater than in the
anesthetized open chest preparations. In Li's study the post ischemic functional
depression associated with the anesthetized model was more than twice that
observed in the awake model. Alternatively, approximately half of the post
ischemic depression of contractility observed in the anesthetized open chest
model was absent in the conscious animal.
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The production of free radicals in open chest animals has two components: A
smaller component caused by ischemia and reperfusion, and a larger component
caused by factors unrelated to ischemia, such as trauma and adrenergic activity
(Li 1993). In open chest animals, recovery of function ceases at one hour of
reperfusion, no further improvement takes place between one and four hours of
reflow. In contrast, in the conscious animal, recovery continues unabated
throughout the first six hours of reperfusion until complete normalization is
achieved (Triana 1991) (Fig. 4.1).
Triana (1991) showed that the stunned myocardium is sensitive to variations in
temperature. There is an inverse relationship between the temperature and post
ischemic recovery in the open chest anesthetized model. Temperature increases
in the 34° tot 37°C range exert a selective depressant effect on the mechanical
function of the stunned myocardium (Fig. 4.2). This finding emphasizes the
importance of carefully controlling temperature in the open chest preparations of
myocardial stunning. In the present study the temperature of the individual
animals varied between 36 and 39°C and this may well have affected the
severity of stunning, however there was no difference in the average
temperature between the various groups, hence it is presumed that all groups
would have been equally affected.
In this study the anesthetized open chest model was employed in all the groups,
thus any exaggeration of myocardial stunning, abnormal hemodynamic
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Figure 4.1
Systolic thickening fraction in a myocardial region during ischemia
and reperfusion.Thickening fraction expressed as percent of baseline
values. Data are mean/SDM.
JF Triana. Circ Res 1991: 69:731-747
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Systolic thickening fraction in ischemic / reperfused myocardium in normo and
hypothermic dogs. Thickening fraction is expressed as percentage of baseline.
Values are mean / SDM. Upper graph illustrates the systolic function and lower
graph depicts the esophageal temperature. Temperatures were manipulated
with a heating blanket.
JF Triana eire Res 1991: 69: 731 - 747
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conditions or excessive levels of catecholamines, would have affected all groups
equally.
Myocardial stunning is often a problem in the clinical setting after coronary
artery bypass grafting. These patients, like the animals in this study, are
subjected to myocardial ischemia in the operative setting, under anesthesia, with
the chest open. Hence, although the severity of myocardial stunning is greatly
exaggerated in the surgical setting of the anesthetized open chest preparation
(Triana 1991), this model is applicable to the clinical setting, specifically in the
patient after cardiopulmonary bypass.
Previous studies have shown that calcium antagonists enhance recovery of
ventricular function (Lamping and Gross 1985, Przyklenk and Kloner 1988,
Warltier 1988, Taylor 1990, Ehring 1992, Gross and Pieper 1992). It is
however often difficult to discern how much of the dysfunction seen in these
models is due to stunning, and how much is due to infarction. This is because
long periods of ischemia were used in reported studies.
Myocardial cells rendered anoxic by sudden complete occlusion of the coronary
artery, cease to contract within 60 seconds (Sayen 1958). Such cells stay
viable for some time, as shown in dogs by the fact that restoration of blood flow
at any time during the first 18 minutes of ischemia is followed quickly by
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resumption of normal cellular structure, function and metabolism (Jennings
1963). Thus, affected cells are injured by ischemia, but the injury is "reversible"
provided blood flow is restored within this period. Further prolongation of
ischemia beyond 18 minutes results in death of an increasing number of affected
cells, irrespective of whether or not their blood supply is restored. Injury to
these cells is "permanent" (Jennings 1963).
Mortally injured myocardial cells are first apparent after twenty minutes of
ischemia. 55% of ischemic cells are dead after 45 minutes, and almost 100%
after 60 minutes of ischemia (Jennings 1965).
Jennings (1965) showed reversible changes induced by coronary occlusion
lasting 15 minutes or less (Fig. 4.4). These included: moderate relaxation of
myofibers, margination of nuclear chromatin, moderate glycogen depletion, and
loss of cristae and less dense matrices in occasional mitochondria. However, as
in non-ischemic (control) myocardium, intra mitochondrial granules were not
seen, and the sarcolemma, intercalated disks, sarcoplasmic reticulum and
transverse tubular system were normal, as was capillary morphology.
If however ischemia lasts 30 minutes or longer, myocardial cells were irreversibly
injured. This is demonstrated by extreme relaxation of myofibers, more marked
margination of nuclear chromatin, a virtual absence of glycogen, and extensive
mitochondrial abnormalities. Intra mitochondrial granules, representing calcium
accumulations, became increasingly prominent with more prolonged ischemia.
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Disruptions and discontinuities of the sarcolemma and sarcoplasmic reticulum
occurred after 60 minutes of ischemia (Fig. 4.3, 4.5, 4.6).
Heyndrickx (1975) demonstrated that when reperfusion occurred after 15
minutes of coronary artery occlusion, electrographic changes revert to normal
within 1 minute and necrosis does not ensue. However, regional myocardial
function in the previously ischemic zone of the heart remains depressed for at
least 6 hours. Regional function does recover completely between 6 and 24
hours post reperfusion, which is consistent with the concept that no permanent
damage has occurred. Hence, the threshold for irreversible myocardial injury is
reached at approximately 20 minutes of ischemia, at which point occasional
small focci of necrosis result (Jennings 1965, Reimer 1977). A coronary
occlusion period of 15 minute duration results in structural and functional
alterations that are ultimately fully reversible (Heyndrickx 1977, 1978).
In the present study an ischemic period of 15 minutes was chosen as this
ensures the presence of the reperfusion injury (stunning and dysrhythmias)
without resulting in irreversible myocardial damage.
Systemic administration of anyone of several calcium channel blocking drugs
(verapamil, diltiazem, nifedipine, nitrendipine, amlodipine) has been shown to
improve recovery of function in regionally stunned myocardium in intact animals
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Figure 4.3
Myocardial cell after 60 minute coronary artery occlusion. The myofibrils are
moderately contracted, the nuclear and sarcolemmal membranes are scalloped.
Transverse tubules (t), which are morphologically similar to the sarcolemma, are
seen at or near to the Z bands. The granular chromatin of the nucleus (n) is
evenly dispersed and the nucleolus (nu) prominent. The mitochondriae (m)
have moderately dense matrices, normal cristae and do not contain dense
granules. The glycogen (g) content is normal.
RB Jennings et al Arch Pathol 1965: 79: 135 - 143
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Figure 4.4
Fifteen minutes of ischemia. The nucleus (n) shows dispersion and
some margination of chromatin material. The amount of glycogen is
diminished.
RB Jennings Arch Pathol 1965: 79: 135 - 143
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Figure 4.5
Forty minutes of ischemia. Chromatin margination in the nucleus (n) is more
striking and mitochondrial changes are more advanced. Small granules are
present in some mitochondria (arrow). Glycogen is virtually absent.
Nucleolus (nu) and intercalated disc (id) visible.
RB Jennings Arch Pathol 1965: 79: 135 - 143
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Figure 4.6
Sixty minutes of ischemia. The myofibrils are relaxed and clearly show an N
line and the I band on either side of the Z band. The M band is present within
the H band. Margination of nuclear chromatin is prominent and mitochondrial
changes include loss of dense matrices, disruption of cristae and the
presence of intramitochondrial granules.
RB Jennings Arch Pathol 1965: 79: 135 - 143
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(Lamping and Gross 1995, Przyklenk and Kloner 1988, Warltier 1988, Przyklenk
1989, Taylor 1990, Ehring 1992, Gross and Pieper 1992). However, in most of
these studies it is unclear whether the beneficial effects reflected a direct
protective action of the drug on the myocardium, or were mediated by favorable
modifications of afterioad, preload, heart rate and regional myocardial blood
flow. If the drug is administered directly to the ischemic myocardium, the dose
may be adjusted in such a way that no systemic hemodynamic alterations take
place, so that any improvement in function is due to a direct myocardial
protective action of the drug.
It is also of importance that therapeutic concentrations of the drug are present in
the ischemic myocardium at the very onset of reperfusion. Drugs given
intravenously during ischemia may not reach the ischemic area in the absence of
a collateral circulation. Even in the presence of collaterals, a large intravenous
dose is usually needed to achieve significant drug concentrations in the ischemic
area. Systemic effects of the drug may then induce negative hemodynamic side
effects. In contrast, local drug administration, such as antegrade intracoronary
administration, has the advantage that the compound is selectively delivered into
the targeted region, reaching a sufficient level without affecting the non-
ischemic myocardium (Wang 2002). For these reasons in this study, drug or
placebo were delivered directly into the proximal LAD, just distal to the
occlusion. In addition, during coronary bypass procedures, there exists the
unique opportunity to deliver a protective drug directly into the region at risk.
This was one of the potential clinical applications of this study.
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It is important that therapeutic concentrations of verapamil are present in the
ischemic myocardium at the very onset of reperfusion (Wang 2002). Studies
have shown that calcium channel blocking drugs effectively attenuate the
reperfusion injury when administered before the onset of ischemia (Knabb 1986,
Garcia-Dorado 1987, Vatner 1988) . However, since long acting calcium
antagonists were used, these studies do not distinguish between protection
against ischemic injury and reperfusion injury.
A number of studies have shown that calcium antagonists administered
immediately before or at the onset of reperfusion are protective (Klein 1989,
Hatori 1993). Herzog (1997) showed that a low dose of diltiazem administered
via the LAD in the swine heart during early reperfusion only, diminished infarct
size. Because most studies have shown that calcium channel blockers provide
benefit when given before ischemia or before reperfusion, but not at or after
reperfusion, it has been postulated (Taylor 1990) that the benefit is due to
protection from the effects of ischemia rather than from decreases in reperfusion
related calcium influx. However bearing in mind that calcium influx and
contraction band necrosis take place in the first few seconds of reperfusion, and
that time is required for drug binding and action, it follows that the calcium
channel blocker needs to be present, bound and active at the time of reperfusion
to be effective. In the present study the verapamil infusion was started either 3
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minutes before reperfusion or at the onset of ischemia i.e. 15 minutes before
reperfusion.
The usual clinical dose of verapamil in the human is 0.07 mg/kg (Opie 1988).
This dose will result in systemic hemodynamic changes in most cases. The dose
response curve of verapamil in the porcine model is unknown.
Intracoronary verapamil was used in two previous studies: Klein (1989), used
intracoronary verapamil in a porcine model: After 45 minutes of ischemia
intracoronary verapamil was started 60 seconds before reperfusion, continued at
a high dose: 0.125 mg/min for 16 minutes and then a low dose: 0.062 mg/min
for 30 minutes. Thus the total dose was 2mg + 1.86 mg = 3.86mg over 46
minutes, and the dose in the first 8 minutes was 1mg.
Lo (1985) used intracoronary verapamil in a canine model where dogs were
subjected to 3 hours of coronary artery occlusion followed by 3 hours of
reperfusion. In their protocol A, verapamil was infused at 0,01 mg/kg/min from
90 minutes of occlusion until 1 hour after reperfusion. In their protocol B
verapamil was infused at the same rate starting just before reperfusion and
continuing throughout the reperfusion period. The total dose of verapamil in
dogs weighing ± 30kg was: 45mg over 2 YS hours. The dose in the first 8
minutes of infusion was 2.4mg.
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In this study the average weight of the animal was 30.55 ± 3.55kg and the
average weight of the ischemic segment of the left ventricle that would be
perfused by the intracoronary verapamil was 41.97 ± 11.74g. The low dose of
verapamil chosen in this study was O,5mg or O,017mg/kg. This dose is unlikely
to cause any systemic hemodynamic changes in the animal. However a dose of
O,5mg of verapamil administered into the proximal LAD supplying ± 40g of
myocardium, is a dose of 12,5mg/kg into the LAD perfusion bed. This dose may
have local effects on the cardiomyocyte.
To decide on the "high" dose of verapamil to be used in this study, 6 pigs were
subjected to an 8 minute systemic infusion of verapamil at 1mt/min in increasing
concentrations (increasing total dosages). The high dose of verapamil was the
highest dosage that, when administered in an infusion at 1mt/min for 8 minutes,
did not lead to a decrease in mean arterial pressure of more than 10%. The
dose so identified was 2mg.
2mg verapamil: O,07mg/kg total weight
20 mg/kg heart muscle
50mg/kg ischemic heart muscle
In the present study, when 2 mg of verapamil was infused over 8 minutes into
the normal LAD coronary artery (absence of ischemia), the mean arterial pressure
decreased (83 ± 18.33mmHg to 66.3 ± 10. 7mmHg), remained decreased at
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10 minutes after the infusion (69.5 ± 11.8mmHg), but had returned to baseline
by 30 minutes after the infusion (79.8 ± 13.4mmHg). However when 2mg of
veraparnil was infused into the occluded LAD coronary artery (presence of
ischemia), either at the onset of ischemia, or 3 minutes before reperfusion, there
was no change in mean arterial pressure.
The use of anesthesia is unavoidable in the open chest preparations. It is
important to realize that these agents may modify the effects of myocardial
ischemia and reperfusion, and affect cardiovascular responses to pharmacologic
agents. In this study the anesthetic used was pentobarbital and fentanyl
infusions, with pancuronium as the neuromuscular blocking agent. Ketamine
was used as premedication.
Racemic ketamine has been found to block early and late preconditioning in
rabbit and rat myocardium (Ko 1997, Zaugg 2003, MOllenheim 2001).
In the porcine model, pentobarbital reduces stroke volume by direct cardiac
depression. It also increases systemic vascular resistance and heart rate. The
drug however depresses the baroreceptor induced reflex tachycardia as the mean
arterial pressure falls, and since hypotension is a common feature during
myocardial ischemia, the ischemia induced response may be modified (Verdouw
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1988). Most commonly used barbiturates inhibit mitochondrial KATP channel
activity and therefore inhibit preconditioning (Zaugg 2003, Kohro 2001).
Fentanyl, through interaction with delta-opiate receptors, enhances mitochondrial
KATP channel activity and results in myocardial preconditioning (Wild 1991, Zaugg
2002).
Pancuronium, which is the most widely used neuromuscular blocking agent in
the swine model, has no effect on myocardial substrate utilization (Dhusmana
1982).
Inhalation agents, which profoundly influence myocardial functional and
metabolic responses to ischemia and reperfusion in swine and dogs (Coezee
1993, Warltier 1988, Verdouw 1988, Merin 1982), and are potent agonists of
myocardial preconditioning (Zaugg 2003), were avoided in the present study.
In view of the potential effects on ischemia and reperfusion, of the individual
anesthetic agents used, an identical anesthetic technique was used in all animals
in this study. Therefore any difference in function on reperfusion between the
groups would be due to the different protocols for intracoronary verapamil or
saline.
193
Stellenbosch University http://scholar.sun.ac.za
4.3 Evidence of myocardial ischemia.
Prior to examining the effects of the reperfusion injury it is important to establish
that significant ischemia was indeed present in the experimental preparation.
This will be done in two parts:
• Functional evidence of myocardial ischemia.
• Metabolic evidence of myocardial ischemia.
Sudden occlusion of the LAD coronary artery caused severe regional myocardial
dysfunction, evident within 3 to 4 beats in the LAD perfusion bed. The
myocardial function in the region supplied by the circumflex coronary artery
remained unchanged. Myocardial dysfunction preceded ST segment changes on
EeG by several minutes.
The myocardial dysfunction was visible as weaker contraction followed
promptly by systolic outward movement (bulging) of the affected ventricular
wall. These classic visible signs of left ventricular segmental ischemia have been
published by several investigators (Tennant and Wiggers 1935, Edwards and
Rankin 1981, Forrester 1972, Perzada 1975, Glower 1988).
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The following measured parameters changed significantly during ischemia
compared to control values in all the groups studied:
1. There was an increase in maximum LAD segment length (Lmax).
2. There was an increase in LAD segment length when the extrapolated left
ventricular pressure is zero (Lo).
3. There was a decrease in both systolic shortening of the LAD segment
(LAD syst dL) and LAD segment systolic shortening as a percentage of
maximum LAD segment length (syst dL %).
4. There was an increase in both LAD segment post systolic shortening
(PSS) and LAD segment post systolic shortening as a percentage of total
LAD segment shortening.
5. There was a decrease in LAD segment stokework (SW).
In this study the pressure length loop was used to analyze segment
function. The pressure-length loop provides a sensitive way of examining
the synchrony of contraction of a given segment with respect to the rest
of the left ventricle (Wyatt 1975). Regional segment length reflects the
time course of contraction of the ischemic segment interacting with the
normal myocardium adjacent to it. Left ventricular pressure reflects the
time course of contraction of the entire ventricle (Wyatt 1975).
After occlusion of the LAD coronary artery, segment lengthening instead
of shortening occurs during systole in the ischemic segment of the LAD
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perfusion bed (Tyberg 1974). This represents an inability of the ischemic
muscle segment to contract against the stress developed by the non-
ischemic lV muscle mass. The ischemic segment bulges outwards as the
rest of the ventricle contracts. On the pressure-length loop segment
length increases as a result of increased total lV pressure (Normally
segment shortening results in an increase in lV pressure) (Fig. 4.7).
Under non-ischemic conditions, as the segment shortens during systole it
produces an anti-clockwise loop or positive loop (Wyatt 1975). The area
enclosed by a pressure-length loop over one cardiac cycle represents the
mechanical work done by that segment during that cycle (Forrester 1974).
Due to ischemia the affected segment is paralyzed and lengthens instead
of shortening during systole, as it is "bulged" outward by the normally
contracting non-ischemic ventricle. This ischemic paralysis results in a
clockwise pressure-length loop, with a negative value for loop area. This
indicates that work was done by the rest of the ventricle on the ischemic
segment, as opposed to work done by the ischemic segment (Wyatt
1975). This systolic bulging explains the finding in the present study of
an increase in maximum lAD segment length during ischemia. The
ischemic paralysis described above also explains the decrease in systolic
shortening of the lAD segment during systole seen in the present study
and the clockwise direction of the pressure-length loop with the negative
value for loop area explains the decrease in lAD segment strokework
observed in the present study.
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In this study acute ischemia shifted the pressure-length loop, and thus the
end-systolic pressure-length relation (ESPLR) to the right. La,which is the
intercept of the ESPLR with the length (x) axes was therefore also right
shifted. Hence, any particular pressure at the end of systole was
associated with an increased regional end-systolic myocardial length. This
increase in La indicates a decreased elasticity at the end of systole which
underscores the previously noted paralysis of the acutely ischemic
myocardium. These findings confirm previously reported results (Tyberg
1974, Osakada 1983, Theroux 1974, Warltier 1988, Ross 1976, Victory
1991 ).
As shown by Stahl (1986), the slope of the ESPLR in the present study
remains constant during ischemia. This does not represent an active
process, and is simply the result of an interaction between the increase in
LV pressure and the absence of regional shortening (Victory 1991,
Sunagawa 1982). Elasticity (contractility) certainly does decrease during
ischemia and this index looses its validity during acute ischemia.
Concerning systolic function during acute ischemia the consistent finding
among investigators is a right shifted pressure-length relationship and the
complete loss of systolic shortening (Sunagawa 1983, Kaseda 1984).
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Post-systolic shortening (PSS), which is an indication of early diastolic
dysfunction (Bonow 1981, Theroux 1976, Takayama 1988), is the
systolic shortening that occurs after aortic valve closure, it is represented
by the upper left hand corner of the pressure-length loop (Brown 1987).
PSS is also expressed as a percentage of total shortening (PSS%) (Brown
1987, Coetzee 1991). The significant increase in PSS and PSS as a
percentage of total shortening seen in this study during ischemia, confirm
the results of several investigators (Theroux 1974, Vatner 1977, Smalling
1983, Wyatt 1975, Forrester 1976, Kumada 1979, Brown 1987).
Coetzee (1991) showed that in the open chest animal model PSS%
greater than 20% indicates ischemia. In the present study the average
PSS% during ischemia was 50%.
In this study there is therefore significant functional evidence of
myocardial ischemia.
In this study blood samples were taken from the proximal aorta for arterial blood
gas measurements and from the anterior inter ventricular vein for venous blood
gas measurements. The anterior inter ventricular vein runs parallel to the LAD
which was occluded during the ischemic section of the protocol. Whereas
coronary sinus blood represents mixed venous blood from both ischemic and non
ischemic myocardium (Owen 1970), venous blood sampled from the anterior
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inter ventricular vein accurately reflects venous drainage originating almost
exclusively from the myocardium perfused by the LAD under normal and
ischemic conditions (Vinten-Johansen 1987, Constantini 1975, Roberts 1976,
Marshall 1974). Furthermore reperfusion after transient ischemia does not
change the unique origin of the anterior inter ventricular vein blood. This
technique may therefore be used to reliably assess oxygen utilization and
metabolic variables in the myocardium perfused by the LAD (Vinten-Johansen
1987). Also, validation of the selective sampling of anterior inter ventricular
venous effluent in ischemic-reperfused segments, makes reliable serial
assessment of the metabolic status of this zone possible, independently of other
areas in the in vitro heart (Vinten-Johansen 1987) (Fig. 4.8).
The results of venous blood gas samples taken 10 minutes after LAD coronary
artery occlusion during the ischemic step of the protocol differed significantly
from control values in all groups studied.
When the LAD coronary artery was occluded, there was, as expected, a
significant reduction in both CBF (1,58 ± 5,59 ml/min vs 27,13 ± 7,78 ml/min)
and CBF/100 g (4,08 ± 14,27 ml/min vs 73,76 ± 26,54 ml/min) compared to
control measurements. The reduction in CBF is similar to that in other studies
(Heyndrickx 1975, Laxson 1989, Owen 1970). As a result of the decrease in
CBF there was a significant reduction in oxygen consumption in the ischemic
segment compared to control values (0,17 ± 0,46 ml/min vs 2,47 ± 0,85
ml/min). This is confirmed by other studies (Laxson 1989, Liedtke 1978).
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The accumulation of CO2 within the myocardium reflects the balance between
tissue CO2 production and its clearance by regional blood flow (Khuri 1975).
During ischemia, coronary blood flow and its associated delivery of oxygen, are
drastically reduced. As a result myocardial cells convert to anaerobic
metabolism which causes intracellular acidosis (Liedtke 1976, Scheuer 1967)
due to the production of lactic acid (Liedtke 1976). The lactic acid diffuses into
the interstitium resulting in an increased concentration of hydrogen ions. These
combine with HC03-, resulting in the production of CO2 and water (Khuri 1979).
Any continued aerobic metabolism within the cells also produces carbon dioxide,
which diffuses into the interstitium, as CO2 is freely diffusible across cell
membranes (Khuri 1979). As ischemia becomes more severe, there is an
increase in the production of hydrogen ions and, as a result in the quantity of
CO2 that is produced. Simultaneously there is a reduction of CO2 clearance.
Consequently the severity of myocardial ischemia is reflected in the magnitude
of the elevation of intramural (interstitial) PC02 (Khuri 1979). Khuri (1979)
confirmed that the magnitude of rise of intramural PC02, following coronary
artery occlusion, is an excellent predictor of the extent of myocardial ischemic
injury, as assessed histologically, as well as with the reduction of regional
myocardial blood flow. The rise in intramural PC02 is also a sensitive indicator
of the presence of myocardial ischemia.
Hillis (1979) showed that interventions that modify the severity of ischemia can
be evaluated by measuring intramural carbon dioxide tension. The rapid
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diffusability of CO2 through tissues results in an essentially equal PC02 in
interstitial tissue and coronary venous blood. Wallace and Hastings (1942)
suggested that it was unlikely that any gradient in CO2 tension of significant
magnitude existed between tissue and serum due to the high value of the
diffusion coefficient for CO2, This was confirmed by Case (1979), who
concluded that extracellular myocardial PC02 is essentially equal to that in
coronary venous blood.
In the present study there was a statistically significant increase in PC02 in the
anterior inter ventricular vein blood during the ischemic step of the protocol
compared to control values (9,79 ± 1,77 kPa vs 7,78 ± 2,67 kPa). This
suggests the presence of significant ischemia.
The arterio-coronary venous lactate difference is a commonly used indicator of
transmural metabolic change (Gonschior 1992). During aerobic activity the
cardiac muscle utilizes lactate for energy production. However, when oxygen is
not in adequate supply, the cardiomyosyte produces lactate by anaerobic
glycolysis (Gibbs 1978, Waters 1978) (Fig. 4.9 and 4.10).
It is commonly considered a sign of ischemia when the extraction of lactate out
of the arterial blood is less than 10% (under normal non-ischemic conditions it is
20 to 40%) and lactate production begins (Waters 1978). Arterio-coronary
lactate difference is negative if coronary venous lactate concentrations are
higher than arterial lactate concentrations, and this implies a net production of
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lactate. It has been shown that coronary venous lactate concentration during a
moderate stenosis is highest 10 to 20 minutes after the onset of stenosis (Ferrari
1986). In the present study measurements were made after 10 minutes of
ischemia.
There is a close and linear correlation between the degree of ischemia and the
magnitude of changes in arterio-venous lactate difference (Gonschior 1992).
Hence, lactate production is a distinct, easily measurable metabolic abnormality
that can be quantitated in myocardial ischemia (Scheuer 1967). Coronary
venous lactate concentration is also a sensitive marker of ischemia, and will
increase before the appearance of clinical symptoms of ischemia (Guth 1990).
Gugh (1990) showed that increased lactate release is a sensitive marker of
myocardial ischemia in patients and experimental animal models. He
demonstrated a close inverse relation between regional myocardial lactate
release and regional subendocardial blood flow during graded ischemia.
In this study there was an increase in anterior interventricular venous lactate
levels during ischemia compared to control values (2,97 ± 0,21 mmol.I' vs 0,57
± 0,71 rnrnol/l'). There also was a significant change in the arterio-venous
lactate difference as a percentage of arterial lactate concentration between the
ischemic step and the control values: -1465 ± 35,88% during ischemia vs. -
51,1 ± 8,84% control values. The above results confirm that significant
ischemia was indeed present during the ischemic step of this protocol.
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Due to the increased hydrogen ion production during ischemia there was an
expected significant decrease in anterior intra ventricular venous pH during
ischemia (7,24 ± 0,02 vs 7,34 ± 0,08). There was also a decrease in
bicarbonate concentration in the venous blood during ischemia due to increased
consumption of this buffer (30,51 ± 0,14 rnmot.l' during ischemia compared to
33,48 ± 1,2 rnrnol.l' before ischemia).
In the present study there was a significant decrease in anterior intra ventricular
vein P02 during ischemia compared to control values (2,81 ± 0,8 kPa vs 3,48
± 0,00 kPa). This finding is confirmed by Gonschior (1992) in a study on the
effects of acute LAD coronary artery occlusion in pigs. Analysis of coronary
venous blood samples in Gonschior's study revealed that P02, O2 content and
oxygen saturation significantly decreased, whereas lactate significantly increased
during stenosis. In clinical studies, Messer (1962) found increased myocardial
oxygen extraction after exercise and a decline in coronary sinus oxygen content
in 82% of patients with coronary artery disease. Coronary venous P02 is
considered a sensitive indicator of myocardial oxygenation because it represents
the end capillary P02 (Feigl 1983). However, although there is a decrease in P02
during myocardial ischemia, studies have shown that changes in intramural
oxygen tension with coronary artery occlusion are unreliable in the quantification
of the severity of ischemia.
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This metabolic evidence confirms that significant ischemia was indeed present in
the experimental model used in this study.
4.4 Evidence of reperfusion (Table 3.8.2).
In all animal studied eBF decreased during ischemia and was increased at 10
minutes after reperfusion compared to both control, and other post ischemia
values. By 30 minutes after reperfusion, eBF had returned to control values and
remained so until the end of the experiment. These findings confirm those of
other investigators (l.axon 1989, Lange 1984, Stahl 1986, Heyndrickx 1978),
and provide evidence that the previously ischemic myocardium was indeed
reperfused.
4.5 The characteristic reperfusion injury.
The effects of a 15 minute regional coronary artery occlusion, followed by
reperfusion on:
• Myocardial function
• Regional myocardial bloodflow
• Myocardial histology
were examined and described by Heyndrickx et al. in 1978. These effects are
remarkably similar in all respects to the findings obtained in the two saline
groups in the present study, and are discussed below.
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Effects of coronary occlusion and reperfusion on the myocardial function:
Overall left ventricular function:
Heyndrickx found that a 15 minute regional coronary occlusion induced only
slight changes in global left ventricular function: (Fig. 4.11 l.
• Left ventricular systolic pressure remained unchanged.
• dP/dt decreased.
• Heart rate increased slightly.
By 1 5 minutes after reperfusion all values had returned to normal and remained
so.
The finding in the two saline groups in this study confirmed the above with no
change in left ventricular systolic pressure, dP/dt, or heart rate.
Regional wall thickness
Regional wall thickening occurs during systole when myocardial fibers shorten.
Changes in wall thickness are thus reciprocal to changes in segment length.
Segment shortening is directly proportional to wall thickening. In the present
study segment length and segment shortening were measured as indexes of
systolic function.
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Heyndrickx demonstrated a severe loss of systolic wall thickening during
coronary artery occlusion. Upon reperfusion systolic wall thickening increased
transiently to a level slightly below pre-occlusion baseline. By 15 minutes after
reperfusion however, systolic wall thickening was again decreased and remained
so for as long as three hours (Fig. 4.12).
In the present study, in the saline groups, as reported in the Heyndrickx study,
segment shortening decreased during ischemia and remained decreased for the
duration of the experiment.
Heyndrickx found that not only was the wall thickening depressed, but it also
showed a marked delay in "time-to-peak" shortening. This resulted in a marked
change in the configuration of the phasic wave form for wall thickening, with
wall thickening (or segment shortening) persisting into early diastole. This
shortening in early diastole is referred to in the present study as post systolic
shortening. In the Heyndrickx study, post systolic shortening normalized only
after three hours of reperfusion.
In the present study post systolic shortening increased during ischemia in both
saline groups. In the one saline group baseline levels had again been reached by
60 minutes after reperfusion, but in the other saline group post systolic
shortening was still significantly increased at the end of the experiment (90
minutes after reperfusion).
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Heyndrickx, in his study found that end diastolic wall thickness also decreased
during ischemia but to a lesser degree than systolic wall thickness. (In the
present study end diastolic wall thickness is represented by the segment length
value Lmax, the reciprocal of wall thickness). On reperfusion there was an
immediate rebound of diastolic wall thickness to above control values, however
by 15 minutes post reperfusion, end diastolic wall thickness was no different
from control.
In the saline groups in this study, L-max did increase during ischemia, only to
return to control values by 30 minutes after reperfusion.
Hence, despite the use of saline as an infusion in the placebo (control) groups in
this study, the course of the reperfusion injury closely followed that described by
previous investigators (Heyndrickx 1978, Smith 1980, Lamping 1985, Przyklenk
1986, Gross 1986).
Effects of coronary artery occlusion and reperfusion on regional myocardial blood
flow:
Heyndrickx (1978) found an expected decrease in bloodflow during ischemia,
followed by a hyperemic response on reperfusion. By 15 minutes after
reperfusion myocardial bloodflow had returned to pre-ischemic control values.
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This finding corresponds to the finding in both saline groups in this study where
coronary bloodflow decreased during ischemia (intentionally decreased with LAD
occlusion), was increased (twice baseline levels) at 10 minutes post reperfusion
and had returned to control values by 30 minutes post reperfusion.
Effects of a 15 minute coronary occlusion and reperfusion on myocardial
histology:
Histologic and histochemical studies after a short period of occlusion did not
show any anatomical or histological defects (Heyndrickx 1978). This finding fits
the concept of "stunning" which, by definition, implies a temporary decrement in
function which is totally reversible. In the current study, histology was not done
and cannot be compared to the already accepted findings.
Conclusion:
In the present study the author attempted to study the effects of verapamil on
the elements of the reperfusion injury i.e. stunning and arrhythmias. Data from
the saline groups in this study (no active intervention) confirms that the model
closely follows the pattern of temporary dysfunction after reperfusion already
published and serves to validate the experimental model used.
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4.6 Verapamil and the reperfusion injury.
The role of calcium and the calcium antagonists in the reperfusion injury was
elegantly described by Bourdillon (1982).
"Myocardial ischemia in humans occurs after myocardial infarction or during
open heart surgery under conditions of cardiopulmonary bypass. Limitation of
the size of the necrotic area in myocardial infarction and preservation of
myocardial function after cardiac surgery are important therapeutic objectives.
During reperfusion after a period of ischemia, calcium accumulates in
myocardium and particularly in mitochondria.
Since part of the total calcium influx into the myocardial cell is through the slow
calcium channel of the cardiac action potential, this channel may be the pathway
for calcium accumulation associated with reperfusion after ischemia. Verapamil
and other calcium antagonists block the slow calcium current of the action
potential. When these drugs are given prior to or at the onset of a period of
ischemia, they have been shown to preserve tissue ultra structure, to reduce
enzyme release, to diminish S-T elevation, to improve hemodynamic function, to
maintain tissue ATP, and to prevent calcium accumulation in whole tissue and
isolated mitochondria. The uniformly beneficial results obtained in such
experiments are in sharp contrast to the results of experiments in which calcium
antagonists have been administered, not prior to ischemia, but either after the
ischemic myocardium has seized to contract or at the time of reperfusion. Under
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these conditions, cardiac function is not preserved, tissue ATP is not maintained,
calcium accumulation is not prevented, and enzyme release is unaltered.
Calcium accumulation on reperfusion has been shown to be due to increased
influx probably related to a specific abnormality of ionic channels. The extent of
calcium accumulation is related to the severity and duration of ischemia, and to
the degree of mechanical recovery."
Several in vitro studies support the finding that when calcium antagonists are
given prior to a period of myocardial ischemia, tissue damage is prevented or
delayed, ATP and mitochondrial function are preserved, calcium accumulation is
reduced and functional recovery is improved (Henry 1977, Watts 1980, Lefer
1979, Nayler 1980, Nayler 1987, Hamm 1983, Bourdillon 1982, Nayler 1990,
Yao 1994, Boraso 1993, Kirkels 1992, Bush 1982, Buser 1991, Nayler 1976,
Yamamoto 1983, Watts 1986).
In contrast to the studies by Kirkels (1992), Higgins (1982) and later studies by
Massoudy (1995) and Bernstein (1996), Watts (1986) found that calcium
antagonists had to depress pre-ischemic contractile function in order to afford
protection.
Most in vitro studies of ischemia-reperfusion failed to demonstrate a beneficial
effect of calcium channel blockers administered after the onset of ischemia or on
reperfusion (Watts 1980, Nayler 1978, Bourdillon 1982, Ferrari 1986, Heusch
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1992, Watts 1986, Yamamoto 1983). In Bourdillon's study (1982) this
negative finding was not due to insufficient time for verapamil binding and effect
before reperfusion, because the introduction of verapamil during low flow
ischemia, 10 minutes before reperfusion, also failed to reduce calcium uptake.
Nayler's study (1978) also used a hypoxic model where verapamil was added to
the perfusate after the decline of developed tension.
These in vitro studies suggest that pre-treatment with calcium antagonists is
beneficial to the ischemic myocardium due to a cardioplegic effect. Myocardial
metabolism and V02 are decreased (Nayler 1972, Fleckenstein 1983, De Jong
1985, Nayler 1990). The rate of ATP consumption during ischemia is reduced
(Higgins 1983, Bourdillon 1982, Jolly 1981, Nayler 1980, Watts 1980,
Weishaar 1980). Sufficient ATP is maintained to ensure preservation of
membrane function and intracellular calcium homeostasis (Ferrari 1984,
Bourdillon 1982, Nayler 1980). As membrane function is preserved, the rate of
sodium gain and potassium loss will be slowed (Nayler 1980) and therefore the
consequent calcium gain and resultant ischemic contracture will be decreased.
Because intracellular calcium accumulation is decreased, the mitochondria will be
protected against calcium overload (Bernstein 1996, Ashraf 1984). Carafoli
(1985) found that mitochondria that are overloaded with calcium deteriorate
functionally and have impaired ATP production. Hence "protected" mitochondria
will be more functionally intact during reperfusion, and better able to support
ATP synthesis.
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The ATP sparing effect of calcium antagonists is only present if the drug is
administered before the onset of ischemia, and absent in hearts treated only
during reperfusion (Watts 1980, Watts 1985, Watts 1986). As most studies
(De Jong 1985, Watts 1986) showed that calcium antagonists decreased lactate
production by the ischemic myocardium, the increased ATP levels in the hearts
protected by calcium antagonists are not due to increased glycolytic flux. The
increased ATP levels are most likely due to reduced energy consumption by the
ischemic myocardium in the presence of calcium antagonists (Watts 1986).
Interestingly, contractile depression during early ischemia does not account for
all the ATP sparing effects of, or the decrease of glycolysis due to the calcium
antagonists. Watts (1986) found that diltiazem administered to hearts that had
been rendered quiescent with potassium arrest prior to the onset of ischemia,
significantly reduced lactate accumulation. Therefore the effects of diltiazem on
lactate production, or the need for glycolysis due to ATP-depletion is at least
partly independent of the contractile effects of the drug.
The following in vitro studies do however demonstrate a protective affect of
calcium antagonists administered after the onset of ischemia or at reperfusion.
Bernstein (1996) in isolated isovolumic blood perfused rabbit hearts subjected to
90 minutes of low flow ischemia (eBF 22 - 24% of baseline) followed by 30
minutes of reperfusion, found that felodipine was protective if administered from
15 minutes after the onset of ischemia until 15 minutes after reperfusion.
Bernstein found that felodipine conferred a significant protection against
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ischemic diastolic dysfunction (less ischemic contracture), and on reperfusion as
there was significantly better recovery of systolic and diastolic function in the
presence of felodipine. However, even though contractility, V02 , lactate
production and coronary bloodflow were identical between the two groups
during ischemia, ATP levels in the felodipine group were more than twice that in
the control group. This suggests that the protection afforded by felodipine was
at least in part, due to an ATP preserving effect during ischemia. The fact that
there was significantly less severe acidosis during ischemia in the felodipine
group (a finding supported by Kirkels, 1992), suggests that less anaerobic
glycolysis was necessary in this group, probably due to better ATP preservation
and a lower ATP requirement.
Massoudi (1995) in isolated working guinea pig hearts subjected to 15 minutes
of ischemia followed by 15 minutes of reperfusion found that short term post-
ischemic application of the calcium antagonists gallopamil was as effective in
restoring pump function as pre-ischemic application. In addition gallopamil did
not need to depress pre-ischemic cardiac function in order to elicit protection.
Higgins (1984) studied the effects of verapamil, nifedipine and diltiazem in
isolated working rat hearts subjected to 30 minutes of ischemia followed by 30
minutes of reperfusion. All the drugs improved recovery of function and
inhibited intracellular calcium accumulation if administered before ischemia. If
given only during reperfusion nifedipine was almost as effective as when
administered before ischemia, but verapamil and diltiazem were not effective.
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Van Amsterdam (1990) suggested two modes of protection against ischemia-
reperfusion by the calcium antagonists: A negative inotropic or energy sparing
activity protecting during ischemia, and vasodilatation resulting in improved
recovery during reperfusion. However, Higgins (1982) suggested that the
improved perfusion seen during reperfusion in calcium antagonist treated hearts
may result from prevention of ischemic contracture (via a cardio protective
effect), which preserves a better transmural distribution of myocardial perfusion
during the ischemic period and during reperfusion, rather than from direct
coronary vasodilatation by the drug.
Results obtained in these buffer perfused, non working, globally ischemic hearts
may not necessarily be extrapolated to regional ischemia in blood perfused
hearts in intact animals.
Confirming the findings in the in vitro studies Warltier (1988) and Lamping
(1985) reported a beneficial effect on cardiac functioning on reperfusion after
pre treatment with calcium antagonists before a short period of reversible
ischemia in the intact canine model. However, in all these studies the use of
calcium antagonists caused a statistically significant decrease in mean arterial
pressure, and this may have contributed to the beneficial effect.
Ehring (1992) studied the effects of nisoldipine administered at different times,
in attenuating the reperfusion injury after a 15 minute coronary artery occlusion
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in anesthetized open chest dogs. In this study the mean arterial pressure was
kept constant with an aortic balloon pump and regional myocardial blood flow
during ischemia and reperfusion was the same in all groups. They reported that
nisoldipine was beneficial only if given before occlusion, but not when given 5
minutes before reperfusion or 4 minutes after reperfusion. Nisoldipine was
administered intravenously in these animals and it is possible that the nisoldipine
administered during ischemia did not reach the affected myocardium, and that
this may be the reason why no beneficial effect was seen in the group where
nisoldipine was administered 5 minutes before reperfusion. When nisoldipine
was administered 4 minutes after reperfusion, the transient calcium overload
seen immediately after reflow (Kusuoka 1987) had abated and cytosolic calcium
levels had probably already returned to normal (Steenbergen 1987).
Functional recovery in this study was relatively poor; only 60% of control value
was achieved in the group pretreated with nisoldipine, and there was no
recovery in the other groups. This is unusual, as in most studies of myocardial
stunning, even the control groups recover 30 - 40% of pre-ischemic function
after an extended period of reperfusion. This finding may be due to the
anesthetic technique used (Thiamylal 15mg/kg ivi; 1,4% enflurane in 2: 1 nitrous
oxide/oxygen mixture).
In the canine model of myocardial stunning Przyklenk (1988) reported that an
intravenous verapamil infusion started 30 minutes before a 15 minute artery
occlusion and continued for 180 minutes of reperfusion (total dose 2,45 mg/kg)
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completely ablated contractile dysfunction (115 % of pre-ischemic values) and
preserved ATP content in the post ischemic myocardium. However, verapamil
infusion started directly before reperfusion, and even started 30 minutes after
reperfusion (same total dose as pre-treatment) resulted in recovery of contractile
function to 66% of control values compared to only 31 % if no verapamil was
administered. ATP content was however not preserved in these animals. The
conclusion in this study was that verapamil administered at or after reperfusion
significantly enhanced contractile function, and pre-treatment with verapamil
prevented myocardial stunning.
A very large dose of verapamil (2.45 mg/kg) was administered systemically in
this study, and as can be expected, this had an effect on systemic
hemodynamics, leading to a decrease in MAP, heart rate, and inotropy from the
onset of the infusion, hence more favorable hemodynamics before and during
ischemia in the pre-treated group. This large dose of verapamil before and
especially during ischemia would have increased coronary collateral circulation to
the ischemic area (due to vasodilatation and reduced ischemic contracture) in the
pre-treated group in this canine model, and this may have decreased the severity
of ischemia. There was also insufficient time for drug binding and effect of the
verapamil administered at the onset of reperfusion, for it to be effective during
the critical first moments of reperfusion when increased calcium flux is relevant
(Kusuoka 1987, Steenbergen 1987).
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In contrast to the present study, Przyklenk found that verapamil administered at
the time of reperfusion did not protect against ventricular fibrillation. Only
verapamil pre-treatment was protective. This again is probably due to
insufficient time for drug binding and effect at the very onset of reperfusion.
Przyklenk (1989) in open chest anesthetized dogs subjected to 15 minutes of
coronary artery occlusion followed by reperfusion, compared the effects of high
dose intravenous nefedipine administered 30 minutes after reperfusion to low
dose intracoronary nefedipine administered 30 minutes after reperfusion. They
reported that the high dose intravenous nefedipine restored contractile function
of the stunned myocardium to pre-occlusion values, however it also caused a
decrease in afterload and an increase in regional myocardial blood flow. Low
dose intracoronary nifedipine did not alter afterload or coronary blood flow, but
did restore systolic contractile function to 90% of pre-occlusion values
(compared to 37% if no nifedipine was given). These results indicated that the
improvement in systolic contractile function was not entirely the result of
decreased afterload and increased myocardial blood flow, and that nifedipine
may act by favorably modulating calcium flux within the stunned myocytes.
The confounding factor in this study is that the calcium antagonist was only
administered 30 minutes after the onset of reperfusion in all animals. As argued
earlier myocardial stunning results from a transient calcium overload immediately
after reflow (Kusoaka 1987), and the increased cytosolic calcium levels returned
to normal within a few minutes after reperfusion (Steenbergen 1987, Marban
217
Stellenbosch University http://scholar.sun.ac.za
1987). By 30 minutes after reperfusion the "damage is done" and intracellular
calcium has returned to normal levels. This is not the critical period of
reperfusion.
Park (1996) investigated the effect of intravenous nisoldipine in the conscious
porcine model of repetitive ischemia. Pigs underwent 10 two minute coronary
artery occlusions separated by two minutes of reperfusion, in the treatment
group, nisoldipine was administered from 15 minutes before the first occlusion
until 30 minutes after the last reperfusion. The systemic hemodynamics
remained unchanged, there was zero collateral blood flow in the ischemic region,
the ischemic myocardial function was identical in treatment and control groups
and importantly, nisoldipine infusion did not affect myocardial contractility in the
non-ischemic zone. This study demonstrated that nisoldipine markedly
attenuated myocardial stunning independently of any hemodynamic changes or
changes in coronary blood flow. This suggests a direct cardio protective action
of nisoldipine.
There was active preconditioning in this study, but this was present in the
control and nisoldipine groups, and nisoldipine conferred added protection.
Interestingly, the recovery of function in the nisoldipine group in this study (58%
of pre-ischemic value by 60 minutes post reperfusion, 66.8% by 120 minutes)
was slower than in the author's study (100% of pre-ischemic values by 10
minutes after reperfusion). There was also a convergence of recovery between
the nisoldipine group and the control group throughout reperfusion. By 5 hours
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after reperfusion the nisoldipine group had recovered to 97.9% of pre-ischemic
values and the control group tot 88.9% of pre-ischemic values.
Park proposed that the major mechanism of action of nisoldipine in this study
was to decrease calcium influx during ischemia, resulting in an attenuation of
ischemic injury, and as a secondary effect, the attenuation of the reperfusion
injury. However, as argued earlier (Chapter 1) the increase in cytosolic calcium
during ischemia is the result of Arp depletion, failure of sarcolemma and
sarcoplasmic reticulum calcium ATP-ase, failure of Na+ IK +ATP-ase resulting in
intracellular sodium accumulation and reversal of the Na+Ca2+ exchanger. The
L-type calcium channels affected by nisoldipine do not playa role in the increase
in cytosolic calcium during ischemia, but are important at the very onset of
reperfusion. Nisoldipine does however probably have an ATP sparing effect
during ischemia (Watts 1980, 1985, 1986).
Verdouw (1983) studied the effects of intravenous nefidipine administered from
10 minutes before reperfusion until 5 minutes after reperfusion in the
anesthetized open chest porcine model, subjected to 30 minutes of low flow
ischemia (25 to 30% of normal flow), followed by 60 minutes of reperfusion.
This study reported 75% recovery of systolic and diastolic wall thickening during
reperfusion in the nisoldipine group, compared to only 50% recovery in the
control group.
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As the calcium antagonist in this study was administered timeously (10 minutes
before reperfusion, and low flow ischemia as opposed to zero flow ischemia was
used, there may well have been time for local drug binding and effect by the
time of reperfusion. This study provides evidence of a protective effect of
calcium antagonists at the time of reperfusion.
There have been several studies (Klein 1989, Gao 2001, Hatori 1993, Segawa
2000, Gourine 2001, Segawa 2002) where intracoronary administration of
calcium antagonists has been effective in attenuating the ischemia-reperfusion
injury in the open chest porcine model. However, all these studies had LAD
occlusion times of 45 minutes or longer, resulting in infarction as opposed to
reversible myocardial stunning.
The hypothesis of this study was that an adequate dose of verapamil,
administered timeously directly into the coronary artery supplying the ischemic
segment, would attenuate the reperfusion injury due to a direct effect on the
myocardium.
To evaluate myocardial function indexes of:
• Systolic function
• Diastolic function
• Myocardial metabolism
were considered.
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The indexes of systolic function measured were:
• LAD L max (maximum LAD segment length)
• LAD syst dL (the systolic shortening of the LAD segment)
• LAD syst dL% (LAD segment systolic shortening as a percentage of
maximum LAD segment length)
The latter parameter was used because the magnitude of change in segment
length depends in part on the initial segment length (placement of crystals), the
changes expressed in absolute length (mm) would vary in relation to the extent
that the initial segment lengths varied. Therefore segment shortening observed
in this study was also calculated as a percentage change of initial segment
length. LAD segment stroke work was also considered as an index of function
(Chapter 2).
The indexes of diastolic function used were:
• Post systolic shortening (PSS)
• Post systolic shortening as a percentage of total segment shortening
(PSS%) (Coetzee 1991)
The hypothesis of this study was confirmed in that both groups of animals
where 2mg of verapamil was administered either at the onset of ischemia (group
5) or 3 minutes before reperfusion (group 3), had faster recovery of systolic and
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diastolic myocardial function compared to the groups where saline or the low
dose of verapamil were administered.
The greatest difference was in the indexes of systolic function. In the saline
groups and the low dose verapamil group, these indexes had not yet recovered
to control values by the end of the experiment at 90 minutes post reperfusion
(Table 3.2.3, 3.4.3, 3.6.3) whereas the group that received 2mg of verapamil at
the onset of ischemia had recovered full systolic function (all indexes normalized)
by the first measurement at 10 minutes post reperfusion (Table 3.5.3). In the
group where 2mg of verapamil was administered from 3 minutes before
reperfusion, all the indexes of systolic function had normalized by the second
measurement at 30 minutes post reperfusion (Table 3.3.3).
The recovery of diastolic dysfunction was more varied between groups. The
groups receiving 2mg of verapamil either from 3 minutes before reperfusion or
from the onset of ischemia, had full recovery of diastolic dysfunction by the first
measurements at 10 minutes after reperfusion (Table 3.3.3, 3.5.3). The low
dose verapamil group had recovered diastolic function by 30 minutes after
reperfusion (Table 3.2.3), the group where saline was administered from the
onset of ischemia, by 60 minutes after reperfusion, and the group that received
the saline infusion starting 3 minutes before reperfusion, had not recovered
diastolic function by the end of the experiment (Table 3.6.3, 3.4.3). The
recovery of diastolic function is more graded between groups compared to the
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recovery of systolic function. The former may be a more sensitive marker of the
degree of stunning.
The effects of reperfusion on diastolic function as shown in this study, are
similar to those reported by Krause (1986). They reported a decrease in activity
of the sarcoplasmic reticulum ATP-ase following brief ischemic episodes. This
resulted in the decreased ability to transport calcium during relaxation and hence
prolonged contraction into the diastolic period (contracture). Weiss (1986)
found that delayed contractile recovery during reperfusion is attributable in part
to an adverse effect of increased diastolic calcium oscillation induced by calcium
overload during reperfusion.
Although the high dose verapamil groups performed better than both the saline
groups and the low dose verapamil group, there were important differences
between the two high dose groups. The group where the verapamil infusion
was started at the onset of ischemia (group 5), had full recovery of systolic
function by the first measurement at 10 minutes after reperfusion. The group
where the verapamil infusion was started 3 minutes before reperfusion (group 3)
had slower recovery of systolic function (30 minutes after reperfusion).
The degree of ischemia in both high dose verapamil groups was similar, as
evidence by venous lactate increases. Also V02 /100g and V02 /100g/beat
were the same in the two groups, decreasing during ischemia and normalizing by
10 minutes after reperfusion. Coronary blood flow also decreased to a similar
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degree during ischemia, was increased to a similar degree at 10 minute after
reperfusion, and had normalized to control values by 30 minutes after
reperfusion in both groups.
There are however four possible explanations for the difference in performance
between the two high dose verapamil groups:
Firstly verapamil is protective against ischemia per se. Verapamil administered
prior to ischemia has consistently been shown to attenuate the depletion of high
energy phosphate stores both in models of global ischemia and reperfusion
(Watts 1986, Nayler 1980, Neely 1984) and in in vivo canine models of
stunning (Lange 1984, Przyklenk 1988). This ATP preserving effect was
however not seen in in vitro models of global ischemia where verapamil was
administered after the onset of ischemia (Bersohn 1983, Nayler 1987), or in in
vivo models of regional ischemia when verapamil was administered at or after
reperfusion (Przyklenk 1988). As ATP levels were not measured in this study
they cannot be compared, however the literature strongly supports an ATP
sparing effect of verapamil if present during ischemia.
Secondly the faster recovery of function in the group where verapamil was
administered from the onset of ischemia may be due to the fact that a higher
dose of verapamil had been administered by the critical point where reperfusion
took place. The entire 2mg had been infused, and had time for binding and
action before reperfusion occurred. In the group where the verapamil infusion
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was started 3 minutes before reperfusion only 0.75 mg of verapamil had been
administered by the onset of reperfusion. As discussed previously, it is the
calcium influx at the onset of reperfusion which sets in motion the cascade of
events leading to contraction band necrosis (Piper 2003, Piper 2004). The more
L-type calcium channels that are blocked at this crucial time, the less severe the
reperfusion injury (Chapter 1).
Thirdly, there was a longer period of wash-out of ischemic metabolites,
specifically lactate, in the group where verapamil was administered from the
onset of ischemia. In this group anoxic flow was present for the first 8 minutes
followed by 7 minutes of ischemia. In the group where the verapamil infusion
was started 3 minutes before reperfusion, ischemia was present for 12 minutes
followed by a 3 minute period of anoxic flow. Neely (1984) demonstrated that if
anoxic low flow was present, the ability to recover ventricular function was
maintained for a longer exposure to ischemia, and occurred at much lower levels
of ATP compared to zero coronary flow. These observations suggests that
accumulated metabolic products play an important role in myocardial injury. This
role is independent of oxygen supply and ATP-Ievels. In Neely's study there was
a strong negative correlation between tissue levels of lactate during ischemia
and recovery of function on reperfusion. In the present study the longer period
of anoxic flow present in the group where verapamil was started from the onset
of ischemia may have contributed to the faster recovery of contractile function.
This may also explain the difference in recovery of diastolic function in the two
saline (control) groups in this study. Diastolic dysfunction recovered more
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quickly in the group where the saline infusion was started at the onset of
ischemia (anoxia) compared to when it was initiated 3 minutes before
reperfusion (ischemia). Although this difference between the effects of hypoxia
and ischemia, may partly explain the differences in recovery between the two
high dose verapamil groups, and between the two saline groups, the significantly
faster recovery of both systolic and diastolic function in both ischemic and
anoxic high dose verapamil groups compared to the anoxic saline group is due to
the presence of verapamil.
Fourthly, verapamil depresses contractility only when coronary blood flow is
normal (Romson 1986) as was the case during the last 5 minutes of verapamil
infusion in the group where the infusion was started 3 minutes before the onset
of reperfusion therefore in this group verapamil had a negative inotropic effect
which was absent in the group where the verapamil infusion was started at the
onset of ischemia.
Several investigators have suggested that the stunned myocardium may be
sensitive to both arterial vasodilatation (Stahl 1986, Lamping 1985, Przyklenk
1988, Warltier 1988, Tayler 1990), and increases in regional myocardial blood
flow (Stahl 1986, 8erdeaux 1976, Matsuzaki 1984, Heusch 1987).
Improvement in systolic contractile function would result from the inotropic
effect of baroreflex-mediated sympathetic activation due to systemic
vasodilatation, or from the increase in myocardial blood flow. Neither of these
two factors are applicable in the present study:
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As a porcine model with a sparse coronary collateral circulation was used, and
the LAD coronary artery was completely occluded during ischemia, there
probably was no difference in tissue blood flow during ischemia between the
groups. In addition data from this study showed no difference in the degree of
ischemia. On reperfusion there was a similar hyperemic response in coronary
blood flow, with values at 10 minutes post reperfusion being higher than control
values, but coronary blood flow had normalized to control values in all groups by
30 minutes after reperfusion. Coronary blood flow did not differ between the
different groups.
Secondly the improved function was not due to more favorable systemic
hemodynamics during ischemia or reperfusion, as mean arterial pressure did not
decrease at any time compared to control values in any of the groups. Heart
rate also remained constant throughout and left ventricular end-systolic pressure
and volume did not decrease or differ. Therefore the improved function seen on
reperfusion in the two high dose verapamil groups is due to a direct effect of
verapamil on the myocardium.
Investigators using models of both global (Krause 1984), and regional ischemia
(Krause 1986) have shown that calcium flux within myocytes is impaired after
brief ischemic episodes, and that elevated concentrations of intracellular calcium
adversely affect both mitochondrial ATP production (Nayler 1987) and
myocardial contractility (Shen 1981).
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To further clarify this direct effect of verapamil on the myocardium, the effect of
an intracoronary infusion of 2mg of verapamil on the non-ischemic myocardium
was studied.
In contrast to the ischemic model, the mean arterial pressure decreased when
verapamil was infused in the absence of myocardial ischemia. Mean arterial
pressure remained decreased 10 minutes after the infusion and had only
normalized by 30 minutes after the infusion. The possible explanation for the
decrease in mean arterial pressure is that the markedly increased coronary blood
flow seen after infusion of verapamil in the non-ischemic heart, caused a faster
washout of verapamil from the myocardium and increased systemic effects.
Alternatively, the hypotension may have been the result of negative inotropic
effects of verapamil. Romson (1986) found that the effects of verapamil varied
as a function of myocardial blood flow: During normal coronary blood flows,
verapamil had a negative inotropic effect while at low flow (30% of normal), it
had no effect on contractile function.
Verapamil did seem to have a negative inotropic effect in the this non-ischemic
model, as maximum LAD segment length did increase significantly after the
verapamil infusion, and control values were only reached by 30 minutes after the
infusion was terminated. Although the other indexes of systolic function i.e.
segment shortening, decreased numerically after the infusion, the reduction did
not reach statistical significance. The decrease in systolic function may have
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been masked in part, by a decreased afterioad, due to the fall in mean arterial
pressure.
Verapamil infusion also resulted in diastolic dysfunction. Although PSS was not
nearly as severe as that seen during ischemia, it did increase directly after the
verapamil infusion and had returned to control values by 30 minutes after the
infusion (Table 3.1.3). This differential effect of verapamil on diastolic function
in the normal and ischemic hearts has been well described (Pagel 1993).
Verapamil enhances regional diastolic mechanics in the ischemic heart (Bonow
1981) but , in the normal heart, calcium channel blockers impair isovolemic
relaxation (Walsh 1985).
This decreased inotropy and lisinotropy in the normal heart is readily explained
by the decrease in calcium influx through the voltage gated L-type calcium
channels resulting in decreased calcium induced calcium release from the
sarcoplasmic reticulum, and consequently less calcium available for binding
troponin C. However as stated earlier (Romson 1986) this negative inotropic
effect of verapamil is absent if verapamil is administered during ischemia. This
differential effect of verapamil on contractility in the presence or absence of
ischemia, may also, in part, explain the slower recovery of contractile function in
the group where the 2mg of verapamil infusion was started 3 minutes before
reperfusion (compared to when it was started at the onset of ischemia), as a
large portion of this infusion would have been delivered during reperfusion, when
the coronary blood flow was raised. Verapamil may therefore have contributed
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to the negative inotropic effect of the reperfusion injury, slightly delaying
recovery of function in this group. No negative inotropic effect would have
resulted from the 2mg of verapamil infused at the onset of ischemia, as this
infusion was completed 7 minutes before reperfusion.
The pertinent finding in the non-ischemic group was that despite a threefold
increase in LAD coronary artery blood flow on verapamil infusion, oxygen
consumption in the LAD segment decreased significantly (1.34 ± 0.5 vs 2.48 ±
1.6ml.min-1). By 10 minutes after verapamil infusion oxygen consumption was
again approaching control values (1.76 ± 0.45ml/min-1), while coronary blood
flow was still twice control values. Usually oxygen consumption in the
myocardium determines coronary blood flow (Ross, 1985). In the presence of
verapamil there seems to be an uncoupling of this relationship resulting in luxury
perfusion. It is also important to note that this is not merely a normal V02 in the
face of coronary vasodilation due to verapamil; oxygen consumption is in fact
clearly decreased (Table 3.1.1, 3.1.6). This is probably due to decreased
myocardial metabolism and possibly due to decreased cardiac function
(decreased external work). Nayler and Szeto (1972) were the first to describe
the decrease in myocardial V02 due to veraparnil.
Nayler (1972) showed that verapamil decreased myocardial V02 and improved
myocardial efficiency. Myocardial V02 is known to depend on heart rate (Evans
and Matsuoka 1914, Cohn and Steele 1935), velocity of contraction
(Sonnenblick 1965), and work done by the ventricle in overcoming pressure
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(Evans and Matsuoka 1914, Katz and Feinberg 1958). Verapamil decreases the
maximum tension developed, the rate at which tension is developed, the area
under the contraction curve, and the heart rate (Nayler 1972). It alters neither
the ability of the sarcoplasmic reticulum to accumulate calcium, or the activity of
calcium ATP-ase (Nayler 1972). Verapamil does however reduce the amount of
calcium which is stored at membrane located binding sites, hence the amount of
calcium taken up by the cell per beat is decreased (Nayler 1972). Verapamil
therefore also interferes with the mechanisms whereby intracellular distribution
of calcium in cardiomyocytes is regulated: As calcium entry into the cell per
beat is decreased, calcium release from the sarcoplasmic reticulum will be
decreased, resulting in less calcium available for binding to Troponin C.
Verapamil may have two distinct effects during ischemia and reperfusion; one
specific to ischemia, due to the effect of verapamil on the myocardial
metabolism ('V02), and one specific to reperfusion due to the effect of verapamil
on the L-type calcium channels on the sarcolemma, resulting in decreased
calcium entry, and therefore decreased calcium induced calcium release from the
sarcoplasmic reticulum at the onset of reperfusion (Barry 1993, Beukelmann
1988, Sperelakis 1988).
Verapamil decreases myocardial V02 (or myocardial metabolism) therefore,
during ischemia, it may result in a better supply: demand ratio due to decreased
demand, resulting in "less severe" ischemia. "Less severe" ischemia means less
intracellular calcium accumulation during ischemia and smaller sarcoplasmic
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reticulum calcium stores and sarcoplasmic reticulum calcium release on
reperfusion (Chapter 1).
Bourdillon (1982) and Watts (1985) suggested that a negative inotropic effect,
resulting in decreased myocardial \102, may be a mechanism by which calcium
antagonists enhance post ischemic myocardial function. Smith (1976)
suggested that verapamil may reduce myocardial injury through a selective
depression of contractility and \102 in ischemic myocardium, when given in a
dose too low to affect contractility in normal myocardium. De Jong (1984)
suggested that calcium antagonists directly reduced myocardial \102 (not
necessarily by negative inotropy), and so diminish the effect of flow impairment.
Decreased breakdown of ATP has been suggested to be a mechanism by which
calcium channel blockers may protect ischemic myocardium, independently of
their effect on calcium entry (De Jong 1984, Hamm 1983, Nayler 1980).
Several investigators have demonstrated ATP preservation associated with pre-
treatment with verapamil (Hamm 1983, Nayler 1980, Watts 1985), and
diltiazem (De Jong 1984, Hamm 1983). Lange (1984) showed that if verapamil
is infused from one hour before a 15 minute coronary artery occlusion, until the
onset of reperfusion, endocardial ATP levels are preserved compared to an
untreated group. Przyklenk (1988) also found that endocardial ATP stores were
preserved when verapamil was administered 30 minutes before coronary artery
occlusion. Verapamil given at or after reperfusion however, had no beneficial
effect on depletion of ATP stores.
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In Lange's study however, heart rate and mean arterial pressure was significantly
lower in the treatment group throughout the experiment than in the control
group. In the Przyklenk study mean arterial pressure was also decreased
significantly by verapamil infusion throughout the experiment in the groups that
received verapamil 30 minutes before occlusion (where ATP was preserved),
compared to the groups receiving verapamil at or after reperfusion. This
decrease in mean arterial pressure may result in lower ATP turnover, and may
have contributed to the ability of verapamil to preserve ATP stores in the
presence of ischemia. However, Nayler (1976) in isolated globally hypoxic rabbit
hearts, observed that verapamil reduced myocardial uptake of sodium and loss of
potassium, slowed the rate of creatine kinase release, decreased ATP and
phosphocreatine breakdown, maintained the fine morphology of cells and
prevented contraction bands.
The author's deduction is that if ATP is preserved during ischemia, membrane
ATP-ase will continue to function, sodium and consequently calcium will not
accumulate within the cell, the direction of the Na+Ca2+ exchanger will not
reverse, hence the total intracellular calcium concentration during ischemia will
be lower leading to lower sarcoplasmic reticulum calcium stores and less calcium
induced calcium release on reperfusion, and attenuation of the reperfusion injury
(Chapter 1).
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Kloner (1982), in open chest dogs subjected to one hour of myocardial ischemia,
observed that verapamil treatment resulted in striking preservation of the
mitochondrial ultrastructure. Verapamil has also being shown to have a
protective effect on the mitochondrial respiratory function (Clements 1978).
Ischemia followed by reflow causes marked ventricular contracture (Apstein
1977, Bush 1982, Henry 1977, Jolly 1981, Weishaar 1980). This contracture
is associated with large increases in mitochondrial calcium content (Henry
1977). Calcium antagonists protect mitochondria against calcium overload
during ischemia (Bernstein 1996, Ashraf 1984), and prevent the deterioration of
mitochondrial respiration (Boraso 1993). From the above observations it follows
that verapamil treatment may preserve mitochondrial integrity and hence
mitochondrial ATP synthesis. The balance between ATP synthesis and
degredation may be better preserved in verapamil treated hearts:
• Increased ATP synthesis due to protection of the mitochondria
against calcium overload.
• Decreased ATP requirement due to a lower myocardial
metabolism (Vo2) as seen in this study, and as shown by Nayler
(1972).
Attenuation of ischemic acidosis by calcium antagonists (Kirkels 1992,
Bernstein 1996) may also contribute to myocardial protection (Ochi 1988, Hara
1988, Ichiahra 1979). The higher pH during ischemia may be the result of
reduced anaerobic glycolysis during ischemia (Kupriyanov 1988). Catecholamine
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stimulation enhances the breakdown of glycogen (Ichiahra 1979), and has
several other detrimental effects during ischemia and reperfusion e.g.
vasoconstriction, platelet aggregation, excessive energy utilization and
arrhythmias. Calcium antagonists reduce norepinephrine stores before ischemia
(Nayler 1987, Chaudhry1984, Nayler 1988), and reduce norepinephrine release
during ischemia and reperfusion (Nayler 1984, Nayler 1987, Nayler 1985). The
calcium antagonists may therefore facilitate myocardial protection by indirectly
increasing intracellular pH during ischemia.
Several studies have demonstrated that verapamil given at the time of
reperfusion will enhance contractile function without preserving myocardial ATP
content (Przyklenk 1988, Przyklenk 1986, Neely 1984). Kusuoka (1987)
demonstrated that myocardial ATP after ischemia did not correlate with
functional recovery. These studies provide evidence that the depletion of high
energy phosphate stores alone cannot fully account for the contractile
dysfunction seen after a transient brief period of myocardial ischemia. It
therefore appears that there has to be a second positive effect of verapamil
occurring at the time of reperfusion.
Neely (1984) demonstrated that the inability of a reperfused heart to recover
mechanical function was not due solely to low levels of ATP. The two most
important factors determining the ability of reperfused hearts to recover
ventricular function were firstly, the level of extracellular calcium and secondly
the accumulation of tissue lactate during ischemia. The effect of calcium on
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ischemic damage was largely independent of residual ATP levels during
reperfusion.
There is an abundance of evidence confirming massive influx of calcium and
intracellular calcium overload upon reperfusion. Jennings (1985), Bourdillon
(1982), Shen (1972), and Nayler (1981), all demonstrated a massive and
uncontrolled influx of calcium into the cardiomyocyte upon reperfusion. Calcium
entry upon reperfusion plays a major role in the pathogenesis of myocardial
stunning (Kusuoka 1987). Mitchell (1992) showed that calcium influx occurs
during the onset of reperfusion and contributes to stunning of the heart; and
that sarcoplasmic reticulum calcium release on reperfusion also contributes to
overall calcium overload.
Kitakaze (1987) noted that a brief period of transient global ischemia
significantly elevated levels of free cvtcsetic calcium during both the final
minutes of ischemia and the initial 10 minutes of reflow. Kusoaka (1987)
showed that myocardial stunning results from the transient calcium overload
immediately after reflow and Steenbergen (1987) and Marban (1987) confirmed
that this increased cvtosolic calcium level returned to normal within a few
minutes after reperfusion.
There is also evidence for the role of calcium antagonists at the time of
reperfusion. Ashraf (1984), Nayler (1980), and Higgins (1984) found that
diltiazem decreases intracellular calcium accumulation upon reperfusion. Higgins
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and Blackburn (1984) found that nifedipine given at the time of ref low was
virtually as effective in restoring function as nifedipine given before ischemia in
the isolated working rat heart model of myocardial stunning. Przyklenk (1988),
Bush (1985), and Knabb (1986) also showed that calcium channel blockers are
protective against stunning even when given before reperfusion. Bush (1985), in
conscious dogs, showed that administration of diltiazem one hour after LAD
occlusion prevents the worsening of segmental contractile dysfunction early
after coronary reperfusion after two to four hours of LAD occlusion.
The following two facts are evident:
1. Increased intracellular calcium contributes to myocardial stunning and
ventricular fibrillation (apie 1989, Bolli 1990, Kloner 1989, Tani 1990,
Duff 1995).
2. The reperfusion injury results from changes occurring both during ischemia
and after reperfusion.
Intracellular calcium increases during ischemia due to:
• Depletion of ATP.
• Inactivity of sarcoplasmic reticulum Ca2+ ATP-ase.
• Inactivity of sarcolemmal Na+ IK + IATP-ase.
• Intracellular acidosis.
237
Stellenbosch University http://scholar.sun.ac.za
• Increased activity of Na+/H + exchanger.
• Intracellular Na+ accumulation.
• Reversal of Na +/Ca2 + exchanger.
• Increased intracellular calcium ion concentration.
These processes can be summarized in a schematic fashion:
Tani (1990)
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Ischemia
ATP depletion
Intracellular acidosis
Inactivity of SR and SL
Ca2 + ATP-ase
Inactivity of SL Na +IK + ATP-ase Intracellular accumulation of H +
Intracellular Na + overload Increased activity of
Na +IH + exchanger
Reversal of Na+ ICa2+ exchanger
SR - sarcoplasmic reticulum
SL - sarcolemma
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These changes during ischemia occur within the first 5 - 10 minutes of
ischemia due to ionic changes, therefore their contribution to injury only
occurs early during occlusion (lmai 1991, Ver Konck 1993, Silverman 1994).
Smart (1997) reported that reversal of the Na+/Ca2+ exchanger contributed to
stunning early during occlusion rather than after reperfusion. In Smart's
study, amiloride (inhibitor of Na+/Ca2+ exchanger) was only protective if
started before and administered throughout occlusion. The prevention of
stunning correlated with inhibition of Na+/Ca2 + exchange during the first 5 -
7 minutes of ischemia. Smart showed that after 7 minutes of ischemia, and
during reperfusion, inhibition of Na+/Ca2+ exchange had no beneficial effect
on stunning.
Smart's study supports findings during myocardial hypoxia. During hypoxia
as ATP is depleted, intracellular Na+ rises, leading to a reversal of Na+/Ca2 +
exchange and resulting in intracellular calcium overload. Studies confirmed
that inhibition of Na+/Ca2+ exchange reversal during hypoxia, rather than
after reoxygenation, prevents injury (Zeigelstein 1992, Haigney 1992).
The effects of calcium antagonists during ischemia can be summarized in a
schematic fashion:
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Less ATP production required
1
Calcium antagonists
1
Decrease basal metabolism ("V02) ~
during ischemia l
Less anaerobic glycolysis of glycogen
1
Less accumulation of lactate
1
Lower [H+]j during ischemia
1
Increased intracellular pH during ischemia
1
Less exchange of H+ for Na +
1
Less accumulation of intracellular Na +
L Less exchange of Na + for Ca2 +
1
Better preservation of:
Na+K+ ATP ase
Ca2+/ATPase: SR + SL
Less intracellular Ca2+ accumulation
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Intracellular calcium increases further upon reperfusion due to reactivation of
L-type calcium channels and consequent calcium release via the calcium
overloaded sarcoplasmic reticulum, before re-uptake has been restored (Tani
1990, Sperelakis 1988, Opie 1992). The sarcoplasmic reticulum accounts
for more than 90% of the calcium transient (Wier 1990, Barry 1993). The
sarcoplasmic reticulum calcium content and release is regulated by the
sarcolemmal L-type calcium channels (Barry 1993, Beukelmann 1988,
Sperelakis 1988).
Calcium channel antagonists often have no effect on post-ischemic
dysfunction when infused at or after reperfusion. However, important in this
regard are: (Smart 1997)
• The fact that inhibitors are not effective for several minutes after
administration, so infusion at reperfusion may not be effective during
the critical first few minutes of reperfusion.
• The fact that an adequate concentration of drug needs to be present
during the critical periods: Early during ischemia or at the onset of
reperfusion.
Smart (1997) argued that an intracoronary nifedipine infusion starting 2 minutes
before until 5 minutes after reperfusion (after 15 minutes of ischemia), would
attenuate the initial burst of calcium influx due to reactivation of the L-type
calcium channel on reperfusion. Consequently the sarcoplasmic reticulum
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calcium release would be attenuated. In Smart's study stunning and ventricular
fibrillation were prevented by a large dose intracoronary nifedipine infusion
started 2 minutes before reperfusion until 5 minutes after reperfusion. Smart
(1997) concluded that reactivation of myocardial L-type calcium channels at
reperfusion contributes to both myocardial stunning and ventricular fibrillation on
reperfusion, whereas increased intracellular calcium accumulation during
ischemia due to reversal of the Na+ /Ca2+ exchanger contributes only to stunning.
4.7 The effect of verapamil on reperfusion arrhythmias.
The second important component of the reperfusion injury is arrhythmia. This is
a common occurrence during the first few minutes of reperfusion, and is almost
always ventricular in origin (Becker and Ambrosio 1987).
Calcium antagonists have been shown to reduce reperfusion arrhythmias. Smart
(1997) reported that an intracoronary infusion of nifedipine from 2 minutes
before to 5 minutes after reperfusion resulted in a lower incidence of ventricular
fibrillation on reperfusion in the canine model subjected to 15 minutes of
coronary artery occlusion followed by three hours of reperfusion. Verapamil also
exerts a protective effect against ventricular fibrillation (Sherman 1981, Temesy-
Armos 1985, Brooks 1980, apie 1988). This protection may be due to an
increase of ventricular fibrillation threshold (Brooks 1980, apie 1983) and a
reduction in conduction delay (Elharrar 1977, Nakaya 1981).
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In the present study the administration of 2mg of verapamil, either from the
onset of ischemia, or from 3 minutes before reperfusion, abolished ventricular
fibrillation compared to saline infusion (Table 3.7). None of the 13 animals that
received 2mg of verapamil, developed ventricular fibrillation on reperfusion,
whereas the incidence of ventricular fibrillation in the two saline groups was
40% (6/15). The lignocaine dosage required per animal to control ventricular
dysrhythmias was 14.62mg in the verapamil groups and 54mg in the saline
groups.
Smart (1997) in his study reported an incidence of ventricular fibrillation of 50%
in control animals upon reperfusion and 38% if the intracoronary nifedipine was
administered after reperfusion. However, as in the present study, Smart
reported that pre-treatment with nifedipine (40 minutes before occlusion to 30
minutes after reperfusion) or administration of intracoronary nifedipine from 2
minutes before until 5 minutes after reperfusion, prevented reperfusion
ventricular fibrillation. Bay K 8644 is a calcium channel agonist with an effect
on calcium channels opposite to that of nifedipine. If Bay K 8644 was added to
the intracoronary nifedipine infusion in the group where nifedipine was
administered from 2 minutes before until 5 minutes after reperfusion, the
incidence of ventricular fibrillation was 63%. If Bay K 8644 was substituted for
nifedipine, the incidence of ventricular fibrillation on reperfusion was 75%. This
finding strongly suggests that the initial burst of calcium influx via the L-type
calcium channels at the onset of reperfusion mediates reperfusion ventricular
fibrillation.
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Brooks (1995) demonstrated that the initiation of ventricular
tachycardia/fibrillation upon reperfusion was immediately preceded by large
increases in the amplitude of the calcium transient. Abrupt increases in peak
cytosolic intracellular calcium concentration are clearly associated with the
initiation of reperfusion induced arrhythmias. Several other studies of beat to
beat measurements of calcium (Kihara 1989, 1991, Thandroyen 1991, Smith
1988) have shown an association between an increase in intracellular calcium
concentration and the induction of ventricular fibrillation. Intracellular calcium
overload on reperfusion induces oscillatory calcium release from the sarcoplasmic
reticulum (Opie 1988). Ryanodine (which inhibits sarcoplasmic reticulum
calcium release), decreases the incidence of ventricular fibrillation in rat hearts
on reperfusion, following regional ischemia (Thandroyen 1988).
Evidence further supporting the concept that changes in intracellular calcium
concentration are important in the induction of reperfusion ventricular fibrillation
are observations by Hirayama (1993) that verapamil significantly attenuates the
magnitude of electrical alternans in vivo, and by Kimura (1986) that verapamil
reduces the incidence of rapid ventricular activity on reperfusion .
Verapamil does not alter vulnerability to ventricular fibrillation in the non-
ischemic/reperfused heart (Brooks 1980, Huang 1977, Fondacro 1978). This
suggests that the protection afforded by verapamil is attributable to
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pathophysiological changes that occurred during ischemia and especially at the
time of reperfusion.
The importance of the role of calcium and the L-type calcium channels in the
development of reperfusion arrhythmias was demonstrated in a study of the
electrophysiologic consequences of both regional and global ischemia and
reperfusion, by Kimura (1986) in the isolated cat myocardium. They reported
the following: (Fig. 4.13).
During ischemia (30 minutes duration):
• The cell depolarizes: Resting membrane potential decreased by 21 .6%.
• The action potential amplitude decreased by 29 %.
• The action potential duration decreased by 54%.
• Ectopic activity occurred after 5 to 10 minutes (more frequent in regional
than global ischemia), but rapid ventricular activity was rare during
ischemia (17%).
On reperfusion:
• Rapid ventricular activity occurred in 83 % of cases (global and regional
ischemia), starting from 5-40 seconds after reperfusion and stopping
spontaneously after ± 2 minutes.
• All cellular electrophysiologic changes seen during ischemia returned to
baseline within 5 minutes of reperfusion.
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Figure 4.13
B
VERAPAMIL
1 mg/L
_j 50mV
~ec
_j 50 mV
1 sec
Effects of verapamil on transmembrane action potoential changes during ischemia
and rapid ventricular activity during reperfusion.
A: Transmembrane action potential changes during ischmeia and the first 20
seconds of reperfusion.
B: Transmembrane action potential changes during the second ischemia-reperfusion
Period in the presence of verapamil.
Verapamil did not have an effect on the action potential during ischemia but
prevented the reperfusion induced rapid ventricular activity.
S. Kumara J Am Call Cardiol 1986: 7: 833 - 842
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Figure 4.14
B
Ca'" FREE
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_j 50mV
J~
- U '\Ul lH I. _j 50 mV.........JlU ~\jW~ 1 sec
Effect of calcium free Tyrodé s solution on transmembrane action potential
changes during ischemia and reperfusion ventricular activity.
A: Transmembrane action potential changes during the first ischemic period
and rapid ventricular activity observed during the first 30 seconds of
reperfusion.
B: Changes in transmembrane action potential and rapid ventricular activity
during reperfusion in the presence of the calcium free solution.
Calcium free solution had similar effects as verapamil i.e. no effect during
ischemia but successfully preventing the rapid ventricular activity.
S. Kumara J Am Coli Cardiol 1986: 7: 833 - 842
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Kimura concluded that verapamil (1mg/I) did not affect the electrophysiologic
changes during ischemia, but did prevent reperfusion induced rapid ventricular
activity (a lower concentration of verapamil, 0.1 mg/I was not as effective).
Perfusion with calcium free solution just before ischemia and during reperfusion
also did not affect the electrophysiologic changes during ischemia, but did
suppress reperfusion induced rapid ventricular activity (Fig. 4.14).
The author concludes that the ventricular fibrillation seen on reperfusion is due
to rapid calcium cycling by the SR, which is triggered by calcium entry through
the L type calcium channels at the time of reperfusion.
This study demonstrates that if the L type calcium channels are blocked by
verapamil at the time of reperfusion, ventricular fibrillation does not occur.
(Table. 3.7)
Conclusion and proposed clinical application.
Verapamil is effective in attenuating the reperfusion injury by means of separate
effects, both during ischemia and at the time of reperfusion.
To gain maximum benefit from verapamil administration it is important that the
drug be present in the ischemic myocardium , in adequate concentration, both
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during early ischemia and before reperfusion, without adversely affecting
systemic hemodynamics.
During cardiac surgery there is direct access to the coronary vasculature to
exactly those areas at risk of ischemia (and hence reperfusion). This poses an
ideal scenario for the clinical application of the findings of this study. In addition,
because of the small amounts of drug delivered directly into the myocardium, it
is speculated that the effects on the systemic hemodynamics would be
negligible. In any event, if it should affect the systemic vasculature tone, it
would be a simple matter to correct this with an alpha adrenergic agonist
without affecting the loading conditions of the heart which, at that time, is
excluded from the circulation.
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